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ABSTRACT 
 
Immunomodulatory Roles of Endotoxin and Glutaraldehyde in the  
Development of Latex Allergy  
 
Michael D. Howell 
 
 
Although much data has been obtained related to the clinical manifestations of 
latex allergy and the characterization of the protein allergens, little is known regarding 
the natural history of the disease.  These studies were undertaken to demonstrate the 
immunological relevance of both dermal and respiratory exposure in the development of 
latex allergy and to investigate the role of co-exposure by these routes to other agents in 
the health care environment on the development of NRL sensitization.   
An initial study in female BALB/c mice demonstrated comparable rates of 
induction of latex specific IgE following dermal and respiratory latex exposure, 
demonstrating the importance of both routes in the development of latex allergy.  Upon 
further investigation using whole body plethysmography, non-specific airway hyper-
reactivity to methacholine was observed in mice following both dermal and intratracheal 
sensitization with latex proteins.  In contrast, at these exposure levels latex specific 
airway hyper-reactivity was only observed in dermally sensitized mice.   
Endotoxin, a common contaminant of powdered gloves, and glutaraldehyde, a 
frequently used cold sterilant, were chosen to investigate the immunomodulatory effects 
of other agents in the health care setting on the development of latex allergy. In 
comparison with mice exposed to latex alone, mice concurrently exposed to latex and 
increasing concentrations of endotoxin demonstrated ~50% lower levels of latex specific 
IgE and a decrease in latex specific airway hyper-reactivity and mucin production.  The 
same animals demonstrated increased levels of latex specific IgG2a and IgA, cellular 
infiltration (i.e. macrophages and neutrophils) into the peribronchial and perivascular 
regions of the lung, messenger IFN-γ and IL-12 levels in the draining mediastinal lymph 
nodes, and non-specific airway hyper-reactivity upon respiratory challenge with 
methacholine.  Upon concurrent dermal exposure to latex and concentrations of 
glutaraldehyde surrounding the permissible exposure limit, mice demonstrated a dose 
responsive increase in latex specific IgE levels through an as yet undetermined 
mechanism.   
These studies demonstrate the potential for mixed exposures in the health care 
environment to diversely modulate the development of IgE mediated responses to NRL 
proteins underscoring the importance of environmental factors in the development of 
allergies to foreign antigens. 
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INTRODUCTION 
 
 
 
 Despite efforts to reduce protein and allergen content in natural rubber latex 
gloves, latex allergy continues to pose a serious health risk to those occupationally 
exposed to natural rubber latex products.  Exposure to latex proteins in natural rubber 
latex products has been shown to induce an IgE mediated response (Czuppon et al., 1993) 
which upon subsequent exposure may elicit urticaria, rhinitis, or anaphylactic shock 
(Sussman et al., 1991; Tomazic et al., 1992; Alenius et al., 1994; Kagy and Blaiss, 1998; 
Kelso, 1998; Tomei et al., 2000).  While the prevalence of latex allergy among the 
general population is believed to be less than 1% (Liss and Sussman, 1999), 
approximately 5 – 17% of health care workers have been reported to have serum IgE 
specific for NRL allergens (Turjanmaa, 1987; Arellano et al., 1992; Lagier et al., 1992; 
Grzybowski et al., 1996; Liss et al., 1997; Liss and Sussman, 1999; Sinha and Harrison, 
1999).  
 
Other adverse reactions to natural rubber latex products include irritant dermatitis 
and allergic contact dermatitis.  Irritant dermatitis is the most frequently observed 
manifestation among health care workers due to occlusion and the frequent donning and 
removal of gloves (Sussman and Beezhold, 1995; Alessio et al., 1997).  Additionally, 
chemicals added to latex gloves have been shown to induce contact dermatitis 
(Turjanmaa et al., 1988; Stingeni et al., 1995; Turjanmaa, 1997) which has been 
suggested as a predisposing factor in the development of an IgE mediated 
hypersensitivity response (Turjanmaa et al., 1996). 
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The increased prevalence in latex allergy observed among health care workers has 
predominantly been associated with an increase in exposure resulting from an increase in 
glove usage in employees following the recommendations for barrier protection to 
prevent blood borne pathogen transmission (CDC, 1987; CDC, 1988; CDC, 1989).  In 
addition to increased exposure, other factors may be responsible for the increased 
prevalence of latex allergy.  Health care workers are concurrently exposed to multiple 
chemicals and/or contaminants in the health care environment in addition to latex 
products.  Endotoxin, a common contaminant in the health care environment, is a known 
B cell mitogen which has previously been shown to modulate the development of IgE 
mediated hypersensitivity responses to allergen (Danneman and Michael, 1976; 
Mizoguchi et al., 1986; Slater et al., 1998).  Studies have shown that endotoxin is a 
contaminant of latex gloves (Tomazic et al., 1994; Williams and Halsey, 1997) and, upon 
donning and removing gloves, health care workers may potentially be exposed to 
endotoxin in the glove powder (Swanson et al., 1994).   
 
Glutaraldehyde is another immunologically active chemical frequently 
encountered due to its extensive use in the sterilization of surgical instruments in medical 
facilities.  Concentrations of glutaraldehyde in sterilant solutions range between 1 – 5%, 
and have been shown to induce numerous adverse reactions such as irritation and contact 
dermatitis (Benson, 1984; Jachuck et al., 1989; Fisher, 1990; Vyas et al., 2000).  While 
the permissible exposure limit is 0.8 mg/m3 (0.2ppm), aerosolization of the sterilant 
solutions has been shown to result in an exposure of up to 2.6 mg/m3 (Gannon et al., 
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1995) which is sufficient to induce both respiratory and cutaneous irritation (Corrado et 
al., 1986; Norback, 1988).   
 
Given that studies have demonstrated the ability of other agents (i.e. diesel 
exhaust particles, proteolytically active dust mite allergen, polystyrene particles) to 
augment the development of allergen specific IgE responses (Suzuki et al., 1996; Lovik 
et al., 1997; Miyabara et al., 1998; Wang et al., 1999; Gough et al., 2001; Granum et al., 
2001; Heo et al., 2001); it was hypothesized that concurrent exposure to other agents with 
latex proteins would modulate the induction of IgE and the elicitation of symptoms 
associated with latex allergy.   
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LITERATURE REVIEW 
 
 
 
Natural Rubber Latex  
 
Numerous reviews have covered the history of natural rubber latex allergy 
(Sussman et al., 1991; Slater, 1994; Sussman and Beezhold, 1995; Germolec et al., 1999; 
Tomei et al., 2000; Toraason et al., 2000; Meade et al., 2002).  Natural rubber latex 
(NRL) is recovered from the lacticiferous cells of the Hevea brasiliensis rubber tree 
grown primarily in Southeast Asia, but also found in South America and West Africa.  
Analysis of the collected latex product has demonstrated the presence of rubber particles 
(cis-1,4-polyisoprene units), carbohydrates, lipids, and proteins (Levy et al., 1992; Jacob 
et al., 1993; Slater, 1994; Landwehr and Boguniewicz, 1996; Warshaw, 1998).  In 1993 
Czuppon demonstrated that these latex proteins induce IgE mediated hypersensitivity 
responses (Czuppon et al., 1993).  Due to the severity of the reactions associated with 
latex protein exposure, numerous studies have since focused on the identification and 
characterization of the allergenic Hevea brasiliensis proteins.  To date, eleven allergenic 
latex proteins (Hev b 1 – 11) have been identified, cloned or purified, and named by the 
International Union of Immunological Societies (Table 1) (reviewed in) (Meade et al., 
2002).   
 
Natural rubber latex is collected by tapping the Hevea brasiliensis tree and 
collecting the latex product in a container.  Immediately following collection of the latex, 
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chemicals, such as ammonia, formaldehyde or zinc oxide, are often added to prevent 
coagulation, degradation, and bacterial growth (Jacob et al., 1993).  To separate the 
rubber particle fraction from the aqueous latex serum, the latex product is centrifuged and 
concentrated to approximately 60% latex.  During product manufacturing, chemicals 
including accelerators (e.g., mercaptobenzothiazole, thiurams, and carbamates) and 
antioxidants (e.g., p-phenylenediamine) are added.  For the production of dipped latex 
products, porcelain or ceramic molds are first coated with coagulants and then immersed 
into the compounded rubber solutions, leached, vulcanized (dried in ovens), and leached 
again.  Following the final leaching step, lubricants may be added to the glove to ease 
donning and removal.  During the vulcanization process, proteins migrate to the surface 
of the latex product and therefore, upon inversion when stripped from the mold, permits 
direct skin contact with potentially allergenic latex proteins (Beezhold et al., 1994).  
Dipped latex products are available for both medical (latex gloves, intratracheal tubing, 
anesthesia masks, etc.) and commercial use (balloons, rubber bands, condoms, etc.) 
(DHHS, 1997; Kelso, 1998; Tomei et al., 2000). 
 
While natural rubber latex has been in use since the early 1500’s (Coates, 1987), 
the first reported case of an adverse reaction due to latex exposure was not until 1927 
when an allergic reaction was observed in a woman using a dental plate (Stern, 1927).  
Despite the continued exposure of individuals to latex products, another adverse reaction 
to latex was not reported until 1979 when a housewife developed contact urticaria 
following exposure to rubber gloves (Nutter, 1979).  Increased medical awareness and 
diagnosis of adverse reactions to NRL proteins resulted in an increase in the number of 
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reported cases of immediate hypersensitivity to latex products in the literature (Forstrom, 
1980; Kleinhans, 1984; Meding and Fregert, 1984; Carrillo et al., 1986; Frosch et al., 
1986; Axelsson et al., 1987; Spaner et al., 1989).  Between the years of 1988 and 1992, 
over 1,100 cases of allergic responses and 15 cases of anaphylactic related deaths due to 
latex exposure were reported to the Food and Drug Administration (Slater, 1994).  This 
trend continued from 1992 – 1997 as an additional 1,200 allergic responses and 13 
anaphylactic related deaths were reported in 1998 by Dr. Gawchik at the National Latex 
Allergy Conference in San Antonio, TX (Gawchik, 1998). 
 
Several factors may be responsible for the dramatic increase in the number of 
reported cases of latex allergy.  In the late 1980’s the Center for Disease Control and 
Prevention issued a set of “Universal Precautions” recommending the use of latex gloves 
as a protective barrier in the handling of bloodborne pathogens (CDC, 1987; CDC, 1988; 
CDC, 1989).  These recommendations stimulated an increase in glove usage among 
health care workers, as well as individuals employed in non-health care occupations.  To 
address the increased usage, there was an increase in the worldwide manufacturing of 
latex gloves as well as a rise in the importation of latex gloves into the US from less than 
1 billion gloves a year in the late 1980’s to approximately 11 billion gloves a year in 
1992 (Warshaw, 1998), followed by a rise to approximately 20 billion gloves a year in 
1996 (DHHS, 1999).  Other additional factors have been proposed to account for the 
drastic increase in the number of reported allergic responses to latex proteins.  Due to the 
increased demand for barrier protection, numerous new latex manufacturers entered the 
industry, each attempting to keep up with product demand by altering the manufacturing 
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process (i.e. decreased washes, removal of final leaching step, etc.) for increased 
turnaround.  A recent study demonstrated that removal of the final leaching step from the 
manufacturing process resulted in higher levels of protein and allergen when compared to 
another glove of the same brand that underwent the whole process (Brehler et al., 2002).   
  
Adverse reactions to natural rubber latex products can manifest themselves 
clinically as irritant dermatitis, allergic contact dermatitis (delayed type hypersensitivity 
[DTH], T cell mediated hypersensitivity), and, most importantly, immediate type 
hypersensitivity (IgE mediated hypersensitivity) (Kelso, 1998; McCracken, 1999).  
Irritant dermatitis is characterized by dry, cracked skin that is often attributable to 
chemical additives in the latex products or friction associated with latex glove usage 
(Sussman and Beezhold, 1995; Alessio et al., 1997).  Allergic contact dermatitis to latex 
products is characterized by erythema and edema, cracked or blistered skin, and 
sometimes thickening of the skin (Charous et al., 1994; Stingeni et al., 1995; Tomei et 
al., 2000).  T cell mediated dermatological responses are thought to be predominantly 
generated against the rubber additives (i.e. thiuram mix, carbamates, phenylene diamine, 
mercapto compounds) (Cohen et al., 1998; Tomei et al., 2000).  Several cases have 
described the development of contact hypersensitivity reactions following exposure to 
latex products.  In 1993, Conde-Salazar et al. reported positive patch tests to at least one 
rubber additive in greater than 14% of 4360 hospital patients from non-medical 
occupations (Conde-Salazar et al., 1993).  Recently, Nettis et al. demonstrated a positive 
patch test response to rubber related chemicals in 31 out of 295 health care workers with 
contact dermatitis (10.5%) (Nettis et al., 2002).  While it is the least frequently observed 
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adverse reaction, IgE mediated hypersensitivity comprises the most severe 
immunological response following latex exposure.  An IgE mediated hypersensitivity 
response to latex products can occur within minutes of exposure in a sensitized individual 
and can manifest itself as urticaria, rhinitis, asthma, or potentially fatal anaphylaxis 
(Sussman et al., 1991; Tomazic et al., 1992; Alenius et al., 1994; Kagy and Blaiss, 1998; 
Kelso, 1998; Tomei et al., 2000). 
 
Due to the frequent use of natural rubber latex (NRL) gloves by health care 
workers in medical facilities, primary concern has been given to the dermal and 
inhalation routes of exposure (Kujala and Reijula, 1995; Phillips et al., 1999; Zak et al., 
2000). During the manufacturing of latex gloves, lubricating powders (i.e. corn starch, 
dextran) are often added in an effort to ease the donning and removal process.  These 
powders have been shown to bind to latex proteins and therefore permit the 
aerosolization of latex proteins (Jaeger et al., 1992; Tomazic et al., 1994; Vandenplas, 
1995; Crippa and Pasolini, 1997; Edelstam et al., 2002).  The frequent donning and 
removal of powdered latex gloves creates an environment rich with respirable latex 
proteins within the health care setting.  Several studies have demonstrated elevated levels 
of latex aeroallergen in medical facilities.  Swanson et al. (Swanson et al., 1994) 
demonstrated airborne latex protein concentrations of up to 1000 ng/m3 in areas of high 
powdered glove usage.  A year later Baur et al. (Baur et al., 1995) found levels of latex 
aeroallergen as high as 205 ng/m3 in non-ventilated hospital rooms where powdered latex 
gloves were used.  Elevated latex specific antibody levels were observed in individuals 
employed in rooms with latex aeroallergen levels as low as 0.6 ng/m3 (Baur et al., 1998).  
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In addition to serving as a carrier molecule for latex proteins, corn starch may serve as a 
source of nutrients facilitating the growth of bacteria in powder slurries.  Studies have 
demonstrated significant levels of endotoxin in powdered surgical and exam gloves 
(Peiro, 1990; Williams and Halsey, 1997).  Endotoxin may stimulate an early 
inflammatory reaction that modulates the development of immunological responses 
(Danneman and Michael, 1976; Mizoguchi et al., 1986), including IgE responses to latex 
proteins (Slater et al., 1998).   
 
Several case studies have also demonstrated the potential for the development of 
IgE mediated hypersensitivity responses (i.e. urticaria) following dermal exposure to 
latex proteins (Forstrom, 1980; Meding and Fregert, 1984; Carrillo et al., 1986; 
Turjanmaa et al., 1988; Turjanmaa, 1997).  Latex gloves have been shown to contain as 
much as 181.1 µg of protein per gram of glove (Beezhold et al., 1996; Howell et al., 
2002b). Using a fingerprint assay, Beezhold et al. (Beezhold et al., 1994) demonstrated a 
significant transfer of proteins from latex gloves to the skin.  Hamilton and Adkinson 
confirmed the elicitation of an allergic cutaneous reaction to latex proteins by dermally 
exposing an individual wearing eye protection and a non-latex respirator (Hamilton and 
Adkinson, 1996).  Recent studies have also demonstrated that latex proteins can penetrate 
through intact and abraded skin and may potentially enter the systemic circulation (Hayes 
et al., 2000) resulting in the induction of an IgE mediated hypersensitivity response.   
 
Two populations at higher risk of developing latex allergy have been identified.  It 
is currently estimated that the prevalence of latex allergy among the general public is less 
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than 1% (Turjanmaa, 1987; Liss and Sussman, 1999), while the reported prevalence 
among health care workers (physicians, nurses, dentists, etc.) and children undergoing 
multiple surgeries (i.e. spina bifida patients) ranges between 5 – 17% and  25 – 70%, 
respectively (Grzybowski et al., 1996; Liss et al., 1997; Cremer et al., 1998; Sussman et 
al., 1998; Kattan et al., 1999; Liss and Sussman, 1999; Sinha and Harrison, 1999; 
Galobardes et al., 2001; Garabrant et al., 2001).  The increased prevalence among health 
care workers is predominantly attributed to the increased inhalation and dermal exposure 
due to the frequent use of latex gloves (Kujala and Reijula, 1995; Phillips et al., 1999; 
Zak et al., 2000).  In contrast, children undergoing multiple surgeries are additionally 
exposed to latex proteins through mucosal and direct tissue contact with natural rubber 
latex products (i.e. gloves, medical devices) (Chen et al., 1997; Szepfalusi et al., 1999; 
Buck et al., 2000). 
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Table 1.  Major Allergens of Natural Rubber Latex 
 
Nomenclature 
 
Protein Identification 
 
Approximate Size (kD) 
Hev b 1 Rubber elongation factor 14.6 
Hev b 2 β-1,3-glucanase 35 
Hev b 3 Rubber particle protein 22-27 
Hev b 4 Microhelix protein 100 
Hev b 5 Acidic protein 16 
Hev b 6.01 Prohevein 20 
Hev b 6.02 Hevein 4.7 
Hev b 6.03 Prohevein 14 
Hev b 7 Patatin-like protein 43-46 
Hev b 8 Profiling 14 
Hev b 9 Enolase protein 47.6 
Hev b 10 Manganese superoxide  
dismutase like protein 
26 
Hev b 11 Chitinase 33 
    Data reviewed in Meade et al. (Meade et al., 2002). 
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Overview of the IgE Mediated Allergic Response 
 
 IgE mediated hypersensitivity responses are comprised of two immunological 
phases: the induction or sensitization phase and the elicitation phase (Galli and Lantz, 
1999).  The events within these two phases are summarized briefly in the following 
paragraphs and in Figure 1.   
 
Upon initial exposure, antigen presenting cells (APC; i.e. Langerhans cells, 
macrophages, dendritic cells) take up allergen into a phagolysosome where the allergen is 
then degraded into peptide fragments due to a drop in the pH.  Upon fusion with another 
lysosome containing preformed major histocompatibility complex (MHC) class II 
molecules, allergenic peptide fragments bind to the variable cleft region of the MHC 
class II molecule.  During this process the APC migrates from the exposed tissue to the T 
cell rich regions of the local, draining lymph node.  Once in the T cell region of the 
draining lymph node the MHC class II molecule expressing antigenic peptide is escorted 
to the surface of the APC and presented to CD4+ T helper cells.  The antigen presenting 
process is initiated when the MHC class II:peptide complex on the APC is recognized by 
the T cell receptor (TCR) on CD4+ T cells.  T cell activation and proliferation is induced 
during the antigen presentation process by the interaction between the co-stimulatory 
molecules CD86 (B7.2) on the APC and CD28 on the T cell.  T cells release IL-2 and up-
regulate their expression of CD25 (IL-2Rα) to facilitate activation. During the activation 
process, APC and T cells release cytokines which aid in the differentiation of CD4+ T 
cells into either Th1 or Th2 subsets.  In the event of a Th2 response, T cells up-regulate 
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the expression of CD40 ligand and migrate to the B cell rich areas of the draining lymph 
node.   Cytokines important in the development of a humoral response (IL-4, IL-5, IL-6, 
IL-10 and IL-13) are secreted by Th2 cells while Th1 cells produce IFN-(, IL-12 and 
TGF-β that play a role in the development of cell-mediated responses.  Although these 
cytokine profiles have been well characterized; the initial signals triggering the 
differentiation into the specific CD4+ T cell subsets are not completely understood.  It 
has been hypothesized that early sources of IL-4 are required for the induction of an IgE 
mediated allergic response, and while several possible sources have been suggested 
(NK1.1+CD4+ cells, naive CD4+ cells, mast cells, basophils and eosinophils), the source 
of this “Early IL-4” remains unclear (Galli and Lantz, 1999; Haas et al., 1999). 
  
The induction of an IgE mediated allergic response also requires the direct 
involvement of B lymphocytes.  B cells bind to and internalize allergen through the B cell 
receptor.  Upon internalization, the antigen is processed and presented to activated Th2 
cells via MHC class II molecules.  Upon recognition of the MHC class II molecule by the 
T cell receptor (TCR), activated T cells provide two costimulatory signals important for 
the development of IgE antibodies: 1) secretion of IL-4 and IL-13, and 2) expression of 
CD40 ligand to maintain the required physical interaction with B cells via CD40 (Hermes 
et al., 1997; Jeppson et al., 1998).  These signals initiate the proliferation of B cells and 
differentiation into antibody secreting plasma cells. 
  
Following secretion from plasma cells, IgE antibodies enter the systemic 
circulation and bind to a variety of cells expressing the high and low affinity IgE 
 
 
14
receptors, Fc,RI and Fc,RII (CD23), respectively.  Fc,RI receptors are important in the 
activation of the signal transduction cascade leading to the release of preformed 
mediators.  While they have been shown to be expressed at high levels on mast cells and 
basophils, low levels of Fc,RI expression have been observed on human Langerhans’ 
cells and eosinophils.  Studies have demonstrated a larger role for Fc,RII/CD23 in the 
regulation of IgE synthesis as mice deficient in CD23 exhibit increased levels of serum 
IgE in comparison with wild type mice following allergen exposure (Dasic et al., 1999; 
Riffo-Vasquez et al., 2000).   While studies have evaluated the role of CD23 in IgE 
regulation, the mechanism remains unclear as contradicting roles have been suggested.  
Whereas one study demonstrated a down regulation of IgE production by soluble CD23 
inhibiting the interaction between IgE and Fc,RI (Kelly et al., 1998), another study 
suggested an additional B cell activation mechanism through the interaction of soluble 
CD23 and CD21 (Payet and Conrad, 1999). 
 
Upon subsequent allergen exposure, IgE antibodies bound to Fc,RI on mast cells 
and basophils are cross-linked, activating tyrosine kinases and thereby initiating an 
intracellular signaling cascade.  Phosphorylation events result in the activation of 
phospholipase C which enzymatically cleaves phosphotidylinositol 4,5-bisphophate into 
diacylglycerol and inositol 1,4,5-triphosphate.  These both activate protein kinase C 
(PKC), triggering the release of calcium from the endoplasmic reticulum.  Upon the 
interaction between PKC and calcium, preformed secretory granules are exocytosed and 
their contents (i.e. histamine, proteases) released.  The release of these preformed 
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mediators initiates a local immediate allergic response by inducing vasodilation, smooth 
muscle contraction, and vascular permeability. 
 
In addition to an immediate allergic response, a late phase allergic response can 
occur up to 24 hours following allergen exposure.  The late phase response is 
characterized by the secretion of prostaglandins, leukotrienes and cytokines.  Increased 
intracellular calcium levels, due to cleavage of phosphotidylinositol 4,5-bisphosphate and 
release of calcium from the endoplasmic reticulum, activate phospholipase A2 to cleave 
phosphytidylcholine and initiate the arachidonic acid pathway.  Prostaglandins and 
leukotrienes are mediators involved in the late phase allergic response that are 
synthesized from arachidonic acid via the cyclooxygenase-2 and lipoxygenase pathways, 
respectively.  Additionally, cytokine message and protein secretion are upregulated 
through the Ras/MAP kinase pathway and contribute to the development of a late phase 
allergic response (Galli and Lantz, 1999).   
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Figure 1.  Overview of the IgE Mediated Allergic Response 
 
 
 
 
 
Modified from figure in Galli and Lantz (Galli and Lantz, 1999). 
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The “Skin Immune System”  
 
 
The skin is the largest bodily organ and is comprised of 3 separate layers: the 
epidermis, the dermis, and the subcutaneous tissue (Figure 2).  Each of these layers is 
distinct in its composition and cellular makeup.  The subcutaneous layer of the skin is 
composed of adipose tissue while the dermis is comprised of connective tissue and an 
extracellular matrix of collagen and elastin.  The microvasculature, which supplies the 
epidermis with blood and nutrients, as well as connective tissue mast cells and 
macrophages are located within the dermis (Elmets et al., 1994). 
 
The epidermis is an immunologically rich layer of skin comprised largely of 
keratinocytes (greater than 90% of cells), as well as melanocytes, Langerhans’ cells, and 
Merkel cells.  It is within the epidermis that basal keratinocytes morphometrically 
differentiate into anucleate cells and form the stratum corneum.  Skin pigmentation is 
provided by the melanocyte-produced melanin.  Merkel cells are neuroendocrine cells 
thought to function as mechanoreceptors for tactile responses.  Langerhans cells are bone 
marrow derived antigen presenting cells that serve to endocytose antigen for processing 
and presentation to T cells in the draining lymph node (Bos and Kapsenberg, 1993; 
Elmets et al., 1994). 
 
In the early 1990’s the term “skin immune system” was coined in reference to the 
number of immunological components identified within the skin.  These components are 
described by Bos and Kapsenberg, each playing a role in the first line of defense to 
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foreign particles and the development of hypersensitivity responses (Bos and 
Kapsenberg, 1993).  Upon antigenic exposure, keratinocytes within the epidermis have 
been shown to produce IL-1β and TNF-α, thereby inducing the mobilization and 
migration of the Langerhans’ cells into the draining lymph nodes (reviewed in 
Cumberbatch et al., 2000).  Additionally, GM-CSF secreted by keratinocytes stimulates 
the maturation of Langerhans’ cells which subsequently allows for increased antigen 
processing and presentation to T cells in the draining lymph node (Burnham et al., 2000).  
The interaction between antigen presenting cells and T cell in the draining lymph node 
initiates the activation of T cells and subsequent secretion of cytokines which drives the 
proliferation and differentiation of the T cells towards either a Th1 or Th2 phenotype.  In 
the case of a cell-mediated hypersensitivity response, activated T cells migrate to the skin 
under the direction of chemokines and adhesion molecules to contribute to the 
hypersensitivity response (Akdis et al., 1997; Akdis et al., 1999).  In IgE mediated 
allergic responses, T cells interact with B cells resulting in the activation of B cells and 
subsequent differentiation and clonal expansion into IgE secreting plasma cells.  
Circulating IgE, secreted by the plasma cells, binds to the high affinity FcεRI expressed 
on mast cells and basophils and, upon subsequent exposure and cross-linking of antibody, 
release mediators that initiate cutaneous allergic responses (Elmets et al., 1994). 
  
Until recently, the prevailing hypothesis in allergic responses has been that 
cutaneous exposure to allergens and xenobiotics results in skin reactions while inhalation 
exposure leads to respiratory responses.  Numerous studies have been reported in which 
animals were cutaneously sensitized to low molecular weight chemicals and upon 
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respiratory challenge, demonstrated increased airway hyper-reactivity.  Guinea pig 
models have been used to demonstrate the development of bronchoconstriction following 
cutaneous exposure to trimellitic anhydride (TMA) (Hayes et al., 1992), 
diphenylmethane-4,4’-diisocyanate (MDI) (Pauluhn and Mohr, 1994; Rattray et al., 
1994), or 3 – carene (Lastbom et al., 2000).  Using a murine model, Arts et al. (Arts et 
al., 1998) and Cui et al. (Cui et al., 1997) demonstrated that cutaneous exposure to TMA 
induces elevated serum IgE levels and bronchoconstriction upon subsequent chemical 
respiratory challenge.  Additionally, similar responses have been observed in mice 
dermally exposed to proteins.   Spergel et al. (Spergel et al., 1998) observed elevated 
serum OVA specific serum IgE levels in mice epicutaneously sensitized and increased 
non-specific airway hyper-reactivity upon subsequent methacholine challenge.  Similarly, 
Woolhiser et al. (Woolhiser et al., 2000) demonstrated that dermal application of latex 
proteins induces elevated total serum IgE levels and, upon subsequent latex specific 
respiratory challenge, bronchoconstriction. These studies indicate the importance of the 
skin immune system in the development of IgE mediated allergic responses.   
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Figure 2.  Illustration of the Different Layers of the Skin  
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Glutaraldehyde   
  
 Glutaraldehyde (1,5-pentanedial) is a low molecular weight chemical that was 
first synthesized in 1908 by Harries and Tank (Harries and Tank, 1908).  Synthesized 
from glutaric acid, glutaraldehyde is a five-carbon aldehyde with a molecular weight of 
100.13.  The two-aldehyde groups have been shown to be readily reactive with proteins 
(Bowes and Cater, 1968; Hopwood et al., 1970).  In 1968, Richards & Knowles 
(Richards and Knowles, 1968) demonstrated the presence of α, β unsaturated aldehydes 
that were highly capable of cross-linking. In its purest form, glutaraldehyde emits a single 
peak at 280 nm, however changes in temperature and pH can induce conformational 
changes that result in the addition or reduction of free aldehyde groups (Gorman and 
Scott, 1980).  These changes have been shown to drastically affect the fungicidal and 
bacteriocidal activity of glutaraldehyde (Beauchamp et al., 1992).  It has also been shown 
that storage of alkaline solutions of glutaraldehyde for extended periods of time will 
result in a decrease in bactericidal activity and overall glutaraldehyde concentration 
(Gorman and Scott, 1980). 
  
 Glutaraldehyde is used in many occupational settings as a leather-tanning agent, 
tissue fixative for electron microscopy, medical treatment for warts, cold sterilant for 
surgical equipment, as well as its commercial use in many cosmetic products.  While 
numerous occupations have employed the use of glutaraldehyde, it is extensively used in 
the health care setting due to the increasing concern over exposure to pathogens such as 
human immunodeficiency virus and hepatitis (Fowler, 1989).  The ability of 
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glutaraldehyde to cross-link proteins is the mechanism behind its use as a biocide, 
tanning agent and tissue fixative.   
  
 While most commercial preparations of glutaraldehyde range in concentration 
from 1 – 50%, exposures to glutaraldehyde exist on two different spectrums. Alkaline 
sterilization solutions are typically comprised of approximately 2% glutaraldehyde.  
Lower levels of glutaraldehyde are observed in the ambient air of sterilization rooms 
where concentrations of glutaraldehyde are measured in parts per million (ppm).  
Exposure at both high (sterilant concentrations) and low levels (aerosol concentrations) 
have been shown to induce adverse effects on the eyes, throat, and nasal passages 
(Norback, 1988; Burge, 1989; Abbott, 1995; Gannon et al., 1995).  Due to the irritant 
nature of this chemical, the Occupational Safety and Health Administration (OSHA) and 
the American Conference for Government Industrial Hygienists (ACGIH) have suggested 
personal exposure limits (PEL) and relative exposure limits (REL) of 0.2 ppm and 0.05 
ppm, respectively, but these have not been established as federal standards (Weinert, 
1996).  The development of both contact and IgE-mediated hypersensitivity reactions has 
been documented at concentrations lower than those suggested by OSHA (Norback, 
1988; Jachuck et al., 1989; Leinster et al., 1993; Gannon et al., 1995; Pisaniello et al., 
1997).   
  
 Health care workers comprise the population with the highest reported prevalence 
of hypersensitivity to glutaraldehyde.  Glutaraldehyde is extensively used to disinfect 
endoscopes, bronchoscopes, and surgical instruments, resulting in increased exposure for 
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individuals employed in areas where these instruments are sterilized.  Numerous case 
reports have described the development of adverse reactions to glutaraldehyde.  In 1994 a 
study of health care workers in an Italian hospital demonstrated that 1 out of 14 
employees had either irritant or allergic contact dermatitis due to glutaraldehyde exposure 
(Stingeni et al., 1995).  Glutaraldehyde exposure was also found to be responsible for the 
development of hand dermatitis in 13 health care workers in a Toronto medical facility 
(Nethercott et al., 1988).  Allergic contact dermatitis has been identified in numerous 
endoscopy workers exposed to glutaraldehyde sterilization solutions (Goncalo et al., 
1984; Fisher, 1990).  A study of 348 current and 18 ex-nurses from 59 endoscopy units in 
the United Kingdom demonstrated that approximately 44% of workers experience 
glutaraldehyde-related contact dermatitis (Vyas et al., 2000).  Another study investigating 
glutaraldehyde exposure in an endoscopy unit at Newcastle General Hospital in the 
United Kingdom revealed that 8 of the 9 staff members tested complained of symptoms 
(dermatitis, rhinitis, shortness of breath) associated with glutaraldehyde exposure 
(Jachuck et al., 1989).  In addition to occupational exposures, exposure to glutaraldehyde 
in commercially available products (i.e. hair conditioner) and medical treatments has 
been shown to induce contact hypersensitivity (Jaworsky et al., 1987; Martin et al., 
1997). 
  
 While glutaraldehyde exposure has been shown to induce dermatitis, several cases 
have arisen implicating glutaraldehyde exposure in the development of occupational 
asthma.  The breathing rates of a nurse employed in an endoscopy unit were monitored 
over a period of two weeks following complaints of shortness of breath.  Pulmonary 
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reactivity was monitored while using a glutaraldehyde solution for a week and another 
detergent solution (Dettox) for the second week.  Upon evaluation, it was determined that 
she had developed occupational asthma to glutaraldehyde (Benson, 1984).  Another study 
of the employees in 19 endoscopy and x-ray departments demonstrated a decrease in the 
forced expiratory volume of 7 out of 8 subjects tested for airway hyper-reactivity at 2 
hour increments throughout the period of a normal day.  Upon further evaluation, levels 
of glutaraldehyde within the endoscopy unit were determined to be 0.94 mg/m3, well 
above the permissible exposure limit (Gannon et al., 1995). 
 
 A majority of individuals working with glutaraldehyde solutions utilize natural 
rubber latex gloves as protection from the deleterious effects of glutaraldehyde (Jordan et 
al., 1996).  While latex gloves have been shown to be effective in reducing the potential 
for adverse chemical exposure, several studies have demonstrated that latex gloves were 
less effective than other glove materials in preventing glutaraldehyde penetration 
(Mellstrom et al., 1992; Lehman et al., 1994; Jordan et al., 1996).  Using diffusion cells 
and a 3H-water barrier integrity test, glutaraldehyde solutions were shown to induce 
greater levels of permeability in latex gloves when compared with tactylon gloves 
(Lehman et al., 1994).  Another study on 3 different glove materials (latex, vinyl, and 
polyethylene) demonstrated greater barrier protection from glutaraldehyde by vinyl and 
polyethylene gloves (Mellstrom et al., 1992).  It was shown by Jordan et al. that solutions 
containing 2% and 50% glutaraldehyde penetrate through latex gloves in less than 1 hour 
(Jordan et al., 1996).  The ineffective barrier protection of latex gloves against 
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glutaraldehyde penetration allows for concurrent exposure to latex proteins and 
glutaraldehyde solutions.   
 
 Several studies have demonstrated the potential in health care workers for dual 
sensitization to glutaraldehyde and latex proteins.  A study in Australia of 336 nurses and 
18 ex-nurses demonstrated 44% skin prick test reactivity to glutaraldehyde and 6% skin 
prick reactivity to latex proteins.  Upon further serological analysis, it was determined 
that 4.1% sero-recognized latex proteins (Vyas et al., 2000).  In another study evaluating 
44 latex allergic health care workers, nine (20.1%) also patch tested positively for 
glutaraldehyde (Taylor and Praditsuwan, 1996).     
 
 Animal studies have been conducted to investigate the effects of glutaraldehyde in 
the development of T cell mediated and IgE mediated hypersensitivity responses.  Using 
the murine local lymph node assay (LLNA), it has been shown that concentrations of 
glutaraldehyde as low as 0.006 M induce significant elevations (threefold increase over 
controls) in cellular proliferation (Hilton et al., 1998).  Further analysis of the interleukin 
(IL)-4, IL-10, and interferon (IFN)-γ levels in the draining lymph node cells from mice 
treated with solutions containing greater than 1% glutaraldehyde, revealed a Th2-like 
cytokine profile indicative of an IgE mediated hypersensitivity response (Dearman et al., 
1999).  B6C3F1 mice and Hartley guinea pigs demonstrated a dose dependent cell 
mediated hypersensitivity response upon induction with 0.3, 1, and 3% glutaraldehyde 
solutions and subsequent challenge with a 10% glutaraldehyde solution (Stern et al., 
1989). Additionally, inhalation studies have demonstrated that concentrations of 
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glutaraldehyde as low as 0.3 ppb induce lesions and metaplasia in the upper respiratory 
tract of exposed mice (Gross et al., 1994; Zissu et al., 1994; Zissu et al., 1998).   
 
Endotoxin  
 
Lipopolysaccharide (LPS), or endotoxin, is a cell wall component of gram-
negative bacteria that can be found ubiquitously as a contaminant in the environment 
(Becker et al., 1996) and house dust (Michel et al., 1991; Michel et al., 1996).  Numerous 
reviews have been written describing the history, composition, and activities of endotoxin 
(Morrison and Ryan, 1979; Morrison and Ryan, 1987; Burrell, 1990; Doran, 1992; 
Rietschel et al., 1994; Rietschel et al., 1996).  Bacterial endotoxins were first identified in 
the by Pfeiffer in the late 19th century; however, the components of endotoxin were not 
identified until the early 20th century when it was determined that the active portion of 
endotoxin was comprised of lipids, polysaccharides and protein, resulting in the term 
lipopolysaccharide (LPS) (Boivin and Mesrobeanu, 1935).  Several reviews further 
describe the components of LPS in three major regions: O-specific antigens, core 
polysaccharides, and lipid A (reviewed in (Morrison and Ryan, 1979; Doran, 1992; 
Rietschel et al., 1996)).  O-antigens are chains of monosaccharides that are unique to 
each bacterial strain.  The core polysaccharides are separated into inner and outer core 
regions.  The outer core polysaccharides are composed of D-glucose, D-galactose, and N-
acetyl-D-glucosamine while the inner core is composed of 2-keto-3-deoxyoctonic acid 
and heptose.  Lipid A is the most conserved portion of the LPS and has been shown to 
consist of a phosphorylated glucosamine-disaccharide backbone attached to chains of 
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fatty acids.  Early demonstrations that the lipid A portion of endotoxin was able to induce 
inflammation (Galanos et al., 1984; Kotani et al., 1984) led to an influx of lipid A related 
research (Kiener et al., 1988; Henricson et al., 1990; Mattern et al., 1994; Salkowski et 
al., 1997).     
 
The immunomodulatory effects of endotoxin have been investigated for decades 
with volumes of literature available on the subject.  Numerous studies have described B 
cell mitogenic activity upon exposure, or the addition of LPS, to in vivo and in vitro 
systems (Melchers et al., 1975; Wetzel and Kettman, 1981; Bessler et al., 1985).  A 
report by Peavy et al. (Peavy et al., 1970) in 1970 demonstrated the ability of Salmonella 
endotoxin to stimulate the proliferation of murine splenocytes. Additionally, lymphocytes 
isolated from CBA/J and C3H/HeJ (endotoxin resistant) mice were later shown to 
proliferate in the presence of endotoxin (Sultzer and Goodman, 1976).  Other studies 
have also demonstrated the ability of endotoxin to induce proliferation of T cells (Milner 
et al., 1983; Vogel et al., 1983; Mattern et al., 1994).  In 1973, Andersson et al. 
(Andersson et al., 1973) compared the mitogenic activity of several smooth and rough 
LPS mutants and determined that the mitogenic activity of LPS was contained within the 
lipid A portion.   
 
Lipopolysaccharide exposure has been shown to induce the production of 
numerous cytokines (Luheshi and Rothwell, 1996).  Increased levels of IFN-γ and the 
pro-inflammatory cytokines IL-1 and TNF-α have been identified in the supernatants 
following LPS addition to lymphoid cell cultures (Friedman et al., 1987) and in the serum 
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following intravenous injection in mice (Kiener et al., 1988).  Upon interacting with 
alveolar macrophages in the lung, endotoxin binds to CD14 and lipopolysaccharide 
binding protein (LBP) stimulating the activation of macrophages and inducing cytokine 
production (TNF, IL-1, IL-6, IL-8)  (Ulevitch and Tobias, 1995; Tobias et al., 1999).  A 
study by Salkowski et al. (Salkowski et al., 1997) demonstrated elevated levels of the 
Th1 cytokines, IL-12 and IFN-γ, in murine macrophages and lymphocytes upon exposure 
to LPS.   
 
Slurries of dextran used to powder latex gloves have been shown to serve as rich 
media sources for the growth of gram-negative bacteria and several reports have 
demonstrated endotoxin contamination in natural rubber latex gloves.  In 1990, the levels 
of endotoxin in powdered surgical gloves were determined to be sufficient to induce 
fever in an exposed individual (Peiro, 1990).  In 1997, a study by Williams and Halsey 
demonstrated levels of endotoxin ranging from 0.09 ng/g to greater than 2800 ng/g of 
glove material (Williams and Halsey, 1997).   
 
Lubricating powders carrying latex proteins and endotoxin may potentially 
expose health care workers via inhalation.  Inhalation of endotoxin has been shown to 
initiate immunological activity in the lungs resulting, in some cases, in the development 
of respiratory complications.  In 1985, Lantz et al. (Lantz et al., 1985) demonstrated a 
decrease in lung volume and an increase in endothelial vesicles upon inhalation exposure 
to LPS in hamsters.  Ginanni et al. (Ginanni et al., 1991) demonstrated several years 
later, that inhalation of LPS induced non-specific bronchoconstriction in both non-atopic 
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and atopic patients.  In 1995, a study of fiberglass manufacturing employees 
demonstrated the development of flu-like symptoms and asthma in individuals exposed to 
high concentrations of endotoxin in a washwater mist (Milton et al., 1995).   
 
 
Several immunological factors are thought to contribute to the morphological 
changes and the development of non-specific bronchoconstriction observed following 
endotoxin inhalation.  In 1987, Rylander and Beijer (Rylander and Beijer, 1987) exposed 
guinea pigs to endotoxin via inhalation and observed an increase in the production of 
platelet activating factor.  Platelet activating factor is a potent inducer of inflammation 
and bronchoconstriction, as well as a chemotactic factor for neutrophil migration.  
Yanagihara et al. (Yanagihara et al., 2001) demonstrated that a single intratracheal 
instillation of endotoxin in mice induced increased mucous production and neutrophil 
recruitment.  Similar observations were reported in mice receiving intratracheal 
instillations of endotoxin, twice weekly for 12 weeks (Vernooy et al., 2002).  Mucous 
production has been shown to be associated with increased non-specific airway hyper-
reactivity (Walter et al., 2001).   
 
Several studies have suggested that endotoxin may serve as an adjuvant in the 
development of an IgE mediated hypersensitivity response.  It has previously been shown 
that pre-exposure of mice to airborne endotoxin will augment the development of an 
OVA specific serum IgE response (Wan et al., 2000).  Slater et al. (Slater et al., 1998) 
demonstrated augmented allergen specific IgE levels in mice intranasally exposed to LPS 
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and Hev b 5.  In 1986, Mizoguchi et al. (Mizoguchi et al., 1986) exposed mice via 
inhalation to 50 mg of OVA with or without 1 mg of LPS for up to 10 weeks.  Mice 
concurrently exposed to OVA and LPS demonstrated significant elevations in OVA 
specific serum IgE levels.  Using a different exposure regimen, it was recently reported 
that mice systemically exposed to endotoxin prior to OVA sensitization demonstrate 
suppressed OVA specific serum IgE levels but increased non-specific airway hyper-
reactivity (Gerhold et al., 2002). 
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MATERIALS AND METHODS 
 
Animals 
 
 Mice. Female BALB/c mice were purchased from Harlan Sprague Dawley, Inc. 
(Indianapolis, IN) or Taconic Farms (Germantown, NY) and were received between 6-12 
weeks of age.   Upon their arrival, mice were maintained under conditions specified 
within NIH guidelines (NRC, 1996) and quarantined for at least one-week prior to use.  
Mice were housed in polycarbonate “shoebox” cages with hardwood bedding and 
provided tap water and Agway Prolab Animal Diet (5% fat) ad libitum.  Animal rooms 
were maintained between 18-26°C and 20-70% relative humidity with light/dark cycles 
of 12-hour intervals. To prevent latex contamination, nitrile gloves were worn while 
handling mice during study procedures.   
  
Guinea Pigs. Male hairless guinea pigs (CrL: IAF/HA (hr/hr)) were obtained from 
a previously established breeding colony at the West Virginia University animal facility.  
To establish the breeding colony, 6 male and 6 female hairless guinea pigs were 
purchased from Charles River Laboratories, Inc. (Wilmington, MA), paired randomly and 
housed in large polycarbonate cages in an environment regulated at approximately 25°C 
and 60% relative humidity.  Three weeks following birth, pups were removed from the 
parents and litters were placed in polycarbonate cages until they attained sexual maturity, 
at which time they were separated by sex and paired for use in breeding.  Guinea pigs 
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between the ages of 4 – 12 months were used in penetration studies. All guinea pigs were 
provided TekLab Guinea Pig Chow (Harlan, Indianapolis, IN) and water ad libitum.      
 
Rabbits.  New Zealand white rabbits were purchased from Harlan Sprague 
Dawley (Oxford, MI). All rabbits were housed under specific pathogen-free conditions at 
the West Virginia University in an environment regulated at approximately 25°C and 
60% relative humidity.  All rabbits were provided Rabbit Chow (Harlan, Indianapolis, 
IN) and water ad libitum and were used for antibody production when they reached 
approximately 6 to 8 kilograms. 
 
 
Test Articles 
 
 
 Glutaraldehyde (Cas No. 111-30-8, M.W. 100.1) and lipopolysaccharide (TCA 
extracted from Salmonella typhimurium; Salmonella typhosa; and Escherichia coli) were 
purchased from Sigma Chemical Co. (St. Louis, MO).  The lot numbers and endotoxin 
content of each strain of lipopolysaccharide (LPS) are listed in Table 2.  Non-
ammoniated latex (NAL) was generously provided by Dr. Che Hasma Hashim of the 
Rubber Research Institute of Malaysia (RRIM). 
 
Table 2.  Lipopolysaccharide and Endotoxin Content in Bacterial Strains 
Bacterial Strain Lot Number(s) Endotoxin Content (EU/mg) 
Salmonella typhimurium 68H4041 
69H4060 
3 * 106 
1 * 106 
Salmonella typhosa 78H4059 5 * 106 
Escherichia coli O111:B4 684091 3 * 106 
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Mice were concurrently exposed to NAL and either endotoxin or glutaraldehyde 
in numerous studies.  Analysis of the NAL protein profile by 10% SDS-PAGE 
methodology revealed that while endotoxin did not affect the overall protein profile, 
concentrations of glutaraldehyde greater than 1ppm caused significant alteration of the 
proteins (Figures 3 and 4).  Therefore, glutaraldehyde dosing solutions were prepared 
separately and applied to the site of exposure first, followed by exposure to the NAL 
dosing solution.  Studies evaluating concurrent exposure to NAL and endotoxin utilized 
the preparation of a single dosing solution since endotoxin failed to visibly alter NAL 
proteins. 
 
Latex Protein Preparation and Quantification 
 
 Raw latex was collected from rubber trees in Malaysia and diluted with a 50% 
glycerol/67mM NaHCO3/2mM L-cysteine buffer (Goodyear Preservative).  Upon receipt, 
an aqueous protein extract was prepared as described by the RRIM.  The latex suspension 
was centrifuged for 40 minutes at 14,400 relative centrifugal force (rcf) to separate the 
rubber fraction from the aqueous protein phase.  Using a 10-cc syringe and an 18-gauge 
needle, the aqueous layer was removed from underneath the rubber fraction and 
centrifuged for two additional 1-hour spins at 40,000 rcf.  The final protein extract was 
filtered through a 0.45 µm bottle top filter, aliquoted into 50 ml conical tubes and stored 
at –80ºC.  As needed, NAL was thawed, aliquoted into eppendorf vials and stored at –
20ºC for daily use.  Using a modified Lowry Assay (ASTM D5712), the total protein 
concentration of the latex extract was determined to be approximately 7 mg/ml.  The 
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protein profile of the NAL extract, as separated on a 10% SDS-PAGE gel, is illustrated in 
Figure 3 (lane A).  Using the Limulus Amebocyte Lysate (LAL) assay (Jacobs, 1997), the 
endotoxin content in the NAL extract was determined to be 87 EU/ml by Mike Whitmer 
of the Analytical Services Branch at NIOSH. 
 
 
 
35
 
 
 
 
Figure 3.  10% SDS-PAGE of Endotoxin from Salmonella tyhpimurium and NAL 
Proteins. 10% SDS-PAGE gel of STD) broad range standard, A) 25 µg NAL proteins in 
PBS, B) 25,000 EU; remaining columns 25 µg with C) 50 EU, D) 500 EU, E)1,250 EU, 
F) 2,500 EU, G) 5,000 EU, and H) 25,000 EU 
 
 
36
 
 
 
 
 
 
 
 
 
 
Figure 4.  10% SDS-PAGE of Glutaraldehyde and NAL Proteins. 10% SDS-PAGE gel 
of STD) broad range standard, A) 25 µg NAL proteins in acetone; remaining columns 25 
µg with B) 0.05ppm, C) 0.2ppm, D) 0.5ppm, E) 0.75ppm, F) 1ppm, G) 0.1%, H) 0.5%, 
and I) 1% glutaraldehyde. 
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Radiolabeled Materials 
 
 
[3H]-H20 (M.W.=18.0), specific activity of 1 mCi/g, was obtained from New 
England Nuclear (NEN, Boston, MA).  Carrier-free Na125Iodine was purchased fresh 
(within two weeks of new commercial lot preparation) from NEN for each custom 
labeling experiment and had a theoretical specific activity of 17.4 Ci/mg upon arrival.  
All radioactive materials were stored in compliance with the Radiation Safety Office at 
NIOSH. 
 
Murine Exposures 
 
Prior to the initial exposure, mice were weighed and assigned to homogenous 
weight groups (n ≥ 5).    To monitor antibody levels in time course studies, mice were tail 
bled prior to initial exposure and weekly/bi-weekly thereafter.   
 
Dermal Exposures.  Prior to initial exposure and weekly thereafter, the dorsal 
thorax of all mice was clipped to remove hair from the site of application.  In some 
murine studies the depilatory agent Nair® was applied to remove remaining hair from the 
exposure site.  Nair® was applied to the clipped dorsal thorax region for up to one minute 
and removed using gauze dampened with tap water.  In studies where skin was abraded, 
the exposure site was tape stripped once a week with ten (10) 22mm stripping discs (D-
Squame® Stripping Discs, CuDerm Corp., Dallas, TX).  Hayes et al. previously 
demonstrated that tape stripping with 10 discs will effectively remove the stratum 
corneum (Hayes et al., 2000).  Mice were dermally exposed by applying 50 µl of vehicle 
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or test article to the dorsal thorax region either every 5th day or 5 days a week.  In studies 
where mice were exposed on the dorsal surface of the ear, 12.5 µl of vehicle or test article 
was applied to each ear 5 days a week for up to 14 weeks.  NAL dosing solutions were 
first prepared in Goodyear preservative and then diluted 1:1 in acetone.  Analysis using a 
10% tris-HCL gel demonstrated that the NAL protein profile is unaffected by acetone 
(see Figure 4, lane A).   Concentrations of test articles used in these studies ranged from 0 
– 25 µg of NAL proteins and 0.05 – 1ppm and 0.1 - 1% of glutaraldehyde.   
  
Intranasal Exposures.  Mice were manually restrained in a supine position while 
10 µl of vehicle or test article was applied to the external openings of both nares (5 
µl/nare).  Mice were exposed either every 5th day or 5 days a week for up to 72 days.  All 
dosing solutions were prepared in Goodyear Preservative and diluted 1:7 in PBS.  
Concentrations of test articles used in these studies ranged from 0 – 25 µg of NAL 
protein and 50 – 50,000 EU of LPS.  To reduce the number of animals, a single vehicle 
(n=10) and latex alone (n=10) exposure group was used for the studies evaluating the 
different strains of bacterial endotoxin. 
  
Robinson et al. demonstrated that intranasal instillation of dosing solutions to 
mice may result in both an upper respiratory and oral exposure (Robinson et al., 1996).  
To determine the distribution of the exposure, 10 µl of Evans blue dye was instilled into 
the nares of mice followed 10 minutes later by dissection.  Following instillation, there 
were no signs of infiltration into the lung, but instead into the stomach.  
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Intratracheal Exposures.  Intratracheal aspirations were performed on mice to 
localize the respiratory tract exposure to the trachea and lung.  Mice were anesthetized 
via Isoflurane (Abbott Laboratories, Chicago, IL) inhalation using a Bell jar and then 
restrained in a vertical position on a Plexiglas stand by the upper and lower teeth. While 
withdrawing the tongue using forceps to prevent swallowing the solution, 50 µl of the 
dosing solution was pipetted into the back of the oral cavity.  The tongue was held 
withdrawn until the dose was inhaled into the trachea and subsequently the lungs.  Mice 
were dosed every 5th day for up to 72 days with 0 – 25 µg of NAL proteins and/or 50 – 
25,000 EU of LPS.   
  
I.t aspirations of 50 µl of 0.5% Evans blue were conducted to demonstrate the 
distribution of dosing solutions throughout the lungs.  Within 10 minutes of i.t. 
aspiration, Evans Blue was visible in the trachea and all lobes of the lung. 
 
Subcutaneous Exposures.  Mice were injected with 50 µg (100 µl) of latex 
proteins in the dorsal thorax region every 5th day for up to 52 days.  All dosing solutions 
were prepared in Goodyear Preservative and diluted 1:7 in PBS.   
 
 
Guinea Pig Exposures 
 
 
The potential for glutaraldehyde to induce alterations in the barrier integrity was 
evaluated by dermally exposing male hairless guinea pigs between the ages of 4 –12 
months 5 days a week for up to 15 weeks.  Eight dosing regions, each approximately 30 
mm in diameter, were identified on the dorsal region of the animals prior to the initial 
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exposure.  Four dosing areas were designated for acetone (vehicle) exposure and four 
designated for glutaraldehyde exposure.  Animals were exposed by applying 50 µl of 
either acetone (vehicle for glutaraldehyde) or glutaraldehyde (0.75, 1ppm) to each dosing 
area.  At the end of the exposure period, animals were sacrificed via carbon dioxide 
asphyxiation and used for in vitro percutaneous penetration studies. 
 
Total IgE ELISA 
 
 Total IgE serum levels were measured using methodology described by Manetz 
and Meade (Manetz and Meade, 1999).  Immulon-2 (Dynex, Chantilly, VA), 96-well flat 
bottom plates were coated overnight (4°C) with 20 µg/ml B1E3 rat anti-mouse IgE 
prepared in boric acid buffered saline (BBS; 60 µl/well).  The B1E3 coated plates were 
blocked the following morning for 1 hour using a 0.05% Tween-20/PBS/2% FBS buffer 
containing 10mM Hepes and 0.05% sodium azide. Using separate u-bottom, 96-well 
plates, 12 two-fold serial dilutions of IgE standard were prepared starting at 500 ng/ml.  
The IgE standard was a mouse anti-DNP IgE purified from a hybridoma prepared 
following hyper-immunization of mice using DNP-Ascaris (Liu et al., 1980).   Serum 
samples from exposed mice were added to the first well beginning with a 1:10 or 1:20 
dilution.  Serially diluted IgE standards and serum samples were transferred from the u-
bottom dilution plates to the blocked Immulon-2 plates and incubated for 2 hours at 
37°C.  Plates were washed and 60 µl of 10 µg/ml of R1E4 (rat anti-mouse IgE) 
conjugated with biotin (EZ-Link™ Sulfo-NHS-Biotin, Pierce, Rockford, IL) or 60 µl of 2 
µg/ml of R35-118 biotinylated rat anti-mouse IgE (Pharmingen, San Diego, CA) was 
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added for 2 hours at 37ºC.  Subsequently, 1 µg/ml streptavidin-alkaline phosphatase 
(Sigma Chemical Co., St. Louis, MO) was added for an additional hour at 37ºC.  
Following the final wash step, p-Nitrophenyl phosphate (Sigma Chemical Co., St. Louis, 
MO) diluted to a 1 mg/ml concentration in substrate buffer (pH 9.8; 50% 
Diethanolamine/200 µg/ml MgCl2/400 µg/ml NaN3) was added and plate absorbance 
determined by a Spectramax Vmax plate reader (Molecular Devices Co., Sunnyvale, CA) 
within 30 minutes at 405 nm.  All standard and sample absorbance were analyzed using 
Softmax Pro (Molecular Devices Co., Sunnyvale, CA).  A plot of the IgE standard curve 
was created using a log-log plot.  Data points determined to be beyond the linear portion 
of the curve were “masked”; at least one point from each edited standard curve had an 
absorbency of greater than 0.5 optical density.  The resulting curves had slopes ranging 
from 0.7 - 1.1 and correlation coefficients greater than 0.98.  IgE concentrations for each 
serum sample dilution were interpolated from the standard curve and the IgE 
concentration for each mouse was determined using a multipoint analysis.  The B1E3, 
R1E4, and IgE standard antibodies were purified from hybridoma cell lines that were 
generously provided by Dr. Daniel Conrad (Medical College of Virginia/Virginia 
Commonwealth University, Richmond, VA). 
 
Latex Specific ELISA.   
 
Latex specific serum immunoglobulin levels were measured using a modified 
sandwich ELISA.  Wells of Immulon-2 plates (Dynex, Chantilly, VA) were coated with 
100 µl of 5 µg/ml rat anti-mouse IgE (R1E4), 2 µg/ml rat anti-mouse IgG1 (A85-3; 
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Pharmingen, San Diego, CA), 2 µg/ml rat anti-mouse IgG2a (Igh-1a; Pharmingen, San 
Diego, CA), or 2 µg/ml rat anti-mouse IgA (C10-3; Pharmingen, San Diego, CA) in BBS 
overnight at 4°C.  The following morning, plates were blocked for one hour with 3% dry 
milk freshly prepared in PBS/Tween 0.05%.  Serum samples were added beginning with 
either a 1:10 (for IgE, IgA) or 1:1,000 (for IgG1, IgG2a) dilution (100 µl/well) and 
incubated for 2 hours at 37°C.  Plates were washed and NAL (precipitated and stored in a 
3:1 H2PO4:NaOH buffer) was diluted to 25 µg/ml and 100 µl was added to each well for 
2 hours at 37°C.  Following the 2-hour incubation period, a polyclonal rabbit anti-NAL 
antibody (see Anti-NAL Antibody Generation) was diluted 1:16,000 and 100 µl/well was 
added for 2 hours at 37°C.  A horseradish peroxidase (HRP) conjugated donkey anti-
rabbit IgG antibody (Jackson Laboratories, Bar Harbor, ME) was diluted 1:2,500 and 100 
µl was added to the wells for 1 hour at 37°C.  O-phenylenediamine substrate was 
prepared at 1 mg/ml and added at 100 µl/well.  Approximately 20 minutes following the 
addition of the substrate, 50 µl of 4N sulfuric acid was added to the plates to stop the 
colorimetric reaction and the optical densities were read by a Spectramax Vmax plate 
reader (Molecular Devices Co., Sunnyvale, CA) at 490 nm.  Sample absorbances were 
analyzed using Softmax Pro 3.1 (Molecular Devices Co., Sunnyvale, CA).  Serum with 
high total IgE levels (> 1500 ng/ml) obtained from mice exposed to toluene di-isocyanate 
was used as a negative control.  Serum from mice with elevated total IgE serum levels (> 
10,000 ng/ml, see Anti-NAL Antibody Generation) was used as a positive control. 
Arbitrary units (AU) for the neat sera were determined by multiplying the dilution for 
each sample by the optical density.  Average AU values were calculated for each mouse 
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and then used to determine the overall mean AU ± standard error (SE) for each exposure 
group.   
 
 
Anti-NAL Antibody Generation  
 
 
 Sera containing antibodies to latex proteins is not currently available 
commercially.  In order to assay the development of latex specific serum antibodies, latex 
was injected into animals to generate latex specific polyclonal antibody development.  
These antibodies were subsequently used as positive control sera in ELISA or as 
secondary reagents in the latex specific ELISA and immunohistochemistry.   
 
 Murine Anti-NAL Antibody Generation.  Female BALB/c mice received weekly 
subcutaneous injections of NAL in the dorsal thorax region for up to 8 weeks.  Mice were 
injected with 25 µg of NAL proteins diluted in PBS to a final volume of 100 µl.  All 
injections were administred using one-cc tuberculin syringes with latex-free plungers 
fitted with 25 gauge needles.  Following 4 weeks of exposure, weekly tail bleeds were 
conducted to monitor total serum IgE levels until levels were greater than 10,000 ng/ml.  
Once total serum IgE levels were greater than 10,000 ng/ml, mice were sacrificed, blood 
was collected via cardiac puncture, and serum pooled to serve as positive control anti-
NAL serum for the latex specific ELISA and immunoblots.  All serum was stored at -
20°C until use.   
 
 Rabbit Anti-NAL Antibody Generation. Rabbits were immunized by injection 
with 200 µg of non-ammoniated latex emulsified with Freund’s Complete Adjuvant on 
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the first day of sensitization. Subsequent immunizations used 200 µg in incomplete 
Freund’s adjuvant. Rabbits were injected at five time points on days 0, 3, 5, 8, and 10.  
One week following the final injection weekly bleeds were conducted to determine the 
titer of the antiserum.  Titers of rabbit anti-NAL serum were determined using a Latex 
ELISA for Antigenic Proteins (LEAP) as previously described (Beezhold, 1992).  The 
titer was then determined using dilution values with an optical density of 1.5.  All sera 
was stored at -20°C until use.  This sera was used for the latex specific ELISA and 
immunohistochemistry.   
 
Before use in immunohistochemistry experiments, it was necessary to reduce the 
amount of immunoglobulins that could potentially cross-react with skin proteins.  Using 
previously described methods (Hayes et al., 2000), rabbit anti-NAL sera (500 µl) was 
incubated for 48 hours at 4°C with 15 mg of stratum corneum scrapings obtained from 
the dorsal lumbar region of hairless guinea pigs.  Antibodies were then passed through a 
0.45 µm filter and further absorbed against normal guinea pig serum for 1 hour.  The 
absorbed rabbit anti-NAL sera was then stored at -20°C until use in 
immunohistochemistry.   
 
Phenotypic Analysis 
 
 Antibodies.  Monoclonal antibodies against CD16/CD32 (Fc Block®, clone 
2.4G2), CD45R/B220 (clone RA3-6B2), IgE (clone R-35-72), CD4 (clone RM4-4), 
CD40 (clone 3/23), CD23 (clone B3B4), I-A/I-E (MHC class II, clone 2G9), CD152 
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(CTLA-4, clone 9H10), CD86 (B7.2, clone GL1), CD28 (clone 37.51) and isotype 
controls conjugated to either fluorescein isothiocyanate (FITC) or phycoerythrin (PE) 
labels were purchased from Pharmingen (San Diego, CA.).   
 
 Flow Cytometry Procedure.  Phenotypic analysis of draining lymph node cells 
was performed according to methods described by Manetz and Meade (Manetz and 
Meade, 1999).  Draining cervical lymph nodes were excised from individual mice, 
collected in tubes containing PBS, and placed on ice.  Single cell suspensions were 
prepared by dissociating lymphoid tissue using frosted microscope slides.  Cell counts 
were determined using a Z2 Coulter® Counter (Hialeah, FL) and approximately 1x106 
cells per sample were added to the wells of 96 well u-bottom plates.  A volume of 100 µl 
was used on all following steps.  The cells were washed with a PBS staining buffer 
containing 1.0% BSA (bovine serum albumin) and 0.1% sodium azide, and then 
incubated with 1.0 µg of Fc Block® for 5 minutes at 4°C. Antibodies were then added at 
a 1:100 dilution in staining buffer and samples were incubated for approximately 45 
minutes in the dark at 4°C. After washing, cells were incubated with 10 µg/ml of 
propidium iodide (PI) in the dark at 4°C for five minutes. Cells were washed, re-
suspended in staining buffer, and analyzed on a Becton Dickinson FACSCalibur or 
FACSVantage flow cytometer.  A PBS sample sheath lacking chelators was used as the 
interaction between IgE and surface CD23 (FcεRII) is calcium dependent.  Using the 
propidium iodide stain as well as the forward and side scatter profiles; cells were gated 
on viability and size to exclude dead cells and red blood cells.  Approximately 10,000 
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viable events were collected for each sample and analysis was performed on gated cell 
populations.   
 
Whole Body Plethysmography 
 
 To determine pulmonary reactivity following sensitization, enhanced pause 
(PenH), an indicator of bronchoconstriction (Drazen et al., 1999), was evaluated in mice 
using whole body plethysmography (Buxco Electronics, Sharon, CT).  Following 
sensitization with latex proteins, mice were challenged via inhalation with methacholine 
(MCH) or i.t. aspiration with NAL protein and pulmonary responses recorded.  Prior to 
all respiratory challenges, mice were placed into plethysmography chambers and 
monitored for five minutes to establish baseline PenH values.  PenH was calculated as 
(expiratory time/relaxation time – 1) * (peak expiratory flow/peak inspiratory flow) 
(Drazen et al., 1999).   
 
Methacholine Challenge.  Increasing concentrations of MCH (10, 25, and 50 
mg/ml) were used for non-specific challenge and were delivered to the mice while in the 
plethysmography chambers using a nebulizer (DeVilbiss HealthCare Inc., Somerset, PA).   
Mice were exposed to each concentration of MCH for 3 minutes followed by exposure to 
dry air for 2 additional minutes.  PenH measurements were calculated and recorded every 
30 seconds for a total of 5 minutes for each concentration of MCH.  For each animal, the 
percent increase in PenH values over baseline was plotted against time for each 
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concentration of MCH and averaged to determine the mean ± SE for each exposure 
group. 
 
NAL Challenge.  Following the five-minute baseline monitoring period, mice 
were removed from the plethysmograph chambers and briefly anesthetized (Isoflurane, 
Schering Plough, NY) to allow for i.t. aspiration of 300 µg of NAL in 50 µl PBS.  
Following NAL challenge, mice were returned to the Buxco chambers within 1 minute.  
PenH values were collected every minute for 25 minutes and percent over baseline 
calculated as described for the methacholine challenge.   
 
Histopathology 
 
 Within 24 hours of the i.t. challenge with latex proteins, mice were sacrificed and 
the lungs were collected for histopathology.  Anesthetized (CO2) mice were 
exsanguinated by transecting the abdominal region of the aorta; the organs of the thoracic 
cavity were removed and the lungs were inflated via intratracheal instillation with ~1ml 
of 10% buffered formalin prior to submersion into 15ml of formalin. Tissues underwent a 
series of alcohol washes followed by immersion in xylene and embedding in paraffin.  
Following embedding, tissues were cut in 5 µm sections and stained for pathological 
evaluation.  All tissues were stained with Hematoxylin and Eosin.  Eosinophilia was 
evaluated by staining tissue sections with 0.5% Chromotrop 2R.  Additionally, Alcian 
blue and periodic acid-Schiff stains were used to visualize the production of 
polysaccharides and mucoproteins.  Slide preparation and staining were performed by the 
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Pathology Laboratory at the Health Effects Laboratory Division, NIOSH.  The left lungs 
of all animals were evaluated for pathological changes.   
 
Dermal Penetration Experiments 
 
Radiolabeling of Latex Proteins.  To reduce the potential interference of glycerol 
in the radiolabeling process, NAL was precipitated according to the American Society for 
Testing and Materials’ protocol D5712 (ASTM 1995) using 72% phosphotungstic acid 
and 72% trichloroacetic acid. The precipitates were resolubilized in a 3:1 phosphate 
buffered saline (100 mM PBS)/0.1N NaOH (pH=7.0) solution and stored at !20EC until 
use.  Concentrations of NAL preparations were determined by the modified Lowry assay 
(ASTM D5712) and diluted with 100 mM PBS (pH=7.0) to 1 mg/ml for radiolabeling.   
 
Non-ammoniated latex proteins used in all in vitro penetration studies were 
radiolabeled with 125Iodine (NEN, Boston, MA) using Markwell’s methodology 
(Markwell, 1982) with minor modifications.  To reduce the potential for radioactivity 
exposure, the entire radiolabeling procedure was carried out in a Class IIB hood.  In an 
Eppendorf tube, carrier-free Na125I (500 µCi) was added to 250 µl of 100 mM PBS 
(pH=7.0) to prevent volatilization of free Iodine.  Prior to the addition of NAL proteins, 
Iodo-Beads® (Pierce, Rockford, IL) were added to serve as a catalyst for the 
radiolabeling reaction.  NAL proteins were then added and the reaction was allowed to 
proceed for 25 minutes at which time the Iodo-Beads® (Pierce, Rockford, IL) were 
removed to stop the reaction.  The radioactive solution was immediately placed into 
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dialysis tubing with a molecular weight cut off of 1,000 Da (Spectrum Laboratories Inc., 
Rancho Dominguez, CA).  To remove any unincorporated label, the tubing was placed in 
two liters of 50 µm KH2PO4 (Fisher Scientific, Pittsburgh, PA) and dialyzed for a total of 
48 hours at 4°C.  The buffer was changed every 12 hours to increase the concentration 
gradient and continue the diffusion of un-incorporated label.  After dialyzing, the 
radioactive protein solution was removed and refrigerated in a lead peg until used.   
 
Penetration Apparatus.  Percutaneous penetration of compounds was measured 
using a previously described one-compartment, flow-through diffusion cell system 
(Figure 5) (Hayes et al., 2000).  In-line, Teflon diffusion cells (Permegear, Inc, 
Riegesville, PA) with an exposure area of 0.64 cm2 and reservoir of 0.26 ml of receptor 
fluid beneath the skin surface were used for all studies.  Aluminum cell warmers securely 
held the diffusion cells in place while flow through tubing was setup to dispense directly 
into corresponding scintillation vials held in an Isco Retriever IVTM fraction collector 
(Fisher Scientific, Pittsburgh, PA). In order to maintain a consistent skin temperature of 
32°C for each cell, a Neslab water circulating bath was connected to the aluminum cell 
warmers.  Receptor fluid was stored in a 2 liter reservoir and was delivered to the flow-
through diffusion via a 16-cartridge peristaltic pump (Ismatec Inc., Zurich, Switzerland) 
with a 14 outlet manifold.  Tygon tubing (Fisher Scientific, Pittsburgh, PA) was used to 
connect the pump to each diffusion cell.  To maintain consistent exposure conditions, the 
diffusion cells were enclosed in a Plexiglas chamber and connected to a temperature-
humidity control system (Miller-Nelson Research, Inc., Monterey, CA) set at 26.7°C and 
50% (temperature and humidity, respectively).  The exact temperature and humidity was 
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monitored by a sensor that was placed above the cells inside the chamber.  The sensor 
gathered twenty readings of the humidity and temperature in five-second intervals, and 
the overall mean ± standard deviation was calculated for each parameter during the entire 
exposure period using the LabView software package (National Instruments, Austin, 
TX).  The environmental chamber was built by Aliakbar Afshari of the Engineering and 
Control Technology Branch, NIOSH.  Figure 6 illustrates a computer generated line 
graph for the humidity and temperature readings from a representative study. 
 
Harvesting Skin for In Vitro Penetration Studies.  At designated time points post 
exposure, hairless guinea pigs were euthanized by carbon dioxide asphyxiation and full-
thickness skin was removed from the dorsal thorax and lumbar areas. Following excision, 
the skin was washed with a 10% soap solution, rinsed with water, and dried using paper 
towels.  To remove the remaining subcutaneous and connective tissue, the skin was 
mounted epidermis side down on Styrofoam blocks and the tissue trimmed using forceps 
and surgical scissors.  Skin was then turned over so that the epidermis side was up and 
secured to the Styrofoam blocks using 90° bent needles. Using an electric dermatome 
(Padgett Instruments, Kansas City, MO), a 250 µm thickness of skin was excised which 
included the entire epidermis and a portion of the upper papillary dermis.  Using a steel 
punch (McMaster-Carr, Inc., New Brunswick, NJ), 12.7 mm (0.5 in) circular punches 
were taken of acetone and glutaraldehyde exposed skin.  In each experiment, the entire 
procedure was accomplished within 2 hours following removal of skin from the 
euthanized animals. 
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In Vitro Percutaneous Penetration Assay.  Cells and tubing were cleaned prior to 
each penetration assay by flushing the system with 70% ethanol.  To prevent fluid from 
leaking out of the diffusion cells, transparency paper punches were placed in the cells.  
HEPES-balanced Hank’s salt solution (HBHSS, Gibco, Grand Island, NY) was prepared 
fresh for each penetration experiment, adjusted to pH 7.4, filtered (0.22 µm), and pumped 
through the cells to displace the alcohol solution.  The HBHSS solution was selected for 
use in penetration studies due to its ability to maintain skin viability for greater than 24 
hours (Collier, 1989).  A complete listing of the components in the HBHSS solution can 
be found in Appendix 1.  Once the system was cleaned (with 70% ethanol) and following 
HBHSS addition, dermatomed punches of the skin samples were placed in each diffusion 
cell epidermis side up and clamped down securely.   
 
Throughout the course of the experimental process, the HBHSS (receptor fluid) 
was pumped by the peristaltic pump at a flow rate of 1.8 ml/hr.  The receptor fluid was 
pumped through the flow through diffusion cells and collected in polypropylene 
scintillation vials using the fraction collector.   
 
Skin Barrier Test.  Prior to evaluating the in vitro percutaneous penetration of 
latex proteins, the barrier integrity of all skin samples receiving radioactive test 
compounds was verified using a 20 minute 3H20 penetration assay (Bronaugh and Collier, 
1991).  Briefly, 200 µl of 3H20 was applied to the skin sample covering the entire 
exposed surface area.  Twenty minutes following application, the solution was removed 
and the skin was blotted dry with cotton-tipped applicators (Fisher Scientific, Pittsburgh, 
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PA).  Each skin sample was rinsed once with 300 µl dH20 to reduce remaining 
radioactivity and then dried again with cotton tipped applicators.  Receptor effluent was 
collected for an additional 60 minutes (total of 80 minutes).  Finally, 10 ml of Scintisafe 
PlusTM 50% scintillation cocktail (Fisher Scientific, Pittsburgh, PA) was added to each 
collection tube and the radioactivity quantified via a Packard Tri-Carb 2500TR beta 
liquid scintillation counter (Downers Grove, IL).  A 200 µl sample of the dosing solution 
was counted in duplicate and averaged.  The percent 3H20 penetration for each cell was 
calculated by the following formula: 
[effluent dpm (80 min) ÷ dosing solution (avg dpm) x 100 = % penetrated] 
Bronaugh and Collier (Bronaugh and Collier, 1991) previously established that greater 
than 0.35% penetration was indicative of abraded skin based on comparing the results of 
the barrier test with calculated permeability constant values (Kp) from the same skin 
samples.  Therefore, only skin samples that passed the test (<0.35% 3H20 penetration) 
were used for intact skin analysis and only cells failing the test were used as abraded 
samples. 
 
Radiolabeled Latex Protein Penetration Studies.  Following the barrier test, 
approximately 100 µg of the radiolabeled latex protein mixture (100 µl) was applied to 
the skin samples covering the entire exposed surface area (0.64 cm2).  To prevent 
evaporation of the radiolabeled NAL protein solution, skin samples were occluded with a 
Teflon plug.   
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Following 24 hours of exposure, the remaining radiolabeled NAL protein solution 
was removed from the skin surface and, the skin samples were washed with 10% soap 
and water using cotton tip applicators.   Washes were continued, usually 9 – 11 washes, 
until less than 0.1% of the original radiolabeled NAL protein solution was detectable by 
gamma counting (Cobra II gamma counter, Packard, Downers Grove, IL).  In order to 
quantify latex protein penetration, as well as calculate mass balance, in the skin and that 
which penetrated through the skin; radioactive counts were obtained for each of the skin 
samples, as well as 500 µl aliquots of receptor effluent for each time point (6, 12, 18, 24 
hr).  Mass balance was calculated as a percentage of the originally applied dosing 
solution by adding together the counts from the soap and water washes, skin samples, and 
the receptor fluid and dividing by the radioactive counts obtained for the original dosing 
solution.  The remaining receptor fluid for each diffusion cell was combined into one 50 
ml conical and freeze-dried (LabConco Corporation, Kansas City, MO).  Following the 
lyophilization process, the remaining product was resuspended in 1 ml 10% formic acid 
and, upon combining samples from each exposure group (acetone or glutaraldehyde), 
dialyzed in tubing with a 1,000 mw cutoff (Spectrum Laboratories Inc., Rancho 
Dominguez, CA) against 4 L dH20 (48 hr, 4°C) to remove the salts and the formic acid.  
The dialyzed solution was lyophilized again and resuspended in 250 µl of 1x sample 
buffer for subsequent protein separation using gel electrophoresis.  For each penetration 
study, two skin samples (one intact and one abraded) were exposed to non-radioactive 
latex proteins under identical conditions as those used for radiolabeled samples for 
immunohistochemical analysis.  The non-radioactive skin samples were fixed in 10% 
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buffered formalin overnight, processed, and embedded in paraffin wax by Patsy Willard 
of the Pathology and Physiology Branch at NIOSH. 
  
SDS-PAGE and Phosphoimaging.  Latex proteins were separated using SDS-
polyacrylamide gel electrophoresis (PAGE) according to previously described methods 
(Laemmli, 1970; Hoefer, 1994).  All samples were diluted in electrophoresis running 
buffer and boiled for 2 minutes prior to loading on gels.  Samples were pipetted into 
wells of a 10% polyacrylamide gel and separated at a constant voltage of 200 V for 
approximately 1 hour (Mini Protean II Cell; Bio-Rad, Hercules, CA).   Broad range, 
molecular weight protein markers (7.4-202 kDa, Bio-Rad, Hercules, CA) were run 
concurrently with the samples for molecular weight estimation.  Coomassie brilliant blue 
(Sigma, St. Louis, MO) was used to visualize proteins followed by drying with a Savant 
SGD2000 slab gel dryer.  In order to visualize the radiolabeled proteins in the dosing 
solution and receptor effluents, dried gels were placed in a storage cassette and exposed 
to a Phosphor screen for approximately 1 hour followed by a scan for gamma radiation 
using a PhosphorImager 445 SI (Molecular Dynamics, Inc., Sunnyvale, CA). 
 
Immunohistochemical Evaluation of HGP skin sections.  Paraffin-embedded NAL 
exposed samples were cut at 5 µm and placed on Superfrost Plus Gold microscope slides.  
Using xylene and a series of alcohol to dH2O washes, slides were first de-paraffinized 
and then re-hydrated.  In order to retrieve masked antigens, tissue sections were 
immersed in a 0.01 M citrate buffer (pH=6) and microwaved for approximately 2 
minutes. Slides were then immersed for 20 minutes in a 1:1 solution of 3% H202 and 
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methanol (Sigma Chemical Co., St. Louis, MO) to block endogenous peroxidase 
followed by a dH20 wash and placement on Sequenza chamber racks (Shandon Inc., 
Pittsburgh, PA).  Following a 5-minute wash with Cadenza buffer (Shandon Inc., 
Pittsburgh, PA), endogenous biotin in the skin was blocked by incubating slides for 30 
minutes in solutions containing 0.1% avidin (DAKO, Carpinteria, CA) and 0.01% biotin 
(DAKO, Carpinteria, CA).  Slides were then coated with 500 µl 10% BSA/PBS block 
buffer (Sigma, St. Louis, MO) for 1 hr at room temperature (RT).  Following the 
blocking step, 160 µl of the adsorbed rabbit polyclonal anti-latex antibody (1:200; See 
Rabbit anti-NAL antibody generation) was added and the slides were incubated overnight 
at 4°C.  Twelve to eighteen hours later, the skin sections were washed with Cadenza 
buffer and 160 µl of biotinylated swine, anti-rabbit F(ab’)2 fragment (1:300, DAKO, 
Carpinteria, CA) was added to the chambers for 30 minutes at room temperature.  Slides 
were washed three more times with Cadenza buffer and the slides were incubated for 30 
minutes at room temperature with 160 µl of streptavidin-horseradish peroxidase 
conjugate solution (NEN, 1:100).  The slides were again washed with Cadenza buffer and 
developed for 5 minutes with liquid 3-amino-9-ethylcarbazole (DAKO, Carpinteria, CA).  
Following one wash with dH20, the skin sections were counter stained with Mayer’s 
hematoxylin (5 minutes).  Finally, the slides were mounted using Crystal/mount, oven-
dried, cover-slipped, and examined under light microscopy.  Under the guidance of 
Lyndell Millechia (Pathology and Physiology Research Branch, NIOSH), 
photomicrographs were taken of representative skin sections. 
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Safety.  To minimize exposure to gamma radiation, all radiolabeling procedures 
were performed in a Class IIB hood and radiolabeled protein solutions were stored in lead 
pegs.  Radiation exposure was monitored by the use of lapel and ring badges which were 
worn during the use of unbound Na125I.  To further monitor exposure to unbound Na125I, 
thyroid scans were obtained within 72 hours of each radiolabeling procedure by the 
Nuclear Medicine department at Ruby Memorial Hospital (Morgantown, WV).  
Radioactive waste was collected and disposed of by the Radiation Safety Office at 
NIOSH.  Following experimentation, the non-radioactive skin samples were placed in 
bio-hazard bags and disposed of by incineration through the safety office at NIOSH.   
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Figure 5.  In Vitro Flow Through Diffusion Cell Apparatus 
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Figure 6.  Representative Graph of Temperature and Humidity Readings in Hairless Guinea Pig In Vitro Percutaneous 
Penetration Experiments.  The lower panel represents the mean for humidity (black line) and temperature (red line) and the 
upper panels are the standard deviations for twenty readings used to generate each point on the line. 
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RNA Isolation 
 
  
RNA was isolated from the mediastinal (intratracheally exposed mice) or cervical 
(dermally exposed mice) draining lymph nodes following the manufacturer’s 
recommendation for the RNeasy® and QiaShredder™ Kits (Qiagen, Valencia, CA).  
Upon excision, tissue was either snap frozen in liquid nitrogen and stored at –80°C until 
isolation or collected in 600 µl of RNAlater™ (Ambion, Houston, TX) and stored at 4°C 
until isolation.  Prior to isolation, β-mercaptoethanol was added to the RLT Buffer 
according to the manufacturer’s guideline giving a 1.0% β-mercaptoethanol solution.  A 
DNase I stock solution was also prepared by dissolving the lyophilized powder in 550 µl 
of RNase free water.  This DNase I stock solution was further diluted for experimental 
use by adding 10 µl of the stock solution with 70 µl of RDD Buffer and storing at 4°C 
until use.  To isolate the RNA, tissue was transferred to a RNase free 1.5 ml eppendorf 
tube containing 600 µl of RLT buffer and dissociated using a rotor-stator hand held 
homogenizer.  To prevent degradation of RNA, samples were placed on ice until the next 
step in the isolation process.  Once samples had been completely dissociated, each 
sample suspension was added to a QiaShredder™ spin column and centrifuged at 20,800 
rcf for 2 minutes.  To further pellet any debris that may have passed through the column, 
caps were placed on the collection tubes and cell lysates were spun for an additional 3 
minutes at 20,800 rcf.  Following centrifugation, the supernatant was transferred to a new 
1.5 ml eppendorf tube containing 600 µl of 70% ethanol and mixed by pipetting.  For 
each sample, 600 µl was added to the RNeasy® columns and centrifuged for 15 seconds 
at 20,800 rcf.  The supernatant was removed and again added to the spin column and 
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centrifuged to maximize purification.  The remaining supernatant was discarded and this 
step was repeated with the remaining sample volume. Once the entire sample had been 
added and run through the RNeasy® column, 350 µl of RW1 Buffer was added to the 
column and the spin columns centrifuged at 20,800 rcf.  The flow through was discarded 
and 80 µl of a diluted DNase I solution was added to the spin columns for a 15-minute 
incubation at room temperature.  Following the incubation, an additional 350 µl of RW1 
Buffer was added to the spin column and the tubes were spun for 15 seconds at 20,800 
rcf.  The columns were placed in new 2.0 ml collection tubes and 500 µl of RPE Buffer 
was added to each column.  The spin columns were centrifuged for 15 seconds at 20,800 
rcf, followed by the addition of another 500 µl of RPE Buffer and centrifugation (15 
seconds, 20,800 rcf).  The spin columns were transferred to a new snap cap eppendorf 
tube and centrifuged for 1 minute at 20,800 rcf to dry the column.  To release the RNA 
from the column, 30 µl of RNAse free water was added to the column followed by a 1-
minute spin at 20,800 rcf.  The supernatant was removed from the collection tube and 
again added to the column for an additional spin.  Following the final spin the tubes were 
closed and stored at –80°C until RNA quantification.   
 
To determine the quantity and purity of the isolated RNA, samples were thawed 
and diluted 1:50 in RNAse free water and analyzed using the Beckman DU650 
spectrophotometer (Beckman Coulter, Fullerton, CA).  Optical density values were 
obtained at wavelengths of 260 and 280nm for each sample and were used to calculate 
the quantity (optical density at 260nm * 40 * dilution= µg RNA) and purity (optical 
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density at 260nm/optical density at 280nm=purity).  Target purity ratios ranged between 
1.5 and 2.0.   
 
In Vitro Transcription 
 
 
 DNA complementary to the RNA for each sample was generated using TaqMan® 
reverse transcription reagents (Applied Biosystems, Branchburg, NJ).  Samples were 
prepared in 0.2 ml MicroAmp PCR tubes (Perkin Elmer, Norwalk, CT) with a total 
volume of 50 µl as outlined in table 3.  Each sample was prepared with 2 µg of total RNA 
(as determined by RNA quantification) and reverse transcription was carried out on the 
GeneAmp PCR system 6700 thermocycler (Applied Biosystems, Branchburg, NJ) with 
settings outlined in table 4.    
 
 
Table 3.  Reverse Transcription Reaction for cDNA in RT-PCR Analysis 
 
Component Volume/Tube (µL) Final Concentration 
10X TaqMan RT Buffer   5.00 1x 
25mM MgCl2 11.00 5.5mM 
10mM dNTP Mix 10.00 500µM each 
Random Hexamers   2.50 2.5µM 
RNase Inhibitor   1.00 0.4U/µL 
MultiScribe Reverse Transcriptase   1.25 1.25U/µL 
RNA Variable 2µg/sample 
Rnase free Water # ----- 
 
#  RNase free water was added to bring total volume of reaction up to 50µL. 
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Table 4.  Thermocycler Setting for Reverse Transcription Reaction 
 
Step Incubation RT RT inactivation 
 HOLD HOLD HOLD 
Time 10min 60min 5min 
Temp 25°C 48°C 95°C 
 
 
 
Real-Time Quantitative Polymerase Chain Reaction  
 
 Individual cytokine message levels were evaluated following amplification using 
real-time, semi-quantitative PCR.  This procedure utilizes fluorescently labeled primers 
and probes in detecting the level of endogenous control (GAPDH) and cytokine target 
(IL-4, IL-10, IL-12, IFN-γ) message.  Each sample was prepared using cDNA from the 
previous amplification step, a PCR master mix (Applied Biosystems, Branchburg, NJ) 
and commercially available probe/primer kits (Applied Biosystems, Branchburg, NJ).  
Samples were prepared for endogenous control detection as outlined in table 5 and 
cytokine target detection as outlined in table 6.  Samples were then added to 96 well Bio-
Rad iCycler iQ plates, centrifuged for 1 minute at 200 rcf, and loaded on the iCycler iQ 
(Bio-Rad, Hercules, CA).  The settings for the real-time PCR are outlined in table 7.  A 
threshold was determined by calculating the mean fluorescent intensity following the 
annealing/extending portions of cycles 2 – 10.  This threshold was subtracted from each 
data point and was used to determine the adjusted threshold intensity.  The threshold was 
averaged for all samples and the cycle threshold calculated as: 10 * standard deviation of 
the threshold.   The relative quantification of the target gene was determined based on the 
relative expression of the target gene compared to GAPDH.  In brief, a cycle threshold 
was determined for both the endogenous control and target genes based on nuclease 
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degradation and the subsequent release of fluorescence.  These cycle thresholds were 
then used to calculate the relative expression of the target gene using the following 
formula (Giulietti et al., 2001; Pfaffi, 2001):  2-∆∆Ct.  ∆∆Ct = ∆Ct(Sample) - 
∆Ct(Vehicle).  ∆Ct = Ct(GAPDH) - Ct(target). 
 
 The efficiency of the thermocycler was calculated as described by the 
manufacturer.  Briefly, sample mRNA was serially diluted and added to corresponding 
tubes containing PCR master mix, GAPDH primers and probes.  Samples were run as 
previously described to determine the cycle thresholds for each sample.  The efficiency 
was calculated by graphing the logarithm of the amount of mRNA versus the cycle 
threshold.  Efficiencies within these studies were within the range specified by the 
manufacturer.    
 
 
Table 5.  PCR Reaction Mix for GAPDH Controls 
 
Component Volume/Tube (µl) Final Concentration 
2X PCR Master Mix 10.0 1X 
Forward Primer   0.2 100nM 
Reverse Primer   0.2 100nM 
Probe   0.2 200nM 
cDNA      4.0¥ -- 
RNase Free Water   5.4 -- 
Total 20.0 -- 
  ¥0.16 µg of cDNA was used for each experiment 
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Table 6.  PCR Reaction Mix for Cytokines 
 
Component Volume/Tube (µl) Final Concentration 
2X PCR Master Mix 10.0 1X 
20X Probe/Primer Mix*   1.0 1X 
cDNA    4.0¥ -- 
RNase Free Water   5.0 -- 
Total 20.0 -- 
 
*  All cytokines from Applied Biosystem come in a master mix containing  
probe, forward and reverse primers, with a constant concentration between  
kits of 20X. 
 ¥0.16 µg of cDNA was used for each experiment 
 
 
Table 7.  RT-PCR Settings for Thermocycler 
 
Stage UNG Incubation AmpliTaq Activation PCR (60 cycles) 
 Hold Hold Denature Anneal/Extend 
Temperature 50.0°C 95.0°C 95.0°C 60.0°C 
Time 2 min 10min 15sec 1 min 
 
 
 
Epidermal Sheet Preparation and Staining 
 
 
 In order to visualize the activation of antigen presenting cells, mice were 
exposed to vehicle or test articles on the dorsal surface of the ear pinna.  Upon sacrifice, 
the dorsal and ventral regions of ears of mice exposed to NAL alone or concurrently with 
glutaraldehyde were separated using forceps.  The dorsal region of the ear was then 
placed into 5 ml of 0.02M EDTA (pH 8.0) and incubated for 30 minutes at 37°C.  Using 
forceps, the epidermal sheets were separated and placed on a microscope slide.  The 
epidermal sheets were then washed with PBS and fixed with acetone at -20°C for 20 
minutes.  Following a 5 minute PBS wash, FITC labeled anti-mouse I-A/I-E (2G9, 
Pharmingen, San Diego, CA) was added to the slides at a 1:100 dilution and incubated 
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for 1 hour at 25°C.  Slides were washed, mounted with ProLong (Molecular Probes, 
Eugene, OR), and sealed with nail polish.  Confocal microscopy was used to visualize the 
expression of cell surface molecules and capture images for analysis.  Under the guidance 
of Lyndell Millechia (Pathology and Physiology Research Branch, NIOSH), at least three 
representative images were collected for each epidermal sheet from the ears of exposed 
mice. 
 
Images obtained from the confocal microscope were analyzed for Langerhans’ 
cell numbers by counting the number of fluorescing cells in a 40mm2 field of focus.  Data 
are presented as the percent increase in MHC class II expressing Langerhans’ cell over 
vehicle.  This value was determined for each mouse by first calculating the average 
number of cells per field for vehicle exposed animals and then using the following 
calculation:  
% Increase over Vehicle = (Count (exposed animal) – Count (vehicle average))  
Count (vehicle average) 
 
Statistics 
 
All statistical analysis was conducted using Graph Pad Prism, version 3.01 (San 
Diego, CA).   Body weights, serum immunoglobulin levels, phenotypic analysis and 
PenH data from vehicle and test article exposed mice were analyzed by one-way analysis 
of variance (ANOVA). When significant differences were detected (p>0.05), test groups 
were compared to the controls using a Dunnett's test.  Dose responsive relationships were 
determined using linear regression.  A one-tailed, unpaired t-test was used to perform pair 
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wise comparisons between skin samples exposed to acetone or glutaraldehyde in the 
dermal penetration experiments. 
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RESULTS 
 
Clinical Observations and Systemic Toxicity 
 
 With the exception of erythema induced by high concentrations of glutaraldehyde 
(1%) at the site of exposure, all mice appeared clinically normal throughout the course of 
the study.  There were no exposure related changes in body weight in any of the studies 
(See Appendix 2).  The only unscheduled deaths occurred due to respiratory 
complications during intratracheal administration of test article while under isoflurane 
anesthesia. 
 
Comparison of Sensitization Routes 
 
 An initial study was conducted to evaluate the induction of sensitization following 
exposure to NAL proteins via the dermal, intranasal (i.n.), intratracheal (i.t.), and 
subcutaneous (s.c.) routes.  All mice were exposed to 50 µg of NAL proteins every 5th 
day for 52 days.  As tape stripping was used to prepare the site for dermal application, an 
additional set of control animals was included in this testing battery to account for 
changes due to inflammation resulting from the disruption of the stratum corneum as well 
as a response to chemicals present in the adhesive of the tape strips.   
 
 Total IgE Response.  Elevations in total serum IgE levels were observed as early 
as day 16 in mice exposed via s.c. injection reaching ~20,000 ng/ml (p<0.01) by day 23 
 68
(Figure 7A).  However, 23 and 37 days of exposure were required before significantly 
elevated serum IgE levels were observed in mice exposed via the dermal (p<0.05) or i.t. 
(p<0.01) routes, respectively.  Total serum IgE production in s.c. and i.t. exposed mice 
appeared to plateau with levels of ~30,000 ng/ml by day 23 and ~10,000 ng/ml by day 
37, respectively.  In mice exposed dermally to NAL proteins, levels of IgE reached a 
maximum of ~6000 ng/ml on day 23.  No significant elevations in total serum IgE were 
observed in mice i.n. exposed to NAL by day 52 of the study (Figure 7B).  No elevations 
in total serum IgE levels were observed in the naïve, vehicle or tape strip control groups 
throughout the course of the study (data not shown).   
 
Latex Specific Immunoglobulin Response.  Levels of NAL specific serum IgE 
were evaluated throughout the study using a modified sandwich ELISA.  Mice exposed 
via s.c. injection of NAL proteins demonstrated significant (p < 0.01) elevations in NAL 
specific serum IgE as early as day 16 (Figure 8A) while significant elevations were not 
observed until day 23 in mice exposed via i.t. aspiration.  On the final day of the study 
(day 52), the levels of NAL specific serum IgG2a and IgA were additionally measured in 
exposed animals.  Whereas animals exposed dermally to NAL proteins demonstrated a 
significant (p < 0.01) increase in NAL specific serum IgE on day 52 when compared to 
vehicle-exposed animals, no significant elevation in the levels of NAL specific IgG2a or 
IgA was observed in these same animals (Figures 8B-D).  Slight increases in NAL 
specific IgE were observed in intranasally exposed mice (Figure 8B).  However these 
mice demonstrated greater than 1000-fold and 40-fold increases over vehicle exposed 
animals in NAL specific IgG2a and IgA, respectively (Figures 8C & D).  In comparison 
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with mice exposed to vehicle alone, mice exposed via the s.c. and i.t routes demonstrated 
approximately 5,000-fold and 3,000-fold increases, respectively, in NAL specific IgG2a 
levels (Figure 8C).  Additionally, mice exposed via i.t. aspiration also demonstrated 
significantly higher levels (~150-fold) of NAL specific IgA than vehicle exposed mice 
(Figure 8D).  No elevations in NAL specific serum IgE, IgG2a or IgA levels were 
observed in the naïve, vehicle and tape strip control groups throughout the course of the 
study (data not shown).   
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Figure 7.  Total Serum IgE Levels in Mice Exposed to 50 µg of Latex Proteins by 
Different Routes of Administration.  Time course (A) and day 52 (B) total serum IgE 
levels were determined in mice exposed to 50 µg of NAL proteins.  Points and bars 
represent means ± standard error for each group.  The number of animals in each 
exposure group is indicated in parenthesis.  Significance from vehicle (VH) was 
determined using a Dunnett’s t test and is indicated by * (p<0.05) and ** (p<0.01). 
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Figure 8.  Latex Specific Serum Immunoglobulin Levels in Mice Exposed to 50 µg of Latex Proteins by Several Routes.  Time course 
NAL specific IgE (A) and day 52 NAL specific serum IgE (B), IgG2a (C), and IgA (D) levels were determined in mice exposed to 50 
µg of NAL proteins.  Points and bars represent means ± standard error for each group.  The number of animals in each exposure group 
is indicated in parenthesis.  Significance from vehicle (VH) was determined using a Dunnett’s t test and is indicated by ** (p<0.01). 
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NAL Sensitization and Airway Hyper-reactivity 
 
The previous study demonstrated that NAL proteins have the potential to induce 
allergen specific IgE upon dermal, s.c., i.n., and i.t. exposure.  To further investigate the 
development of NAL specific IgE and the relationship between IgE induction and airway 
hyper-reactivity; mice were dermally, i.n., or i.t. exposed to increasing concentrations of 
NAL proteins (6.25, 12.5, and 25 µg) until elevations in total IgE were observed.  Airway 
hyper-reactivity was then evaluated following methacholine or NAL respiratory 
challenge.   
 
Total IgE Levels.  Elevated levels of serum IgE were observed as early as day 58 
(>3000ng/ml, p<0.05), 44 (~1000ng/ml, p<0.05), and 37 (>4000ng/ml, p<0.05) in mice 
exposed to 25 µg of NAL proteins via dermal, i.n., and i.t. routes, respectively (Figure 9).  
Whereas exposure to 6.25 or 12.5 µg of NAL proteins via i.n. and i.t. routes failed to 
induce significant elevations in serum IgE by days 51 and 79, respectively, significant 
elevations (p<0.05) were observed on day 93 in mice exposed to 12.5 µg of NAL proteins 
dermally (Figure 10).   
 
In mice exposed via the i.n. and i.t. routes, levels of total serum IgE increased in 
mice exposed to increasing concentrations of NAL reaching significant elevations in 
mice exposed to 25 µg of NAL.  Levels of serum IgE in mice dermally exposed to 25 µg 
of NAL peaked at day 58 and decreased throughout the remainder of the study to ~2000 
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ng/ml while levels of IgE in mice exposed to 12.5 µg of NAL peaked at ~3000 ng/ml on 
day 93 (Figure 10A).   
 
Latex Specific Antibody Responses.  Latex specific antibodies (IgE, IgA, IgG1, 
IgG2a) were measured in the serum of mice exposed to NAL via the dermal, i.n., and i.t. 
routes on the final day of the studies.  Mice dermally exposed to 12.5 µg of NAL proteins 
demonstrated significantly (p < 0.05) elevated levels of NAL specific serum IgE with a 
greater than 6-fold increase over the vehicle-exposed animals (Figure 11A).  When 
compared to mice exposed to vehicles alone, mice exposed to either 6.25 or 25 µg of 
NAL proteins demonstrated at least a 50-fold increase in IgG1 (Figure 11B) and 
approximately a 2-fold increase in IgG2a (Figure 11C).  Less than a 2.5-fold increase in 
IgA levels was observed in mice exposed to 6.25 or 25 µg of NAL proteins (Figure 11D).   
 
Intranasal exposure of mice to increasing concentrations of NAL proteins resulted 
in a dose-responsive increase in latex specific serum antibodies (p<0.05 for all 
subclasses).  Significant increases in latex specific serum IgE (p < 0.01), IgG1 (p < 0.01), 
IgG2a (p < 0.05), and IgA (p < 0.01) were observed in mice exposed to as little as 12.5 
µg of NAL proteins.  Mice exposed to 25 µg of NAL proteins demonstrated greater than 
10, 50, 300, and 1,500-fold increases over vehicle levels of IgE, IgA, IgG2a, and IgG1, 
respectively (Figure 12). 
 
Intratracheal exposure to NAL proteins induced significant increases in all 
subclasses of latex specific antibody evaluated.  Latex specific serum IgE levels reached 
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significant (p < 0.01) elevations in mice exposed to 25 µg of NAL proteins (Figure 13A).  
A dose responsive increase (p<0.05) in latex specific serum IgG1 levels was observed in 
mice exposed to increasing concentrations of NAL reaching greater than a 50-fold 
increase over vehicle exposed animals (Figure 13B).  Greater than 500-fold increases in 
IgG2a (Figure 13C) and IgA (Figure 13D) were observed in animals exposed to 12.5 or 
25 µg of NAL.   
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Figure 9.  Time Course of Total Serum IgE Production in Mice Dermally, Intranasally, or Intratracheally Exposed to Latex Proteins.  
Time course of total serum IgE levels in mice exposed to NAL proteins via the dermal (A), i.n. (B), and i.t. (C) routes.  Points 
represent means ± standard error for each group.  n=5 for all exposure groups except for the vehicle in intratracheally exposed animals 
where the n=4.  Significance from vehicle (VH) was determined using a Dunnett’s t test and is indicated by * (p<0.05). 
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Figure 10.  Final Total Serum IgE Levels in Latex Exposed Mice.  Total serum IgE levels on days 93, 51, and 79 in mice exposed to 
NAL proteins via the dermal (A), i.n. (B), and i.t. (C) routes, respectively.  Bars represent means ± standard error for each group.  n=5 
for all exposure groups except where noted.  Significance from vehicle (VH) was determined using a Dunnett’s t test and significance 
is indicated by * (p<0.05). 
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Figure 11.  Latex Specific Serum Antibody Levels on Day 93 in Dermally Exposed Mice.  Levels of latex specific IgE (A), IgG1 (B), 
IgG2a (C), and IgA (D) were evaluated in serum obtained from mice on the final day of the study (day 93).  Bars represent the means 
± SE for each exposure group.  N.D. represents non-detectable levels.  n=5 for all exposure groups.  Significance from vehicle (VH) 
was determined using a Dunnett’s t test and is indicated by * (p<0.05). 
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Figure 12.  Latex Specific Serum Antibody Levels on Day 51 in Intranasally Exposed Mice.  Levels of latex specific IgE (A), IgG1 
(B), IgG2a (C), and IgA (D) were evaluated in serum obtained from mice on the final day of the study (day 51).  Bars represent the 
means ± SE for each exposure group.  n=5 for all exposure groups. Significance from vehicle (VH) was determined using a Dunnett’s 
t test and is indicated by * (p<0.05) and ** (p<0.01). 
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Figure 13.  Latex Specific Serum Antibody Levels on Day 79 in Intratracheally Exposed Mice.  Levels of latex specific IgE (A), IgG1 
(B), IgG2a (C), and IgA (D) were evaluated in serum obtained from mice on the final day of the study (day 79).  Bars represent the 
means ± SE for each exposure group.  n=5 for all exposure groups except the vehicle where n=4.  Significance from vehicle (VH) was 
determined using a Dunnett’s t test and is indicated by * (p<0.05) and ** (p<0.01). 
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Methacholine Challenge.  Methacholine was used to assess the development of 
non-specific airway hyper-reactivity in mice exposed to NAL proteins via the dermal, 
i.n., and i.t. routes.  Previous studies conducted in our laboratory have demonstrated 
different time requirements for the development of a latex specific IgE response 
following different routes of exposure to latex proteins.  To determine the proper time-
point  to assess the airway hyper-reactivity of previously sensitized mice, levels of total 
serum IgE were monitored.  When the serum IgE levels of the high dose group reached 
statistical significance from vehicle exposed animals, mice were non-specifically 
challenged with methacholine.  On days 60 (dermal), 44 (i.n.), and 47 (i.t.) following 
initial exposure, mice were placed into whole body plethysmography chambers and 
challenged with nebulized methacholine.  Modulation of airway hyper-reactivity was 
evaluated by comparing the percent increase in PenH over baseline between animals 
previously exposed to vehicle and animals previously exposed to NAL at each 
methacholine challenge dose.  Dose-responsive relationships within each exposure group 
were determined using linear regression.   
 
Upon comparing the degree of airway hyper-reactivity between exposed animals 
for each methacholine challenge dose, mice previously sensitized via dermal exposure to 
12.5 or 25 µg of NAL proteins demonstrated significant elevations (p < 0.01) in airway 
hyper-reactivity upon respiratory challenge with either 25 or 50mg/ml of methacholine, 
reaching greater than 400% increase over baseline values (Figure 14A).  Additionally, 
mice intratracheally sensitized with 12.5 and 25 µg of NAL proteins demonstrated 
significant (p < 0.01) increases in airway hyper-reactivity with greater than 350% and 
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400% increases, respectively, over baseline values (Figure 14C).  Since no significant 
differences in airway hyper-reactivity were observed between mice intranasally exposed 
to vehicle or the high dose group (25 µg of NAL), other exposure groups were excluded 
from the non-specific airway challenge (Figure 14B).   Using linear regression, a dose 
responsive relationship (p < 0.01) was observed between the level of airway hyper-
reactivity and methacholine challenge dose (10, 25 and 50 mg/ml) for all exposure groups 
in mice dermally or intratracheally exposed to NAL proteins (Figures 14A and 14C).   
 
NAL Specific Challenge.  Following the non-specific methacholine challenge, 
mice remained on study and continued to be exposed to NAL proteins as previously 
described.  On days 93 (dermal), 51 (i.n.), and 76 (i.t.) following initial test article 
exposure, the development of a latex specific airway hyper-reactivity response was 
evaluated in previously sensitized mice by administering 300 µg of NAL proteins via i.t. 
aspiration and monitoring PenH values over a 25 minute period. 
 
While mice dermally exposed to 6.25 or 25 µg of NAL proteins failed to 
demonstrate significant increases in the level of latex specific airway hyper-reactivity; 
mice previously exposed via dermal application to 12.5 µg of NAL proteins demonstrated 
greater than 1000-fold increase (p < 0.01) over baseline PenH values (Figure 15A).  Upon 
respiratory challenge, mice previously intranasally exposed to NAL proteins failed to 
demonstrate elevations in the levels of airway hyper-reactivity (Figure 15B).  Despite 
inducing elevations in non-specific airway hyper-reactivity, mice intratracheally exposed 
to NAL proteins did not exhibit an elevation in enhanced pause in this study (Figure 
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15C).  This lack of significance may be due in part to the elevated baseline level of 
airway hyper-reactivity in mice intratracheally exposed to vehicle (PBS).  While levels of 
antigen specific airway hyper-reactivity in vehicle mice exposed by the dermal and i.n. 
routes were ~200% over baseline, levels in mice i.t. exposed were ~1,800% over 
baseline.  Similar studies described later evaluating i.t. exposure to NAL proteins 
demonstrated ~1,000% increase over baseline in vehicle exposed mice. 
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Figure 14.  Non-Specific Airway Hyper-reactivity in Previously Sensitized Mice.  Mice previously exposed via the dermal (A), i.n. 
(B), or i.t. (C) routes were evaluated for the development of airway hyper-reactivity following methacholine challenge.  Numbers in 
parenthesis represent the mean total serum IgE levels (ng/ml) on day 58 (dermal), day 44 (i.n.), and day 58 (i.t.) for each 
corresponding exposure group. Bars represent means ± standard error for each group.  n=5 for all exposure groups except for the 
vehicle in intratracheally exposed animals where the n=4.  For each challenge dose of MCH, mice exposed to NAL were compared to 
vehicle animals and statistical significance was determined using a Dunnett’s t test.  Significance is indicated by * (p<0.05) and ** 
(p<0.01). 
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Figure 15.  Latex Specific Airway Hyper-reactivity in Previously Sensitized Mice.  Mice previously exposed via the dermal (A), i.n. 
(B), and i.t. (C) routes were evaluated for the antigen specific airway hyper-reactivity following latex challenge.  Numbers in 
parenthesis represent the mean total serum IgE levels (ng/ml) on day 93 (dermal), day 51 (i.n.), and day 79 (i.t.) for each 
corresponding exposure group. Bars represent means ± standard error for each group.  n=5 for all exposure groups except for the 
vehicle in intratracheally exposed animals where the n=4.  For the NAL challenge, significance was determined by comparing mice 
dermally exposed to NAL to dermally exposed vehicle animals using a Dunnett’s t test.  Significance is indicated by * (p<0.05). 
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Immunomodulatory Effect of Endotoxin on the Development of an IgE Mediated 
Hypersensitivity Response to Latex Proteins 
 
 
Previous studies validated dermal and respiratory exposure in evaluating the 
induction of latex specific IgE.   Individuals within the health care environment are 
exposed to numerous agents in addition to latex proteins.  Endotoxin is a common 
contaminant in the health care environment that has been shown to induce numerous 
inflammatory responses upon inhalation.  It was hypothesized that concurrent respiratory 
tract exposure to endotoxin with latex would modulate the development of an IgE 
mediated hypersensitivity response to latex proteins. 
 
Total IgE Response.  Initial studies were conducted to demonstrate the 
immunomodulatory effect of LPS on the levels of total serum IgE in mice exposed to 
latex proteins.  Total serum IgE levels were monitored in mice exposed i.n. to NAL 
proteins and increasing concentrations of endotoxin from Salmonella typhimurium via i.n. 
instillation for up to 72 days.  Exposure of mice to NAL proteins alone resulted in a time 
dependent increase in total IgE with a peak on day 58 at greater than 1,500 ng/ml (Figure 
16).  In contrast, mice concurrently exposed to NAL and concentrations of endotoxin 
ranging from 5,000 – 50,000 EU demonstrated levels of total serum IgE similar to those 
observed for vehicle-exposed mice (Figure 16B).   
 
A second study was conducted to evaluate the effect of lower concentrations (50 – 
25,000 EU) of endotoxin on the total serum IgE response.  Additionally, a strain 
comparison study was conducted using endotoxin from Salmonella typhimurium, 
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Salmonella typhosa, and Escherichia coli.  To conserve the number of animals, a single 
group of vehicle (n=10) and NAL (n=10) exposed mice were used as controls for the 
strain comparison studies.  As in the previous study, mice exposed to NAL alone 
demonstrated significantly elevated levels of total serum IgE, reaching greater than 1,500 
ng/ml (Figure 17).  Co-administration of NAL proteins with as little as 50 EU of 
endotoxin from Salmonella typhimurium, Salmonella typhosa, or Escherichia coli 
resulted in significantly lower levels of total serum IgE when compared to those observed 
in mice exposed to NAL alone (Figure 17).  Despite using lower concentrations of 
endotoxin (50 – 25,000 EU), no dose responsive relationship was observed in the levels 
of total serum IgE in mice concurrently exposed.   
 
Latex Specific Response.  On the final day of the study, blood was obtained from 
mice via cardiac puncture and serum collected for analysis of NAL specific antibodies. 
Sera from exposed mice were analyzed for the presence of NAL specific IgE, IgG2a, and 
IgA antibodies using a modified sandwich ELISA.  In the initial study evaluating 
concurrent exposure to NAL and concentrations of Salmonella typhimurium endotoxin 
between 5,000 and 50,000 EU, mice exposed to NAL alone demonstrated significant 
elevations (p < 0.01) in latex specific serum IgE, IgG2a, and IgA antibodies (Figure 18).  
While concurrent exposure to NAL and endotoxin resulted in greater than a 50% 
reduction of latex specific IgE production (Figure 18A), levels of IgG2a and IgA were 
elevated approximately 2-fold (p < 0.01) over mice exposed to NAL alone (Figure 18B, 
C).   
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Similar results were observed in the subsequent study evaluating lower 
concentrations of endotoxin (50 – 25,000 EU) from Salmonella typhimurium, Salmonella 
typhosa, or Escherichia coli.  While mice exposed concurrently to NAL and S. 
typhimurium endotoxin demonstrated lower latex specific serum IgE production when 
compared to levels in mice exposed to NAL alone (Figure 19A), a dose-responsive 
increase in latex specific IgG2a antibodies was observed (Figure 19B).  Although not 
dose responsive, concurrent exposure to NAL and concentrations of endotoxin greater 
than 1,250 EU resulted in a significant (p < 0.05) increase in latex specific IgA antibody 
levels when compared to mice exposed to NAL alone (Figure 19C).  Following a similar 
trend as S. typhimurium, concurrent exposure to NAL and endotoxin from S. typhosa 
resulted in a decrease in latex specific IgE levels by approximately 50% (Figure 20A), a 
dose-responsive increase in IgG2a levels with greater than a 2-fold increase over NAL 
exposed mice (Figure 20B), and significantly (p < 0.01) elevated levels of IgA upon 
concurrent exposure with as little as 500 EU (Figure 20C).  Mice exposed concurrently to 
NAL and increasing concentrations of endotoxin from E. coli demonstrated a decrease in 
latex specific serum IgE production, although this reduction was not statistically 
significant from mice exposed to NAL alone (Figure 21A).  However, levels of latex 
specific IgG2a antibodies were dose responsively increased in these mice with greater 
than a 2-fold increase over levels in mice exposed to NAL alone (Figure 21B).  
Concurrent exposure to NAL and greater than 5,000 EU from E. coli strains resulted in 
significantly higher latex specific IgA levels when compared to mice exposed to NAL 
alone (Figure 21C). 
 88
 
0 10 20 30 40 50 60 70 80
0
500
1000
1500
2000
2500 Vehicle
50,000 EU
NAL
NAL/5,000 EU
NAL/50,000 EU
**
**
**
Day of Study
To
ta
l I
gE
 (n
g/
m
l)
VH 50000 0 5000 12500 25000 37500 50000
0
500
1000
1500     0 µg NAL
+25 µg NAL
**
ψ ψ ψψ
ψ
LPS Dose (EU)
To
ta
l I
gE
 (n
g/
m
l)
Day 72
A
B
 
Figure 16:  Total IgE Levels in Mice Intratranasally Exposed to NAL and Endotoxin 
from Salmonella typhimurium.  Time course (A) and day 72 (B) total IgE levels were 
evaluated in mice concurrently exposed to NAL and concentrations of endotoxin ranging 
from 5,000 – 50,000 EU.  Points and bars represent means ± SE for each exposure group.  
n=5 for all exposure groups.  Statistical significance was determined using a Dunnett’s t 
test.  ** represents p<0.01 as compared to vehicle alone. ψ and ψψ represent p<0.05 and 
p<0.01, respectively, as compared to NAL alone. 
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Figure 17.  Total IgE Response in Mice Concurrently Intranasally Exposed to NAL and Different Strains of Bacterial Endotoxin. 
Mice were exposed to NAL and endotoxin (50 – 25,000 EU) from Salmonella typhimurium, Salmonella typhosa, or Escherichia coli.  
Serum was collected following sacrifice on day 65.  n=5 for all exposure groups except for the vehicle and NAL alone groups where 
n=10.  ** represents p<0.01 as compared to vehicle alone.  ψ and ψψ represent p<0.05 and p<0.01, respectively, as compared to NAL 
alone. 
 90
VH 50000 0 5000 12500 25000 37500 50000
0
10
20
30     0 µg NAL
+25 µg NAL
**
ψ
ψ
ψ
ψ ψ
LPS Dose (EU)
A
r
b
i
t
r
a
r
y
 
U
n
i
t
s
VH 50000 0 5000 12500 25000 37500 50000
0
500
1000
1500
+25 µg NAL
    0 µg NAL
**
ψ ψ ψ ψ
ψ
LPS Dose (EU)
A
r
b
i
t
r
a
r
y
 
U
n
i
t
s
NAL Specific IgE
NAL Specific IgANAL Specific IgG2a
VH 50000 0 5000 12500 25000 37500 50000
0
50
100
150     0 µg NAL
+25 µg NAL
**
ψ
ψ
ψ ψ ψ
LPS Dose (EU)
A
r
b
i
t
r
a
r
y
 
U
n
i
t
s
 
Figure 18.  Latex Specific Serum Antibody Response in Mice Intranasally Exposed to NAL and 5,000 – 50,000 EU of Endotoxin 
from Salmonella typhimurium.  Levels of latex specific IgE (A), IgG2a (B), and IgA (C) were evaluated in serum obtained from mice 
on the final day of the study (day 72).  Bars represent the means ± SE for each exposure group.  n=5 for all exposure groups except the 
vehicle and NAL alone groups where n=10.   ** represents p<0.01 as compared to vehicle alone.  ψ represents p<0.05 as compared to 
NAL alone. 
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Figure 19.  Latex Specific Serum Antibody Response in Mice Intranasally Exposed to NAL and Endotoxin from Salmonella 
typhimurium.  Levels of latex specific IgE (A), IgG2a (B), and IgA (C) were evaluated in serum obtained from mice on the final day 
of the study (day 65).  Bars represent the means ± SE for each exposure group.  n=5 for all exposure groups except the vehicle and 
NAL alone groups where n=10.   ** represents p<0.01 as compared to vehicle alone.  ψ and ψψ represent p<0.05 and p<0.01, 
respectively, as compared to NAL alone. 
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Figure 20.  Latex Specific Serum Antibody Response in Mice Intranasally Exposed to NAL and Endotoxin from Salmonella typhosa.  
Levels of latex specific IgE (A), IgG2a (B), and IgA (C) were evaluated in serum obtained from mice on the final day of the study 
(day 65).  Bars represent the means ± SE for each exposure group.  n=5 for all exposure groups except the vehicle and NAL alone 
groups where n=10.   ** represents p<0.01 as compared to vehicle alone.  ψ and ψψ represent p<0.05 and p<0.01, respectively, as 
compared to NAL alone. 
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Figure 21.  Latex Specific Serum Antibody Response in Mice Intranasally Exposed to NAL and Endotoxin from Escherichia coli.  
Levels of latex specific IgE (A), IgG2a (B), and IgA (C) were evaluated in serum obtained from mice on the final day of the study 
(day 65).  Bars represent the means ± SE for each exposure group.  n=5 for all exposure groups except the vehicle and NAL alone 
groups where n=10.   ** represents p<0.01 as compared to vehicle alone.  ψ and ψψ represent p<0.05 and p<0.01, respectively, as 
compared to NAL alone. 
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Characterization of the Immunomodulatory Response  
 
 The previous studies demonstrated the potential for endotoxin to down-regulate 
the induction of IgE.  Further investigation was necessary to elucidate the potential 
mechanisms by which endotoxin altered the immune response.  Due to the complex 
lymphoid drainage system of the nasopharyngeal region, mice in the subsequent studies 
were exposed via i.t. aspiration in order to evaluate the immune response in the lung 
associated lymph nodes.   
 
Total IgE Response.  An initial time and dose response study was conducted to 
confirm that i.t. endotoxin exposure had the same effect on the total and latex specific 
serum IgE levels as observed in the previous studies.  Mice were exposed every 5th day to 
NAL and/or concentrations of S. typhimurium endotoxin from 50 – 5,000 EU.  Peak 
serum IgE production in mice exposed to NAL alone occurred on day 58 when levels 
reached greater than 20,000 ng/ml, however, significant elevations (p < 0.01) were 
observed as early as day 37 (Figure 22A).  On day 58, levels of total serum IgE in mice 
concurrently exposed to NAL and increasing amounts of endotoxin (50 – 5,000 EU) were 
approximately 50 – 70% less than those observed in mice exposed to NAL alone (Figure 
22B).  Intratracheal exposure to NAL and increasing concentrations of endotoxin was 
shown to induce a trend of IgE production in mice similar to those observed in previous 
i.n. exposure studies.  
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Latex Specific Antibody Response.  Sera obtained from mice on the final day of 
the study were analyzed for latex specific antibodies using an ELISA.  As seen in mice 
exposed by the i.n. route, mice i.t. exposed to NAL proteins alone demonstrated 
significant increases (p < 0.01) in latex specific IgE, IgG2a, and IgA.  Whereas the latex 
specific serum IgE levels were significantly lower in all mice concurrently exposed to 
NAL and endotoxin (Figure 23A), both IgG2a (Figure 23B) and IgA (Figure 23C) levels 
in mice concurrently exposed to NAL and as little as 500 EU reached greater than 2-fold 
increases over the levels in animals exposed to NAL alone.   
 
Non-Specific Airway Hyper-reactivity.  Forty-seven (47) days following initial 
exposure, mice were challenged with increasing concentrations of methacholine to assess 
non-specific airway hyper-reactivity.  For each methacholine challenge dose, the levels of 
airway hyper-reactivity (percent increase in PenH over baseline) in mice exposed to NAL 
and/or endotoxin were compared to levels in vehicle control group for significance.   
 
Within each exposure group, the dose responsive relationship between airway 
hyper-reactivity and methacholine challenge dose was evaluated by linear regression.  
While mice previously exposed to 5,000 EU of endotoxin alone demonstrated a dose 
responsive (p < 0.01) increase in airway hyper-reactivity, no other exposure groups 
demonstrated a significant dose responsive relationship between the methacholine 
challenge dose and the levels of airway hyper-reactivity (Figure 24).  Previous exposure 
to NAL and 5,000 EU of endotoxin resulted in a significant (p < 0.05) increase in airway 
hyper-reactivity upon challenge with 25 and 50 mg/ml of methacholine as compared to 
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levels of airway hyper-reactivity in vehicle-exposed mice challenged with the same 
concentration of methacholine.  Although not reaching statistical significance, levels of 
airway hyper-reactivity in mice exposed to 5,000 EU of endotoxin alone were similar to 
those observed for mice concurrently exposed to NAL and 5,000 EU of endotoxin 
(Figure 24).  No significant elevations in airway hyper-reactivity were observed in mice 
exposed to NAL alone or concurrently to NAL and either 50 or 1,250 EU of endotoxin.  
 
Antigen Specific Airway Hyper-reactivity.  Following methacholine challenge, 
mice were dosed for an additional 19 days.  On day 66 following initial exposure, the 
development of a latex specific airway hyper-reactivity response was evaluated in 
previously sensitized mice as previously described.  Although levels failed to reach 
statistical significance from vehicle exposed animals, a 2-fold increase in airway hyper-
reactivity was observed in mice exposed to NAL alone (Figure 25).  Despite an increase 
in non-specific airway hyper-reactivity, mice exposed to 5,000 EU of endotoxin alone did 
not exhibit increased levels of latex specific airway hyper-reactivity.  Mice concurrently 
exposed to NAL and increasing concentrations (50, 1,250, or 5,000 EU) of endotoxin 
demonstrated decreases in airway hyper-reactivity with levels dropping to approximately 
50% of those observed in mice exposed to NAL alone (Figure 25).   
 
Histopathological Evaluation of the Lung Following Concurrent Exposure to 
Latex and Endotoxin.  Twenty-four hours following the latex specific challenge, animals 
were sacrificed, lungs were perfused with formalin and removed for histopathological 
evaluation.  Lungs were processed and stained with: 1) hematoxylin and eosin to 
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visualize cellular infiltration, 2) 0.5% Chromotrop 2R to visualize eosinophils, and 3) 
Alcian blue-periodic acid-Schiff to visualize mucin (polysaccharides and mucoproteins) 
production.   
 
Sections of tissue from the left lobe of the lung were analyzed for the degree of 
cellular and eosinophil infiltration and mucin production.  All vehicle animals 
demonstrated low levels of peribronchial histocytic alveolitis which is suspected to be 
due to repeated i.t. exposure to PBS.  Mice exposed to endotoxin alone exhibited 
perivascular and peribronchial alveolitis with increased numbers of macrophages over 
controls.  Latex exposure resulted in multifocal peribronchial and perivascular alveolitis.  
For animals exposed concurrently to NAL and endotoxin, the severity of the pathology 
appeared to increase with increasing concentrations of endotoxin with animals exposed to 
5,000 EU and NAL demonstrating severe diffuse alveolitis with large numbers of 
macrophages (Table 8 and Figure 26).  Pathological changes were confirmed by a board 
certified veterinary pathologist.   
 
Whereas exposure to NAL and endotoxin resulted in the cellular infiltration of 
macrophages, lymphocytes, and neutrophils, eosinophilia was not observed in mice from 
any of the exposure groups.  Differential mucin responses were observed between 
exposure groups.  Lung sections from mice were scored based on the degree of mucin 
production in the bronchial epithelium and the severity of the responses {scored as ‘–‘ 
(Figure 27F), ‘+’ (Figure 27B&E), ‘++’ (Figure 27D), ‘+++’ (Figure 27C)} are 
summarized in Table 8.  While sections from 3 out of 4 and 3 out of 5 mice exposed to 
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vehicle (Figure 27A) and endotoxin alone (Figure 27B), respectively, demonstrated low 
levels of mucin staining, increased production of mucin was observed in mice exposed to 
NAL alone as evidenced by scoring of ‘++’ or ‘+++’ in all mice of the exposure group 
(Figure 27C).  Mice concurrently exposed to 50 EU of endotoxin with latex demonstrated 
a decrease in the severity of the response as scores for mucin production were ‘-‘ to ‘++’ 
(Figure 27D).  Upon co-exposure with increasing amounts of endotoxin, the mucin 
production further decreased as scores of ‘-‘ to ‘+’ were recorded for mice exposed to 
NAL and 1,250 EU (Figure 27E) and only one mouse stained positively (+) for mucin 
production in mice exposed to NAL and 5,000 EU (Figure 27F). 
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Figure 22:  Total IgE Levels in Mice Intratracheally Exposed to NAL and Endotoxin 
from Salmonella typhimurium.  Time course (A) and day 58 (B) total IgE levels were 
evaluated in mice concurrently exposed to NAL and concentrations of endotoxin ranging 
from 50 – 5000 EU.  Points and bars represent means ± SE for each exposure group.  n=5 
for all exposure groups except the vehicle where n=4.   Statistical significance was 
determined using a Dunnett’s t test.  ** represents p<0.01 as compared to vehicle alone. 
ψ and ψψ represent p<0.05 and p<0.01, respectively, as compared to NAL alone. 
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Figure 23.  Latex Specific Serum Response in Mice Intratracheally Exposed to NAL and Endotoxin from Salmonella typhimurium.  
Levels of latex specific IgE (A), IgG2a (B), and IgA (C) were evaluated in serum obtained from mice on the final day of the study 
(day 67).  Bars represent the means ± SE for each exposure group.  n=5 for all exposure groups except the vehicle where n=4.   
Statistical significance was determined using a Dunnett’s t test. * and ** represent p<0.05 and p<0.01, respectively, as compared to 
vehicle alone.  ψ and ψψ represent p<0.05 and p<0.01, respectively, as compared to NAL alone. 
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Figure 24.  Levels of Non-Specific Airway Hyper-Reactivity in Mice Exposed to Latex 
and Increasing Concentrations of Endotoxin.  Numbers in parenthesis represent the mean 
total serum IgE levels on day 47 for each corresponding exposure group. Bars represent 
means ± SE for each group.  n=5 for all exposure groups except the vehicle where n=4.   
For each challenge dose of methacholine, exposed mice were compared to vehicle 
animals and statistical significance was determined using a Dunnett’s t test.  Significance 
is indicated by * (p<0.05). Within each exposure group, dose responsive trends were 
determined using linear regression. 
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Figure 25.  Latex Specific Airway Hyper-reactivity in Mice Exposed to Latex and 
Increasing Concentrations of Endotoxin.  Numbers in parenthesis represent the mean total 
serum IgE levels on day 66 for each corresponding exposure group. Bars represent means 
± SE for each group.  n=5 for all exposure groups except the vehicle group where n=4.   
Mice concurrently exposed to NAL and endotoxin were compared to animals exposed to 
NAL alone for statistical significance using a Dunnett’s t test.   
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Table 8.  Histopathological Analysis of the Lung Following Concurrent Exposure to Latex and Increasing Concentrations of 
Endotoxin from S. tyhphimurium.   
 
Exposure 
Group 
Mucin 
Scorea 
# of 
Responsesb 
 Hematoxylin & Eosin 
Evaluation  
# of  
Responsesb
Vehicle - 1/4 Mild peribronchial alveolitis 1/4 
 + 3/4 Moderate peribronchial alveolitis 2/4 
   Moderate peribronchial and perivascular alveolitis 1/4 
     
5,000 EU  - 2/5 Multifocal perivascular and peribronchial alveolitis 5/5 
 + 3/5   
     
NAL ++ 2/5 Multifocal peribronchial and perivascular alveolitis 5/5 
 +++ 3/5   
     
NAL - 1/5 Multifocal peribronchial and perivascular alveolitis 5/5 
& 50 EU  + 2/5   
 ++ 2/5   
     
NAL - 1/5 Multifocal peribronchial and perivascular alveolitis 5/5 
& 1,250 EU + 4/5 with areas of diffuse alveolitis  
     
NAL - 4/5 Severe diffuse alveolititis 5/5 
& 5,000 EU + 1/5   
     
 
a Lung sections were scored “-” to “+++” based on the degree of mucin production as visualized by staining with Alcian blue and 
periodic acid Schiff.  
b Represents the number of mice in each exposure group with the particular response  
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Figure 26.  Histopathological Evaluation of Cellular Infiltration Following Concurrent 
Respiratory Exposure to Latex and Endotoxin from S. tyhphimurium.  Lungs were 
excised 24 hours following i.t. challenge with latex proteins and stained with hematoxylin 
and eosin.  Lung sections are representative of mice previously intratracheally exposed to 
Vehicle (A), 5,000 EU of endotoxin (B), NAL (C), NAL & 50 EU of endotoxin (D), 
NAL & 1,250 EU of endotoxin (E), and NAL & 5,000 EU of endotoxin (F).  
Magnification = 20x and bars represent 50 µm. 
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Figure 27.  Mucin Production in Mice Following Concurrent Exposure to Latex and 
Endotoxin from S. tyhphimurium.  Lungs were excised 24 hours following i.t. challenge 
with latex proteins and stained with Alcian blue-periodic acid Schiff for visualization of 
mucin production.  Lung sections are representative of mice previously intratracheally 
exposed to Vehicle (A), 5,000 EU of endotoxin (B), NAL (C), NAL & 50 EU of 
endotoxin (D), NAL & 1,250 EU of endotoxin (E), and NAL & 5,000 EU of endotoxin 
(F).  Magnification = 20x and bars represent 50 µm. 
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Cytokine Evaluation.  Following the evaluation of airway hyper-reactivity, mice 
were sacrificed on day 67 and the mediastinal lymph nodes were excised from exposed 
mice and RNA was isolated to evaluate the message levels of Th1 and Th2 cytokines.  
Interleukin-4, IL-10, IL-12, and IFN-γ messenger RNA levels were evaluated using real-
time quantitative polymerase chain reaction.  No significant alterations were observed in 
the levels of IL-4 mRNA of any exposure groups when compared to mice exposed to 
vehicle alone (Figure 28A).  While no alterations in IL-4 message were observed, i.t. 
administration of endotoxin with or without NAL proteins resulted in at least a 3-fold 
increase in IL-10 messenger RNA levels (Figure 28B).  In contrast, endotoxin exposure 
induced greater than 50-fold and 8-fold increases in IL-12 and IFN-γ mRNA levels, 
respectively, upon comparison with vehicle levels (Figure 29).  Additionally, mice 
concurrently exposed to NAL and increasing concentrations of endotoxin demonstrated 
dose responsive increases in IL-12 and IFN-γ production, reaching greater than a 40-fold 
and 4-fold increase over vehicle levels respectively.    
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Figure 28.  Th2 Cytokine Message Levels in Mice Exposed to Latex and Increasing 
Concentrations of Endotoxin from S. typhimurium.  Increases in IL-4 (A) and IL-10 (B) 
expression were determined for each exposure group by calculating the fold increase over 
vehicle levels as described in the methods.  Bars represent means ± SE for each group. 
n=5 for all exposure groups except the vehicle group where n=4.    
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Figure 29.  Th1 Cytokine Message Levels in Mice Exposed to Latex and Increasing 
Concentrations of Endotoxin from S. typhimurium.  Increases in IL-12 (A) and IFN-γ (B) 
expression were determined for each exposure group by calculating the fold increase over 
vehicle levels as described in the methods.  Bars represent means ± SE for each group. 
n=5 for all exposure groups except the vehicle group where n=4. 
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Correlation between Class Switch and Cytokine Response  
 
 Previous studies demonstrated that concurrent exposure to latex and endotoxin 
results in the development of a predominantly Th1 response characterized by an increase 
in the levels of latex specific serum IgG2a antibodies and an increase in IL-12 and IFN-γ 
production.  Mice were intratracheally exposed to NAL and endotoxin to investigate the 
relationship between IgG2a and cytokine levels. 
 
 Latex Specific IgG2a Antibodies.  An initial study was conducted to identify the 
earliest time point at which latex specific IgG2a was detectable in concurrently exposed 
mice.  Mice were intratracheally exposed to NAL and/or 2,500 EU of S. typhimurium 
every 5th day for 12, 16, or 20 days.  Upon comparison with mice exposed to NAL alone, 
mice concurrently exposed to NAL and 2,500 EU demonstrated significant elevations (p 
< 0.01) in IgG2a levels as early as day 16 (Figure 30). 
  
A subsequent study was conducted to investigate the dose response relationship at 
day 16.  Mice were exposed every 5th day for 16 days and upon sacrifice, blood was 
collected for analysis of serum IgG2a levels.  Levels of IgG2a were dose responsively 
increased (p < 0.01) in mice exposed to NAL and increasing concentrations of endotoxin 
reaching levels 1000-fold greater than those observed in mice exposed to NAL alone 
(Figure 31).   
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Figure 30.  Time Course of Latex Specific Serum IgG2a Levels in Mice Exposed to 
Latex and 2,500 EU of Salmonella typhimurium.  Bars represent means ± SE for each 
group.  n=5 for all exposure groups.  Statistical significance between mice concurrently 
exposed and mice exposed to NAL alone was determined using a Dunnett’s t test.   
** represents p<0.01. 
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Figure 31.  Latex Specific Serum IgG2a Levels on Day 16 in Mice Exposed to Latex and 
Increasing Concentrations of Endotoxin.  Bars represent means ± SE for each group.  n=5 
for all exposure groups. Statistical significance between mice concurrently exposed and 
mice exposed to NAL alone was determined using a Dunnett’s t test.  ** represents 
p<0.01. 
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 Th1 Cytokine Message Levels.  The previous study demonstrated a dose 
responsive increase in latex specific serum IgG2a levels in mice concurrently exposed to 
NAL and increasing concentrations of endotoxin from S. typhimurium.  Mediastinal 
lymph nodes from these animals were excised and evaluated for cytokine message 
analysis.  As was observed in the cytokine levels on day 67, a dose responsive 
relationship was observed between the levels of IL-12 and concurrent exposure to NAL 
and increasing concentrations of endotoxin (Figure 32a).  Although not dose responsive, 
levels of IFN-γ were increased in animals concurrently exposed to NAL and increasing 
concentrations of endotoxin, reaching a 4-fold increase over levels in vehicle exposed 
mice (Figure 32b).  As was the case in the Th2 cytokine levels on day 67, IL-4 and IL-10 
mRNA levels were not significantly altered in any of the exposure groups (data not 
shown).   
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Figure 32.  Th1 Cytokine Message Levels in Mice Exposed to Latex and Endotoxin for 
16 Days.  Increases in IL-12 (A) and IFN-γ (B) expression were determined for each 
exposure group by calculating the fold increase over vehicle levels as described in the 
methods.  Bars represent means ± SE for each group. n=5 for all exposure groups. 
 113
Immunomodulatory Role of Glutaraldehyde in the Induction of Latex Specific IgE  
 
 
 
Due to its immunological activity and extensive use within medical care facilities, 
glutaraldehyde was investigated for the potential to modulate the development of an IgE 
mediated hypersensitivity response to latex proteins following dermal exposure.   
 
Serum IgE Response.  Mice were exposed 5 days a week to NAL and increasing 
concentrations of glutaraldehyde by first applying the vehicle or glutaraldehyde solution 
to the clipped dorsal thorax region of mice.  Approximately 5 minutes later, NAL 
proteins were applied to the same site.  Due to the irritancy potential of glutaraldehyde, 
the application site of mice was monitored throughout the studies for the development of 
skin irritation.   
 
An initial study was conducted investigating concurrent exposure of mice to NAL 
and concentrations of glutaraldehyde representative of those used in cold sterilant 
solutions (0.1, 0.5, and 1%).  Serum IgE levels were monitored bi-weekly throughout the 
course of the study.  Following dermal exposure to solutions containing 1% 
glutaraldehyde, skin in exposed mice failed to re-grow hair and appeared to be thickened.  
Mice exposed to 1% glutaraldehyde alone demonstrated a time dependent increase in 
total serum IgE levels, with a significant increase (p < 0.01) over vehicle exposed mice 
observed as early as day 30 (Figure 33A).  While levels of total serum IgE in mice 
exposed to glutaraldehyde alone increased to levels greater than 3,000 ng/ml on day 79, 
no significant elevations were observed in any of the other exposure groups.  Animals 
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exposed concurrently to 1% glutaraldehyde and NAL had levels of total serum IgE 
approximately 50% lower than those observed in mice exposed to 1% glutaraldehyde 
alone (Figure 33B).  Latex specific serum IgE levels did not reach levels of significance 
in any of the exposure groups (Figure 33C).   
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Figure 33.  Total and Latex Specific Serum IgE Levels in Mice Concurrently Exposed to Latex and Glutaraldehyde for 72 Days.  
Time course of total IgE (A), day 72 total IgE (B), and day 72 latex specific IgE (C) levels were evaluated by ELISA in mice 
concurrently exposed to NAL and concentrations of glutaraldehyde (Glut) ranging from 0.1 – 1%. Bars or points represent means ± 
SE for each exposure group.  n=5 for all exposure groups.  Statistical significance was determined using a Dunnett’s t test.  ** 
represents p<0.01 as compared to vehicle alone.    
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Studies were then conducted to evaluate the effect of exposure to lower 
concentrations of glutaraldehyde ranging from 0.05 – 1ppm (values surrounding the 
permissible exposure limit) on the development of an IgE mediated hypersensitivity 
response to latex proteins.  Data from a representative study is shown in Figure 34.  
Throughout the course of the study, no significant elevation in the levels of total serum 
IgE was observed in animals exposed to NAL alone.  A time and dose dependent increase 
in total serum IgE was observed in mice concurrently exposed to NAL and 
concentrations of glutaraldehyde ranging from 0.05 – 0.75ppm (Figures 34A & B).  No 
significant elevations in total serum IgE were observed in mice exposed concurrently to 
NAL and 1ppm glutaraldehyde throughout the course of the study.  Mice exposed 
concurrently to NAL and 0.75ppm of glutaraldehyde demonstrated significantly (p < 
0.01) elevated levels of total serum IgE as early as day 58 reaching greater than 3000 
ng/ml on day 65. Co-exposure to 0.75ppm glutaraldehyde augmented the latex specific 
IgE response as a 40-fold increase was observed in comparison with levels from mice 
exposed to NAL alone (Figure 34C).   
  
A repeat study was conducted to demonstrate the reproducibility of this effect.  
Mice were again exposed 5 days a week on the dorsal thorax to NAL and up to 1ppm 
glutaraldehyde and serum antibody levels were monitored bi-weekly throughout the 
study.  As in the previous study, mice concurrently exposed to NAL and 0.75ppm of 
glutaraldehyde demonstrated significant elevations (p < 0.05) in total serum IgE as early 
as day 58 following the initial exposure (Figure 35A) reaching levels greater than 2,500 
ng/ml on day 86 (Figure 35B).  Although not statistically significant, increased levels of 
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latex specific IgE were observed in mice concurrently exposed to NAL and increasing 
concentrations of glutaraldehyde reaching 2-fold higher levels in mice exposed to NAL 
and 0.75ppm glutaraldehyde when compared with those from animals exposed to NAL 
alone (Figure 35C).  As in the previous study, animals exposed to NAL and 1ppm did not 
demonstrate significant elevations in either total or latex specific IgE.   
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Figure 34.  Total and Latex Specific Serum IgE Levels in Mice Concurrently Exposed to Latex and Glutaraldehyde for 65 Days.  
Time course of total IgE (A), day 65 total IgE (B), and day 65 latex specific IgE (C) levels were evaluated by ELISA in mice 
concurrently exposed to NAL and concentrations of glutaraldehyde (Glut) ranging from 0.05 – 1ppm. Points and bars represent means 
± SE for each exposure group.  n=5 for all exposure groups.  Statistical significance was determined using a Dunnett’s t test.  ** 
represents p<0.01 as compared to vehicle alone.   ψψ represents p<0.01 as compared to NAL alone. 
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Figure 35.  Total and Latex Specific Serum IgE Levels in Mice Concurrently Exposed to Latex and Glutaraldehyde for 86 Days.  
Time course of total IgE (A), day 86 total IgE (B), and day 86 latex specific IgE (C) levels were evaluated by ELISA in mice dermally 
exposed to NAL and concentrations of glutaraldehyde (Glut) ranging from 0.05 – 1ppm. Points and bars represent means ± SE for 
each exposure group.  n=5 for all exposure groups.  Statistical significance was determined using a Dunnett’s t test.  * represents 
p<0.05 as compared to vehicle alone.   ψ represents p<0.05 as compared to NAL alone. 
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Potential Role for Barrier Disruption 
 
 Given that glutaraldehyde is known to induce dermatitis, these studies tested the 
hypothesis that disruption of the stratum corneum, due to glutaraldehyde exposure, would 
allow for enhanced dermal penetration of latex proteins leading to the observed 
elevations in latex specific IgE. 
  
 In Vitro Percutaneous Penetration of Latex Proteins.  Glutaraldehyde 
concentrations of 0.75 and 1ppm were evaluated for their potential to disrupt the barrier 
integrity of the skin.  Skin from hairless guinea pigs previously exposed to glutaraldehyde 
(0.75 or 1ppm) for up to 56 days was tested using a 3H2O-barrier integrity test followed 
by the evaluation of in vitro percutaneous penetration of radiolabeled NAL proteins.   
  
 Every two weeks post initial exposure (days 14, 28, 42, and 56), a pair of hairless 
guinea pigs were sacrificed and the dorsal lumbar region excised for analysis.  Exposure 
was carried out for up to 56 days due to the initial observation of elevated IgE levels on 
day 58 (Figure 34A) in mice concurrently exposed to NAL and 0.75ppm glutaraldehyde.  
The percent penetration of radiolabeled NAL protein was compared between skin 
previously exposed to acetone (the vehicle for glutaraldehyde) or glutaraldehyde (Tables 
9 & 10).  Upon analysis it was demonstrated that the barrier integrity was conserved in all 
previously exposed skin samples as the percent of 3H2O penetration ranged between 0.03 
and 0.14%; while the established cutoff for determining barrier disruption is 0.35% 
(Bronaugh and Collier, 1991).  Additionally, no significant differences in latex protein 
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penetration were observed between skin samples exposed to acetone or glutaraldehyde 
throughout the course of the study (Tables 9 & 10).  Acetone and glutaraldehyde exposed 
skin samples were found to contain between 0.05% and 0.30% of the applied 
radiolabeled dose, while the percent penetration through the skin and into the receptor 
fluid ranged from 0.20% – 0.60%.  Radiolabel recovery (mass balance) for all studies 
was greater than 85%.  Additionally, immunohistochemical analysis of the skin samples 
previously exposed to acetone or glutaraldehyde demonstrated no differences in the 
stratum corneum integrity, cellular infiltration, or localization of NAL proteins (Figures 
36 & 37).  
 
 Barrier Integrity in Mice Concurrently Exposed to Latex and Glutaraldehyde.  
Barrier integrity was also evaluated in the dose response, time course murine study where 
an elevation in total serum IgE was observed in mice concurrently exposed to NAL and 
0.75ppm glutaraldehyde on day 86 (Figure 35).  Upon sacrifice, skin from the dorsal 
thorax exposure site was excised and subjected to a barrier test.  While skin samples for 
vehicle exposed animals did not demonstrate significant alterations in the barrier integrity 
(0.30% 3H2O penetration); all skin samples previously exposed to NAL and increasing 
concentrations of glutaraldehyde demonstrated greater than 0.35% 3H2O penetration 
(Figure 38).  The percent of 3H2O penetration in skin previously exposed to NAL and 
glutaraldehyde ranged between 0.4 and 0.8%, which, although greater than the cutoff for 
barrier disruption, has been shown to be insufficient to allow enhanced penetration of 
latex proteins (Hayes et al., 2000).  Mass balance for all samples was greater than 90% 
(data not shown). 
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Table 9.  Penetration of Latex Protein through Hairless Guinea Pig Skin Previously Exposed to 0.75ppm Glutaraldehyde. 
 
Time Point Exposure 3H2O Penetrationa Skinb Receptor Fluidb Mass Balanceb 
      
Day 0      
 Unexposed   0.053 ± 0.005 0.54 ± 0.04 0.59 ± 0.05 96.31 ± 1.24 
Day 14      
 Acetone 0.037 ± 0.003 0.25 ± 0.02 0.41 ± 0.04 98.82 ± 2.43 
 0.75 ppm Glutaraldehyde 0.039 ± 0.005 0.30 ± 0.03 0.50 ± 0.04 97.45 ± 1.12 
Day 28      
 Acetone 0.044 ± 0.008 0.07 ± 0.01 0.52 ± 0.28 99.42 ± 0.77 
 0.75 ppm Glutaraldehyde 0.084 ± 0.030 0.15 ± 0.05 0.60 ± 0.34 95.28 ± 4.11 
Day 42      
 Acetone 0.051 ± 0.005 0.19 ± 0.02 0.37 ± 0.02 108.1 ± 2.07 
 0.75 ppm Glutaraldehyde 0.071 ± 0.028 0.26 ± 0.03 0.35 ± 0.03 103.7 ± 2.94 
Day 56      
 Acetone 0.051 ± 0.004 0.16 ± 0.04 0.39 ± 0.04 99.91 ± 1.03 
 0.75 ppm Glutaraldehyde 0.143 ± 0.089 0.14 ± 0.03 0.55 ± 0.12 101.6 ± 1.63 
 
a Values represent the mean percentage ± SE of the applied 3H2O dose. (n=6) 
b Values for the skin, receptor fluid, and mass balance represent the mean percentage ± SE of the applied 125I-NAL 
dose. (n=6) 
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Table 10.  Percutaneous Penetration of Latex Protein through Hairless Guinea Pig Skin Previously Exposed to 1ppm 
Glutaraldehyde.   
 
Time Point Exposure 3H2O Penetrationa Skinb Receptor Fluidb Mass Balanceb 
      
Day 0      
 Unexposed 0.053 ± 0.005 0.54 ± 0.04 0.59 ± 0.05 96.31 ± 1.24 
Day 14      
 Acetone 0.052 ± 0.005 0.05 ± 0.01 0.20 ± 0.02 102.5 ± 1.31 
 1 ppm Glutaraldehyde 0.053 ± 0.006 0.05 ± 0.01 0.20 ± 0.03 101.3 ± 0.47 
Day 28      
 Acetone 0.030 ± 0.003 0.10 ± 0.01 0.27 ± 0.11 96.78 ± 1.22 
 1 ppm Glutaraldehyde 0.030 ± 0.004 0.10 ± 0.01 0.30 ± 0.04 96.21 ± 1.13 
Day 42      
 Acetone 0.108 ± 0.033 0.07 ± 0.02 0.41 ± 0.17 85.58 ± 14.7 
 1 ppm Glutaraldehyde 0.043 ± 0.011 0.07 ± 0.01 0.30 ± 0.08 88.52 ± 10.3 
Day 56      
 Acetone 0.064 ± 0.014 0.25 ± 0.03 0.32 ± 0.08 101.5 ± 2.22 
 1 ppm Glutaraldehyde 0.042 ± 0.003 0.25 ± 0.02 0.31 ± 0.03 100.2 ± 1.30 
 
a Values represent the mean percentage ± SE of the applied 3H2O dose. (n=6) 
b Values for the skin, receptor fluid, and mass balance represent the mean percentage ± SE of the applied 125I-NAL 
dose. (n=6) 
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Figure 36.  Latex Protein Penetration in Hairless Guinea Pig Skin Exposed to 0.75ppm 
Glutaraldehyde.  Latex protein visualization in the skin of hairless guinea pig skin 
previously exposed to either acetone or 0.75ppm of glutaraldehyde for 0 (A, B), 28 (C, 
D), and 56 days (E, F).  Excised skin was exposed to 100 µg of NAL protein for 24 hours 
and stained using a polyclonal rabbit anti-NAL antibody to visualize the degree of protein 
penetration.  Magnification = 40x and bars represent 50 µm. 
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Figure 37.  Latex Protein Penetration in Hairless Guinea Pig Skin Exposed to 1ppm 
Glutaraldehyde.  Latex protein visualization in the skin of hairless guinea pig skin 
previously exposed to either acetone or 1ppm of glutaraldehyde for 0 (A, B), 28 (C, D), 
and 56 days (E, F).  Excised skin was exposed to 100 µg of NAL protein for 24 hours and 
stained using a polyclonal rabbit anti-NAL antibody to visualize the degree of protein 
penetration.  Magnification = 40x and bars represent 50 µm. 
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Figure 38.  Barrier Integrity in Skin Previously Exposed to Latex and Increasing 
Concentrations of Glutaraldehyde.  Skin from the dorsal thorax exposure region was 
excised on day 86 from mice previously exposed to NAL with increasing concentrations 
of glutaraldehyde and subjected to a 3H2O barrier test.  n=5 for all exposure groups.  
Statistical significance and dose responsive trends were determined using a Dunnett’s t 
test and linear regression, respectively. 
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Investigation of the Mechanisms Leading to the Augmented IgE Response in Mice 
Concurrently Exposed to Latex and Glutaraldehyde  
 
 
In order to investigate the mechanism(s) underlying the serum IgE augmentation 
following concurrent exposure to NAL and glutaraldehyde, mice were exposed on the 
dorsal surface of the ear pinna.  This site of chemical exposure allows for analysis of 
multiple endpoints within a given study such as: 1) evaluation of Langerhans’ cell 
activation by the up-regulation of MHC class II expression, 2) phenotypic analysis of the 
draining lymph node cells, and 3) characterization of the cytokine microenvironment 
within the draining lymph node.  These studies evaluated the hypothesis that concurrent 
exposure to glutaraldehyde with NAL would augment the cellular activation by up-
regulating the expression of MHC class II on Langerhans cells, thereby increasing the 
potential for APC – T cell interaction in the draining lymph nodes, subsequent T and B 
cell activation through the up-regulation of CD40 and CD86 on B cells and CD28 on T 
cells, and IgE production through the release of IL-4 by T cells. 
 
Mice were concurrently exposed to glutaraldehyde with latex on the dorsal 
surface of the ear pinna for 86 days.  On day 86, mice were sacrificed and sera collected 
from all animals (n=10 per group).  Cervical lymph nodes were excised and five animals 
per exposure group were used for phenotypic analysis and the other five animals used for 
cytokine evaluation using real-time RT-PCR.   
 
 
 128
Serum IgE Response. As in the previous time course studies, mice concurrently 
exposed to NAL and 0.75ppm glutaraldehyde demonstrated elevated levels of total serum 
IgE reaching approximately 2,000 ng/ml on day 86 as compared with ~1,000 ng/ml in 
mice exposed to NAL alone (Figures 39A & B).  IgE levels were not significantly 
elevated in mice exposed to NAL alone or mice concurrently exposed to NAL and 1ppm 
glutaraldehyde.  Mice concurrently exposed to NAL and 0.75ppm glutaraldehyde 
demonstrated significantly elevated (p < 0.05) levels of latex specific serum IgE on day 
86 reaching greater than a 2-fold increase over levels in mice exposed to NAL alone 
(Figure 39C). 
  
 Cytokine Micro-Environment in the Draining Lymph Node.  Upon activation, 
dendritic cells, B cells, and T cells secrete cytokines that modulate the immune response.  
To investigate the relationship between local cytokine production and the augmented 
total serum IgE response, the draining cervical lymph nodes were excised and analyzed 
for the levels of IL-4, IL-10, IL-12 and IFN-γ messenger RNA.  No significant alterations 
in IL-4 message levels were observed in any of the exposure groups (Figure 40A).  
Concurrent exposure to NAL and either 0.75 or 1ppm glutaraldehyde resulted in slightly 
elevated mRNA levels of IL-10 (Figure 40B), IL-12 (Figure 40C), and IFN-γ (Figure 
40D) in comparison to mice exposed to NAL alone.  While these levels were elevated, 
none of the exposure groups exhibited levels of cytokine message 2-fold greater than the 
vehicle and therefore are not considered biologically significant.   
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 Expression of Cell Surface Markers and Co-Stimulatory Molecules.  Upon 
sacrifice, the cervical draining lymph nodes were excised and cells analyzed for the 
expression of co-stimulatory molecules (CD28, CTLA-4, CD86), activation markers 
(CD40, MHC class II), cell surface markers (CD4, CD8, B220) and IgE antibody 
molecules bound to FcεRII/CD23 on the B cell.  
 
Mice concurrently exposed to NAL and 0.75ppm glutaraldehyde demonstrated 
increased numbers of B220+ cells as evidenced by the increase from 3.31 x 106 (vehicle) 
to 7.67 x 106 B220+ cells (Table 11).  Mice concurrently exposed to NAL and 0.75ppm 
glutaraldehyde also demonstrated an increase in cellular activation and co-stimulation in 
both MHC class II (Table 12) and CD40 (Table 11) expressing cells as evidenced by an 
approximate 2-fold increase when compared with vehicle treated mice.  In correlation 
with serum IgE levels, the expression of CD23 and number of B cells with IgE bound to 
the low affinity receptor were significantly increased (p<0.05) over vehicle exposed 
animals.  Additionally, mice exposed to 0.75ppm glutaraldehyde alone demonstrated 
significant increases in the number of both CD4+ and CD8+ T cells in comparison to 
those levels in mice exposed to the vehicle alone (Table 12).  These mice also 
demonstrated an increase in the number of cells expressing the T cell co-stimulatory 
molecule, CD28, with an approximate increase in cell number 1.5-fold greater than those 
observed in mice exposed to vehicle (Table 12).  With the exception of CD40 expressing 
cells, mice concurrently exposed to NAL and 1ppm exhibited levels of expression similar 
to those observed in mice exposed to NAL alone.  The B cell co-stimulatory molecule, 
CD40, however, was significantly (p < 0.05) elevated in these animals (Table 11).   
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Figure 39.  Total and Latex Specific Serum IgE Levels in Mice Dermally Exposed to Latex and Glutaraldehyde on the Ear Pinna.  
Time course of total IgE (A), day 86 total IgE(B), and day 86 latex specific IgE(C) levels were evaluated by ELISA in mice 
concurrently exposed to NAL and either 0.75 or 1ppm glutaraldehyde (Glut). Bars represent means ± SE for each exposure group.  
n=10 for all exposure groups.  Statistical significance was determined using a Dunnett’s t test.  * and ** represents p<0.05 and p<0.01, 
respectively, as compared to vehicle alone.   ψ represents p<0.05 as compared to NAL alone. 
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Figure 40.  Cytokine Message Levels in Mice Exposed to Latex and Glutaraldehyde for 86 Days.  Increases in IL-4 (A), IL-10 (B), 
IL-12 (C) and IFN-γ (D) expression were determined for each exposure group by calculating the fold increase over vehicle levels as 
described in the methods.  Bars represent means ± SE for each group. n=5 for all exposure groups.   
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Table 11.  Modulation of B Cell Markers Upon Concurrent Exposure to Latex and Glutaraldehyde.   
Exposure Group Cell Count B220+ B220+IgE+ CD40+ CD23+ 
      
Vehicle   8.67 ± 0.72 3.31 ± 0.18 0.82 ± 0.15 2.29 ± 0.18 2.25 ± 0.17 
Glut 0.75ppm   12.61 ± 0.94* 5.02 ± 0.71 1.65 ± 0.36 3.16 ± 0.33 3.07 ± 0.32 
25 µg NAL    9.33 ± 0.50 6.06 ± 0.75 2.50 ± 0.45 3.40 ± 0.37 3.33 ± 0.36 
Glut 0.75ppm/NAL 11.84 ± 1.10      7.67 ± 1.18**     3.28 ± 0.75**     3.95 ± 0.38**   4.01 ± 0.43*
Glut 1ppm/NAL 11.14 ± 1.13 5.52 ± 0.87 1.82 ± 0.55   3.56 ± 0.37* 3.43 ± 0.40 
 
Note. Values represent mean absolute cell numbers (x 106) for each group ± SE. n=5 for all exposure groups.   
* and ** represent significant differences of p<0.05 and p<0.01 compared to vehicle exposed animals, as 
determined by Dunnett’s t test  
 
Table 12.  Modulation of MHC Class II Expression and T Cell Markers Upon Concurrent Exposure to Latex and Glutaraldehyde.   
Exposure Group Cell Count MHC Class II  CD4+ CD8+ CD28+ 
      
Vehicle   8.67 ± 0.72 2.77 ± 0.19 3.81 ± 0.35 1.59 ± 0.15 5.29 ± 0.46 
Glut 0.75ppm   12.61 ± 0.94* 3.68 ± 0.34     5.93 ± 0.50**   2.43 ± 0.21*     7.98 ± 0.62** 
25 µg NAL    9.33 ± 0.50 3.80 ± 0.42 3.83 ± 0.16 1.58 ± 0.08 4.98 ± 0.23 
Glut 0.75ppm/NAL 11.84 ± 1.10    4.50 ± 0.45* 5.01 ± 0.58 2.00 ± 0.21 6.30 ± 0.85  
Glut 1ppm/NAL 11.14 ± 1.13 3.84 ± 0.44 4.72 ± 0.44 1.88 ± 0.25 5.86 ± 0.59 
 
Note. Values represent mean absolute cell numbers (x 106) for each group ± SE. n=5 for all exposure groups.   
* and ** represent significant differences of p<0.05 and p<0.01 compared to vehicle exposed animals, as 
determined by Dunnett’s t test  
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Based on the results from the previous study, it was hypothesized that earlier time 
points were required to elucidate the cellular events responsible for the increase in total 
serum IgE levels in mice concurrently exposed to NAL and 0.75ppm glutaraldehyde.  A 
time course study was designed to evaluate: 1) activation of antigen presenting cells as 
evidenced by increased MHC class II expression, 2) the expression of co-stimulatory 
molecules on B and T cells, and 3) level of IgE bound to CD23 on B cells.  Mice were 
exposed on the dorsal surface of the ear pinna for 2, 4, 6, 8, 15, 22, or 29 days.  Upon 
sacrifice, the epidermal sheets were removed for MHC class II expression on 
Langerhans’ cells and cervical draining lymph nodes were excised and analyzed by 
phenotypic analysis.   
 
Langerhans’ cells uptake and process antigen for presentation to T cells via MHC 
class II molecules.  The level of Langerhans’ cell activation was subjectively evaluated 
by counting the number of MHC class II positive cells within a specified field of focus 
(40x magnification) using confocal microscopy.  A significant increase (~70%, p<0.05) 
in the number of MHC class II positive Langerhans’ cells was observed on day 2 in mice 
exposed concurrently to NAL and 0.75ppm glutaraldehyde as compared to vehicle 
exposed animals (Figure 41).  Although not statistically significant, mice exposed to 
NAL and 1ppm glutaraldehyde exhibited a greater than 25% increase in the number of 
Langerhans’ cells expressing MHC class II.  No significant elevations in Langerhans’ 
cells were observed by any other exposure groups at any time point during the course of 
the study, however mice exposed to 0.75ppm glutaraldehyde with NAL exhibited higher 
numbers of Langerhans’ cells in comparison with mice exposed to NAL alone. 
 134
 
 
 
 
 
0.75 0 0.75 1
-25
0
25
50
75
100
2
4
6
8
29
+25µg NAL
Days of Exposure
*
Glutaraldehyde Dose (ppm)
%
 In
cr
ea
se
 in
La
ng
er
ha
ns
' C
el
ls
 o
ve
r
Ve
hi
cl
e
 
Figure 41.  Time Course Evaluation of MHC Class II Expressing Langerhans’ Cell 
Numbers in Mice Concurrently Exposed to Glutaraldehyde with Latex. MHC Class II 
expressing Langerhans’ cells were evaluated by confocal microscopy in mice 
concurrently exposed to NAL and/or either 0.75 or 1ppm glutaraldehyde. Bars represent 
means ± SE for each exposure group.  n=5 for all exposure groups.  Statistical 
significance was determined using a Dunnett’s t test.  * represents p<0.05 as compared to 
mice exposed to NAL alone.   
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Throughout the course of the study, no significant differences in the total number 
of draining lymph node cells were observed between any of the exposure groups (Table 
13).  In the previous study, mice concurrently exposed to NAL and 0.75ppm 
glutaraldehyde for 86 days demonstrated increases in the number of cells expressing B 
cell surface and co-stimulatory molecules while mice exposed to 0.75ppm glutaraldehyde 
alone exhibited increased numbers of cells expressing T cell surface markers and co-
stimulatory molecules.  At an earlier time point (day 8), mice exposed to 0.75ppm 
glutaraldehyde alone in the time course study demonstrated an almost a 2-fold increase in 
the number of B cells on day 8 when compared to mice exposed to NAL alone (Table 
14), however this observation failed to repeat in a subsequent experiment (data not 
shown).  No other elevations in the number of B220+ expressing cells were observed in 
exposure groups throughout the time course study.  The number of cells expressing IgE 
bound to the low affinity receptor on B cells did not significantly differ between exposure 
groups at any time point up to 29 days post initial exposure (Table 15).  CD86 is a co-
stimulatory molecule expressed on B cells and up-regulated during the activation process.  
On day 22, mice exposed to 0.75ppm glutaraldehyde alone exhibited more than a 6-fold 
increase in the number of B cells expressing CD86 as compared to those observed in 
mice exposed to NAL alone (Table 16).  In a subsequent study, this observation failed to 
repeat (data not shown).  Although B cells and CD86 molecules have been shown to be 
elevated at times during the course of the study, expression of the co-stimulatory 
molecule CD40 on B cells did not significantly differ between exposure groups (Table 
17).  Additionally, there were no statistically significant differences between the numbers 
of CD4+ T cells in mice concurrently exposed to NAL and glutaraldehyde (Table 18).  
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Whereas the number of cells expressing the co-stimulatory molecule CD86 was shown to 
increase in mice exposed to 0.75ppm glutaraldehyde, there was no observed increase in 
the number of T cells expressing the complementary molecule (CD28) in any exposure 
group during the course of the study (Table 19).  Based on the observed increase in MHC 
class II expression in mice following exposure for 86 days; it was initially hypothesized 
that the number of antigen presenting cells would be elevated in mice exposed to NAL 
and 0.75ppm glutaraldehyde.  However, exposure groups did not exhibit statistically 
significant differences in the number of MHC class II expressing antigen presenting cells 
in the DLN at any point during the time course (Table 20).   
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Table 13.  Time Course of DLN Cell Counts in Mice Concurrently Exposed to Latex and Glutaraldehyde. 
 
Cell Counts Day of Sacrifice 
Exposure Group 2 4 6 8 15 22 29 
        
Vehicle   9.44 ± 1.37   8.80 ± 0.96 14.69 ± 1.61   8.68 ± 0.70   8.63 ± 1.40 10.69 ± 0.24   9.25 ± 0.56
Glut 0.75ppm 10.19 ± 1.02   9.35 ± 0.39 11.71 ± 1.87 12.73 ± 1.23   9.34 ± 0.27   9.79 ± 0.95 12.78 ± 1.41
25 µg NAL    8.49 ± 0.68   9.09 ± 0.69 10.76 ± 1.19   9.04 ± 0.83 10.33 ± 1.01 10.96 ± 0.96   9.48 ± 1.18
Glut 0.75ppm/NAL 11.20 ± 1.26 10.11 ± 1.40 11.13 ± 0.48 11.84 ± 1.10   8.87 ± 1.07   9.07 ± 0.79 10.60 ± 1.10
Glut 1ppm/NAL   8.65 ± 0.52   8.94 ± 1.51 10.27 ± 1.75 11.15 ± 1.15   9.15 ± 1.23 10.09 ± 1.53   9.84 ± 0.54
 
 Note. Values represent mean absolute cell numbers (x 106) for each group ± SE. n=5 for all exposure groups.   
 
 
Table 14.  Time Course of B220 Expression in DLN Cells of Mice Following Concurrent Exposure to Latex and Glutaraldehyde 
 
B220 Day of Sacrifice 
Exposure Group 2 4 6 8 15 22 29 
        
Vehicle 0.98 ± 0.18 0.94 ± 0.13 1.70 ± 0.08 1.99 ± 0.23 1.99 ± 0.32 1.07 ± 0.06 0.91 ± 0.16 
Glut 0.75ppm 1.24 ± 0.20 0.82 ± 0.14 1.35 ± 0.28   3.29 ± 0.43* 2.29 ± 0.08 2.02 ± 0.32 1.29 ± 0.18 
25 µg NAL  0.92 ± 0.12 0.92 ± 0.10 0.96 ± 0.14 1.87 ± 0.24 2.70 ± 0.32 1.36 ± 0.16 0.89 ± 0.14 
Glut 0.75ppm/NAL 1.25 ± 0.20 1.12 ± 0.25 1.13 ± 0.10 2.67 ± 0.37 2.22 ± 0.36 1.35 ± 0.17 1.00 ± 0.18 
Glut 1ppm/NAL 0.88 ± 0.14 1.12 ± 0.25 1.09 ± 0.29 2.14 ± 0.40 2.26 ± 0.29 1.30 ± 0.19 0.79 ± 0.15 
 
Note. Values represent mean absolute cell numbers (x 106) for each group ± SE. n=5 for all exposure groups.   
Statistical significance was determined using a Dunnett’s t test. * represents p<0.05when 
compared to mice exposed to NAL alone.  
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Table 15.  Time Course of IgE Expression on B Cells in the DLN of Mice Concurrently Exposed to Latex and Glutaraldehyde 
 
B220+IgE+ Day of Sacrifice 
Exposure Group 2 4 6 8 15 22 29 
        
Vehicle 0.11 ± 0.06 0.05 ± 0.02 0.30 ± 0.09 0.30 ± 0.14 0.49 ± 0.11 0.05 ± 0.02 0.02 ± 0.02 
Glut 0.75ppm 0.17 ± 0.10 0.08 ± 0.03 0.09 ± 0.05 0.32 ± 0.09 0.37 ± 0.09 0.23 ± 0.10 0.10 ± 0.04 
25 µg NAL  0.05 ± 0.02 0.06 ± 0.02 0.14 ± 0.06 0.18 ± 0.05 0.45 ± 0.17 0.13 ± 0.03 0.03 ± 0.01 
Glut 0.75ppm/NAL 0.16 ± 0.08 0.13 ± 0.05 0.28 ± 0.05 0.20 ± 0.08 0.41 ± 0.11 0.18 ± 0.05 0.02 ± 0.01 
Glut 1ppm/NAL 0.10 ± 0.04 0.21 ± 0.06 0.08 ± 0.03 0.27 ± 0.08 0.47 ± 0.10 0.04 ± 0.01 0.05 ± 0.02 
 
Note. Values represent mean absolute cell numbers (x 106) for each group ± SE. n=5 for all exposure groups.   
 
 
Table 16.  Time Course of CD86 Expression on B Cells in Mice Concurrently Exposed to Latex and Glutaraldehyde 
 
B220+CD86+ Day of Sacrifice 
Exposure Group 2 4 6 8 15 22 29 
        
Vehicle N.D.ψ 0.02 ± 0.01 0.04 ± 0.01 0.09 ± 0.02 0.07 ± 0.01 0.03 ± 0.01 0.00 ± 0.01 
Glut 0.75ppm 0.00 ± 0.01 0.02 ± 0.01 0.01 ± 0.01 0.13 ± 0.03 0.10 ± 0.01     0.16 ± 0.05** 0.01 ± 0.02 
25 µg NAL  N.D. ψ 0.01 ± 0.01 0.02 ± 0.01 0.09 ± 0.01 0.10 ± 0.02 0.02 ± 0.01 0.02 ± 0.01 
Glut 0.75ppm/NAL 0.00 ± 0.01 0.03 ± 0.02 0.02 ± 0.01 0.13 ± 0.03 0.08 ± 0.01 0.03 ± 0.01 0.01 ± 0.01 
Glut 1ppm/NAL N.D. ψ 0.02 ± 0.01 0.01 ± 0.01 0.08 ± 0.02 0.09 ± 0.02 0.02 ± 0.00 0.01 ± 0.01 
 
Note. Values represent mean absolute cell numbers (x 106) for each group ± SE. n=5 for all exposure groups.   
ψ represents that levels of cells were non-detectable 
Statistical significance was determined using a Dunnett’s t test. ** represents p<0.01 when 
compared to mice exposed to NAL alone.  
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Table 17.  Time Course of CD40 Expressing B Cells in the DLN of Mice Concurrently Exposed to Latex and Glutaraldehyde 
 
B220+CD40+ Day of Sacrifice 
Exposure Group 2 4 6 8 15 22 29 
        
Vehicle 0.85 ± 0.16 0.79 ± 0.16 1.23 ± 0.08 1.46 ± 0.17 1.89 ± 0.30 0.78 ± 0.07 0.64 ± 0.08 
Glut 0.75ppm 1.03 ± 0.16 0.59 ± 0.11 1.05 ± 0.19 2.49 ± 0.38 1.99 ± 0.05 1.32 ± 0.17 1.19 ± 0.25 
25 µg NAL  0.81 ± 0.15 0.67 ± 0.08 0.94 ± 0.16 1.67 ± 0.31 2.46 ± 0.30 0.98 ± 0.12 0.68 ± 0.12 
Glut 0.75ppm/NAL 0.93 ± 0.21 0.95 ± 0.19 0.89 ± 0.08 2.55 ± 0.41 2.02 ± 0.32 1.01 ± 0.15 0.82 ± 0.14 
Glut 1ppm/NAL 0.83 ± 0.16 0.84 ± 0.16 0.90 ± 0.24 1.58 ± 0.42 2.06 ± 0.26 0.95 ± 0.12 0.67 ± 0.12 
 
Note. Values represent mean absolute cell numbers (x 106) for each group ± SE. n=5 for all exposure groups.   
 
 
Table 18.  Time Course of CD4+ T Cells in the DLN of Mice Concurrently Exposed to Latex and Glutaraldehyde.   
CD4+ Day of Sacrifice 
Exposure Group 2 4 6 8 15 22 29 
        
Vehicle 4.58 ± 0.74 4.72 ± 0.48 7.08 ± 0.62 4.64 ± 0.42 4.39 ± 0.74 5.26 ± 0.36 3.91 ± 0.05 
Glut 0.75ppm 5.09 ± 0.48 4.22 ± 0.71 5.85 ± 1.01 6.65 ± 0.64 4.68 ± 0.23 4.77 ± 0.64 5.98 ± 0.72 
25 µg NAL  4.27 ± 0.35 5.14 ± 0.40 5.60 ± 0.55 4.57 ± 0.40 5.18 ± 0.60 5.29 ± 0.57 5.00 ± 0.63 
Glut 0.75ppm/NAL 5.86 ± 0.59 5.16 ± 0.68 5.38 ± 0.35 5.99 ± 0.68 4.30 ± 0.47 4.43 ± 0.37 5.08 ± 0.62 
Glut 1ppm/NAL 4.31 ± 0.20 4.51 ± 0.75 4.92 ± 0.57 5.22 ± 0.91 4.47 ± 0.54 5.16 ± 0.81 4.56 ± 0.18 
 
 Note. Values represent mean absolute cell numbers (x 106) for each group ± SE. n=5 for all exposure groups.   
 
 140
Table 19.  Time Course of CD28+ Expressing CD4+ T Cells in Mice Concurrently Exposed to Latex and Glutaraldehyde   
CD4+CD28+ Day of Sacrifice 
Exposure Group 2 4 6 8 15 22 29 
        
Vehicle 4.34 ± 0.42 4.20 ± 0.44 6.45 ± 0.59 4.34 ± 0.42 4.26 ± 0.72 4.95 ± 0.42 3.75 ± 0.49 
Glut 0.75ppm 6.23 ± 0.55 3.85 ± 0.68 5.22 ± 0.88 6.23 ± 0.55 4.57 ± 0.24 4.72 ± 0.52 5.78 ± 0.71 
25 µg NAL  4.36 ± 0.37 4.56 ± 0.34 5.04 ± 0.53 4.36 ± 0.37 4.99 ± 0.59 4.97 ± 0.49 4.77 ± 0.53 
Glut 0.75ppm/NAL 5.68 ± 0.64 4.70 ± 0.62 4.87 ± 0.32 5.68 ± 0.64 4.21 ± 0.45 4.25 ± 0.39 4.76 ± 0.63 
Glut 1ppm/NAL 4.97 ± 0.86 4.08 ± 0.72 4.55 ± 0.59 4.97 ± 0.86  4.39 ± 0.53 5.05 ± 0.83 4.31 ± 0.15 
 
 Note. Values represent mean absolute cell numbers (x 106) for each group ± SE. n=5 for all exposure groups.   
 
Table 20.  Time Course of DLN Cells Expressing MHC Class II in Mice Concurrently Exposed to Latex and Glutaraldehyde.   
MHC Class II+ Day of Sacrifice 
Exposure Group 2 4 6 8 15 22 29 
        
Vehicle 1.99 ± 0.30 1.63 ± 0.23 2.64 ± 0.20 1.44 ± 0.11 2.12 ± 0.38 1.31 ± 0.08 1.53 ± 0.19 
Glut 0.75ppm 2.59 ± 0.39 1.47 ± 0.24 2.44 ± 0.43 2.39 ± 0.28 2.25 ± 0.05 1.83 ± 0.18 2.62 ± 0.30 
25 µg NAL  1.86 ± 0.19 1.64 ± 0.22 1.98 ± 0.25 1.60 ± 0.15 2.83 ± 0.34 1.74 ± 0.21 1.72 ± 0.25 
Glut 0.75ppm/NAL 2.49 ± 0.32 2.05 ± 0.41 2.14 ± 0.12 1.94 ± 0.20 2.17 ± 0.30 1.80 ± 0.19 2.13 ± 0.31 
Glut 1ppm/NAL 1.97 ± 0.21 1.94 ± 0.36 2.17 ± 0.56 1.29 ± 0.26 2.19 ± 0.27 1.91 ± 0.29 1.71 ± 0.29 
 
 Note. Values represent mean absolute cell numbers (x 106) for each group ± SE. n=5 for all exposure groups. 
  
 141
  
 
DISCUSSION 
 
In the health care environment there are many factors which affect the 
development of an IgE mediated hypersensitivity response to latex proteins including the 
length of exposure, route of exposure, and other chemicals or contaminants encountered 
within the health care environment that may modulate the immune response.  
Understanding the role of these factors in the development of adverse reactions to latex 
proteins will allow the development of more effective intervention strategies. 
 
Due to ethical limitations and regulations on conducting research with human 
subjects, numerous animal models have been used to investigate the development of IgE 
mediated hypersensitivity.  The murine model has been extensively used in the evaluation 
of IgE mediated hypersensitivity responses following both chemical (Dearman et al., 
1996; Dearman et al., 1998) and allergen exposure (Spergel et al., 1998; Thakker et al., 
1999; Woolhiser et al., 2000; Nelde et al., 2001).  Current studies utilized the BALB/c 
strain of mouse due to its predominant Th2 phenotype and high IgE production following 
allergen exposure (Hilton et al., 1994; Kurup et al., 1994; Saloga et al., 1994; Robinson 
et al., 1996).  Studies using the BALB/c strain to understand the development of latex 
allergy have demonstrated increased latex specific IgE, non-specific and latex specific 
airway hyper-reactivity, eosinophilia in the lungs, and cellular infiltration in the lung 
upon exposure to latex proteins (Kurup et al., 1994; Thakker et al., 1999; Woolhiser et 
al., 2000). 
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While studies have demonstrated the development of a latex specific IgE response 
following intranasal (Kurup et al., 1994; Thakker et al., 1999), dermal, intratracheal, and 
subcutaneous (Woolhiser et al., 2000) exposures; the use of different exposure routes and 
dosing regimens has not allowed for comparison of the timing or intensity of the response 
between the exposure routes.  The present studies were designed to address this issue by 
comparing the rates of induction following dermal, intranasal, intratracheal, or 
subcutaneous exposure to latex proteins using a uniform dosing regimen.  Current studies 
demonstrated that exposure to latex proteins via intratracheal aspiration or dermal 
application induces similar levels of latex specific IgE.  In a recent study evaluating the 
induction of IgE mediated hypersensitivity to low molecular weight chemicals, Warbrick 
et al. (Warbrick et al., 2002) demonstrated similar trimellitic anhydride specific IgE 
following either inhalation or dermal exposure.  While intratracheal and dermal exposure 
resulted in similar levels of latex specific IgE in our studies, mice subcutaneously 
exposed to latex proteins demonstrated higher elevations in total and latex specific IgE at 
an earlier time point in the study as compared to mice dermally or intratracheally 
exposed.  In contrast, mice intranasally exposed to latex proteins failed to demonstrate 
significantly increased levels of IgE when compared to the other exposure routes.   
 
These studies demonstrate the importance of bioavailability in the induction of the 
response as the level of total serum IgE and the timing required for induction correlate 
with the bioavailability by each route of exposure.  It is presumed that 100% of an 
applied dose is bio-available following subcutaneous administration and therefore may 
explain the higher levels and shorter time frame of development in subcutaneously 
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sensitized mice.  In contrast, it has been shown that bioavailability following dermal 
exposure is largely dependent on the condition of the skin.  Recent studies using hairless 
guinea pigs have demonstrated that approximately 30 – 50% of the applied dose of latex 
proteins penetrates into or through the skin following dermal application to disrupted skin 
(Hayes et al., 2000; Howell et al., 2002a).  Following intratracheal aspiration it has been 
shown that greater than 75% of the applied intratracheal dose reaches the lungs and is 
therefore available for induction of an immune response (Ann Hubbs, personal 
communication).  Using an Evan’s blue solution, it was demonstrated that a large portion 
of the intranasally applied dosing solution reaches the stomach resulting in less of a 
respiratory tract exposure.  In addition to less respiratory exposure, studies have 
demonstrated the potential for latex desensitization following oral administration of latex 
proteins, which may explain the lower levels of IgE in intranasally exposed animals (Toci 
et al., 2002).  In addition to bio-availability, differences in the antigen presenting cells – 
Langerhans’ cells in the skin, dendritic cells and macrophages in the lung – and the 
cytokine microenvironment at the site of administration may contribute to differences in 
the degree of the IgE response following different routes of exposure (Knop and Enk, 
1995).   
 
The route of exposure was determined to not only influence the intensity of the 
IgE response, but also influence the class of antibody produced.  Latex specific IgE was 
induced following all routes of exposure.  Whereas no significant elevations were 
observed in the levels of IgG2a or IgA in mice dermally exposed to latex proteins; 
respiratory tract exposure via the intranasal or intratracheal routes resulted in increased 
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levels of serum IgG2a and IgA.  While the induction of IgG2a is not associated with any 
one particular site of exposure, IgA is the major immunoglobulin molecule produced at 
mucosal sites.  IgA antibodies may potentially bind antigen at the mucosal surface and 
thereby inhibit further development of an IgE mediated hypersensitivity response (Frazer 
and Capra, 1999).  In the current studies, mice intranasally exposed to latex exhibited 
significant increases in the levels of latex specific IgA which may contribute to the lower 
IgE response observed in comparison to mice exposed via the dermal and intratracheal 
routes.   
 
Airway hyper-reactivity is a hallmark of an IgE mediated pulmonary response and 
therefore, both invasive and non-invasive methods have been developed to evaluate 
airway hyper-reactivity in sensitized mice following non-specific (cholinergic) and 
antigen specific challenges.  Invasive measurements of airway hyper-reactivity require 
the intratracheal cannulation of mice to measure pulmonary changes. Upon cannulation, a 
tube is inserted in to the esophagus and connected to a transducer to measure pleural 
pressure.  This setup allows for the measurement of the pressure and volume for each 
breath.  These measurements are then used to calculate the compliance, resistance, 
respiration frequency, and tidal volume (Drazen et al., 1999; Thakker et al., 1999).  
While effective in evaluating airway hyper-reactivity; the invasive measurement of 
pulmonary function by intratracheal cannulation is limited by the need for anesthesia and 
the necessity of sacrificing the animals upon completion of the measurements.  This 
terminal act prevents the evaluation of airway hyper-reactivity over a time course and 
does not allow for the evaluation of both non-specific and specific airway hyper-
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reactivity in the same animals.  Whole body plethysmography has the advantage of being 
non-invasive and therefore allowing for repeated evaluation of airway hyper-reactivity in 
exposed animals.  Whole body plethysmograph chambers consist of an upper, reference 
chamber and a lower, animal chamber.  During inspiration, air is warmed as it enters the 
trachea and lungs; heated air expands and the resulting increase in pressure due to volume 
expansion is reflected in a pressure change within the chamber. Each breath results in a 
change in pressure in the animal chamber as compared to the reference chamber and is 
detected via a transducer.  The frequency, magnitude and timing of pressure changes are 
measured and used to determine such parameters as breathing frequency, tidal volume, 
peak expiratory flow, peak inspiratory flow, relaxation time, flow rates or relaxation 
times.  Using these parameters, enhanced pause (PenH) is calculated as an indicator of 
bronchoconstriction (Hamelmann et al., 1997; Drazen et al., 1999).   
 
These studies used whole body plethysmography to measure both non-specific 
and specific airway hyper-reactivity in mice exposed to latex proteins by different routes.  
Mice dermally exposed to latex proteins in current studies demonstrated an increase in 
both non-specific and antigen specific airway hyper-reactivity upon respiratory challenge 
with methacholine and latex proteins, respectively.  While similar elevations in latex 
specific airway hyper-reactivity have been previously observed (Woolhiser et al., 2000), 
this is the first reported observation of increased non-specific airway hyper-reactivity 
following dermal sensitization to latex proteins.   
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Mice intratracheally exposed in the current studies demonstrated increased non-
specific airway hyper-reactivity upon methacholine challenge, but failed to exhibit 
increased airway hyper-reactivity upon respiratory challenge with latex proteins.  The 
lack of significance is potentially due to elevated levels of airway hyper-reactivity in 
vehicle-exposed mice.  Upon comparison with mice dermally and intranasally exposed to 
the vehicle, levels of latex specific airway hyper-reactivity in intratracheally exposed 
vehicle mice were approximately 7 fold higher.  Upon comparison with control animals 
from the study evaluating intratracheal exposure to endotoxin with latex, mice 
intratracheally exposed to the vehicle (PBS) demonstrated comparable levels of airway 
hyper-reactivity and baseline levels of alveolitis.   It is speculated that the infiltration of 
macrophages and neutrophils following i.t. administration of PBS contributed to the 
increased baseline levels of airway hyper-reactivity following latex specific challenge.  
Contrary to the latex specific airway hyper-reactivity response observed in these studies, 
Woolhiser et al. (Woolhiser et al., 2000) demonstrated elevated levels of airway hyper-
reactivity in mice intratracheally exposed to latex proteins.  Mice in the Woolhiser study 
and the current study were exposed using similar dosing regimens and exhibited similar 
levels of total serum IgE, however, different sources of latex proteins were used for 
subsequent respiratory challenge.  While Woolhiser et al. (Woolhiser et al., 2000) used 
proteins which had been prepared from a glycerol free non-ammoniated latex extract, 
proteins used in the current studies were precipitated from a non-ammoniated latex 
extract prepared in Goodyear preservative which contains glycerol.  Glycerol is known to 
irritate the mucosa areas (Material Safety and Data Sheet) and, although precipitated, 
small amounts may remain in the dosing solution which could potentially irritate the 
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respiratory tract and alter the pulmonary response to latex proteins.  It is speculated that 
this may have been partially responsible for the differences in latex specific airway 
hyper-reactivity between mice in the current study and those in the study by Woolhiser et 
al. (Woolhiser et al., 2000). 
  
Mice intranasally exposed in the current studies failed to exhibit an elevation in 
either non-specific or latex specific airway hyper-reactivity.  Contrary to the response 
observed in these studies, Thakker et al. (Thakker et al., 1999) demonstrated an increase 
in both non-specific and latex specific airway hyper-reactivity in mice intranasally 
sensitized with latex proteins.  The difference in airway hyper-reactivity may be 
explained in part by the 25-fold higher levels of total serum IgE in intranasally sensitized 
mice in the study reported by Thakker et al..  Additionally, several other differences in 
the study designs may account for the differences in airway hyper-reactivity.  Different 
exposure regimens were used between the two studies and may play a role in the degree 
of latex sensitization.  While mice in the current studies were exposed to up to 25 µg of 
latex proteins and challenged via the respiratory tract with either methacholine or latex 
proteins; Thakker et al. intranasally exposed mice to 30 µg of latex proteins and 
subsequently challenged sensitized mice with either an intraperitoneal injection of 
methacholine or intravenous injection of latex.   
 
These studies have demonstrated the important contribution of both dermal and 
respiratory exposure in the development of latex allergy.  Subsequent studies evaluated 
the effect of concurrent respiratory exposure to endotoxin with latex or dermal exposure 
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to glutaraldehyde with latex on the development of IgE mediated response to latex 
proteins.   
 
Endotoxin is ubiquitous in nature and exposure has been shown to induce 
irritation, fever, rhinoconjunctivitis, and asthma (Morrison and Ryan, 1979; Lantz et al., 
1985; Rylander and Beijer, 1987; Michel et al., 1991; Sandstrom et al., 1992; Sandstrom 
et al., 1994; Milton et al., 1995; Lefort et al., 1998).  Many of these same symptoms have 
also been reported in individuals exposed to natural rubber latex products (Meding and 
Fregert, 1984; Tomazic et al., 1992; Weytjens et al., 1999; Tarlo, 2001).  Due to the 
overlapping symptomology, it has been speculated that many of the symptoms attributed 
to latex exposure are actually due to endotoxin found within latex gloves (Williams and 
Halsey, 1997).  Our studies investigated both the effect of endotoxin on the development 
of latex specific IgE and the inflammatory effect of endotoxin on the development of 
airway hyper-reactivity. 
  
 Conflicting studies have been published reporting both the ability of endotoxin to 
enhance (Mizoguchi et al., 1986) or inhibit (Gerhold et al., 2002) the development of an 
IgE mediated response to allergens.  The effect of endotoxin on the development of an 
IgE mediated hypersensitivity response has been shown to be dependent on a number of 
factors including route of exposure, timing of endotoxin administration in relation to 
allergen exposure, and quantity of allergen or endotoxin exposure.  Whereas Mizoguchi 
et al. (Mizoguchi et al., 1986) observed augmented allergen specific serum IgE levels in 
mice exposed via aerosolization of LPS and ovalbumin simultaneously, Gerhold et al. 
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(Gerhold et al., 2002) observed a down-regulation of the IgE response when mice were 
pre-exposed systemically to LPS prior to intraperitoneal ovalbumin exposure.  In 
comparing the designs of these studies (Mizoguchi et al. vs Gerhold et al.), additional 
differences identified were: 1) different concentrations of ovalbumin (50 mg vs. 20 µg), 
2) different routes of exposure (aerosol vs. i.p. injection), 3) different concentration of 
LPS (1 mg in aerosol vs. 0.5 mg/kg injections), 4) different strains of mice (SMA, 
C57BL/6, and CBA vs. BALB/c), and 5) different bacterial strains of endotoxin (E. coli 
055:B5 vs. E. coli 0111:B4).  For these studies, concurrent exposure to endotoxin with 
latex was carried out in female BALB/c due to their predominantly Th2 phenotype and 
the historical use of this strain in evaluating the development of an IgE mediated 
hypersensitivity response to allergen.  Glove powder has been shown to be contaminated 
with endotoxin and has also been shown to serve as a carrier molecule for latex (Tomazic 
et al., 1994; Sussman and Beezhold, 1995).  Upon donning and removing powdered latex 
gloves, HCW are potentially exposed to both endotoxin and latex via inhalation.  Mice in 
these studies were concurrently exposed to endotoxin with latex via the respiratory tract 
to mimic the possible occupational exposure from NRL gloves.  Additionally, endotoxin 
differs between bacterial strains due to differences in the makeup of LPS.  Multiple 
bacterial strains of endotoxin (E. coli 0111:B4, S. typhimurium, S. typhosa) were used in 
these studies to compare the different immunomodulatory activities for each strain.   
  
 Upon concurrent intranasal administration of 10 µg of endotoxin from 
Escherichia coli serotype 0111:B4 and 10 µg of rHev b 5, Slater et al. (Slater et al., 
1998) demonstrated elevated levels of rHev b 5 specific IgE, IgG1, and IgG2a.  In 
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contrast, concurrent exposure to NAL and endotoxin by the intranasal or intratracheal 
routes in current studies down regulated the latex specific serum IgE response.  Whereas 
cellular infiltration in the lungs was not observed on either day 51 or 73 in mice exposed 
to rHev b 5 (Slater et al., 1998), mice exposed to 5,000 EU of endotoxin alone (5 µg) or 
NAL alone exhibited peribronchial and perivascular alveolitis, characterized by 
macrophage and neutrophil infiltration, which increased in severity in mice concurrently 
exposed to latex and increasing concentrations of endotoxin in our studies.  Using Alcian 
blue and periodic acid Schiff staining, no mucin production was observed in mice 
exposed to Hev b 5 alone (Slater et al., 1998), however, using the same histological stain, 
mice exposed to NAL alone in the current studies demonstrated an increase in mucin 
production, as compared to vehicle controls, which was reduced by co-exposure with 
endotoxin.  There are several possible explanations for the differing allergen specific 
serum IgE responses observed in our studies and those observed by Slater et al. (Slater et 
al., 1998).  In the previously reported study, mice were intranasally exposed every other 
day for 10 days (6 doses), rested for 6 weeks, and then exposed 3 more times on alternate 
days.  In our studies mice were either intranasally exposed 5 days a week for up to 10 
weeks, or intratracheally exposed every 5th day (Mon – Fri – Wed) for up to 11 weeks.  
Hev b 5 is a single potent latex allergen with 6 IgE binding epitopes (Beezhold et al., 
1999), whereas non-ammoniated latex is an extract of greater than 100 proteins (Figure 
3A).  To date 11 allergens have been identified and characterized from latex extracts, 
however numerous other proteins have been shown to be immunogenic and the relative 
allergenicity of NAL is not known (Czuppon et al., 1993).  Therefore exposure to 10 µg 
of Hev b 5 may pose a more potent allergenic exposure than 25 µg of NAL proteins.  
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Additionally, Slater et al. (Slater et al., 1998) evaluated the histopathology in mice 2 
weeks following the final endotoxin exposure, whereas mice in these studies were 
sacrificed 24 hours following NAL respiratory challenge (6 days following the final 
endotoxin exposure).  A recent study by Yanagihara et al. (Yanagihara et al., 2001) 
demonstrated peak mucin production in the lungs 4 days following endotoxin challenge 
and resolution by day 7.  Therefore the differences in mucin staining between these 
studies may be accounted for by the time of histopathological evaluation post final 
exposure.   
 
 Increases in serum IgE levels are often attributed to increases in IL-4 production 
as it has been shown that Th2 cytokines drive the development of an IgE mediated 
hypersensitivity response.  Following repeated intranasal exposure to 30 µg of latex 
proteins, Kurup et al. (Kurup et al., 1994) demonstrated elevated IL-4 and IL-5 mRNA 
levels in the spleens of mice which correlated with an increase in latex specific serum IgE 
in the same animals.  In the current study, no significant alteration in IL-4, IL-10, IL-12 
or IFN-γ message was observed in the mediastinal lymph nodes (the lymphatic tissue 
draining the site of exposure) of mice intracheally exposed to latex alone.  Mice 
intratracheally exposed to endotoxin with latex demonstrated elevated levels of IFN-γ and 
IL-12 message which corresponded with increased levels of IgG2a and IgA and an 
increase in the severity of macrophage and neutrophil infiltration in the lungs.  Previous 
literature has described the down regulatory role of IFN-γ and IL-12 in the development 
of IgE (Snapper and Paul, 1987; Morris et al., 1994; Metzger et al., 1996; Schwarze et 
al., 1998a).  IL-12 produced by macrophages indirectly down regulates the IgE response 
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by inducing IFN-γ production by natural killer cells and T cells (Morris et al., 1994; 
Metzger et al., 1996) and this up-regulation of IFN-γ acts directly by inhibiting germ-line 
ε chain transcription and inducing a class switch to IgG2a (Berton et al., 1989).  In our 
studies, mice intratracheally exposed to endotoxin with latex demonstrated increased 
levels of latex specific serum IgG2a and increased IFN-γ and IL-12 mRNA levels as 
early as day 16.  This suggests a strong relationship between the induction of a Th1 
cytokine response following endotoxin exposure and the subsequent down regulation of 
the latex specific IgE response.   
 
Upon subsequent latex specific pulmonary challenge, animals sensitized by i.t. 
exposure to NAL alone demonstrated an increase in airway hyper-reactivity.  However, 
as compared to animals sensitized to latex alone, decreased airway hyper-reactivity was 
observed in animals which had been previously sensitized by concurrent exposure to 
NAL with endotoxin.  In addition to down-regulating the allergen specific IgE response, 
IFN-γ and IL-12 have been shown to inhibit the development of allergen specific airway 
hyper-reactivity (Gavett et al., 1995; Huang et al., 2001; Tang et al., 2001).  In a study by 
Huang et al. (Huang et al., 1999), Brown Norway rats treated with exogenous IFN-γ prior 
to ovalbumin sensitization demonstrated a significant reduction in airway hyper-
reactivity with decreases in IL-4, IL-5 and IL-10 mRNA levels upon aerosol challenge 
with ovalbumin.  Schwarze et al. (Schwarze et al., 1998b) demonstrated that local 
administration of IL-12 reduces the airway hyper-reactivity response and Th2 cytokine 
production (IL-4, IL-5) in previously ovalbumin sensitized mice.  Gerhold et al. (Gerhold 
et al., 2002) observed a decrease in ovalbumin specific airway hyper-reactivity upon 
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sensitization with ovalbumin and endotoxin which could be reversed upon administration 
of a neutralizing IL-12 antibody.  Mice concurrently exposed to latex and increasing 
concentrations of endotoxin in these studies demonstrated decreased airway hyper-
reactivity responses which coincided with increases in both IL-12 and IFN-γ mRNA 
levels, as well as IgG2a and IgA antibody levels.  The increased levels of IgA may also 
play a modulatory role in the decreased airway hyper-reactivity as was previously 
discussed that antigen specific IgA has been shown to down-regulate the antigen specific 
airway response upon subsequent respiratory challenge (Schwarze et al., 1998a).  
 
 Unlike allergen specific airway hyper-reactivity, non-specific airway hyper-
reactivity can occur in both sensitized and non-sensitized individuals.  Following chronic 
exposure to endotoxin, Vernooy et al. (Vernooy et al., 2002) demonstrated the 
development of chronic lung inflammation with increased numbers of macrophages and 
lymphocytes to the peribronchial regions of the lung.  Lung inflammation has been 
proposed to play a role in the development of non-specific airway hyper-reactivity.  
Macrophages recruited to the site of exposure have been shown to release excessive 
amounts of nitric oxide (NO) upon chronic exposure to endotoxin.  While nitric oxide is 
traditionally thought to trigger bronchodilation, excessive NO production reacts with 
superoxide anions forming peroxynitrite which induces contraction of the smooth muscle 
resulting in bronchoconstriction (Toward and Broadley, 2001).  Additionally, Lefort et al. 
(Lefort et al., 2001) demonstrated a positive relationship between non-specific airway 
hyper-reactivity to methacholine and the influx of neutrophils into the lungs following 
endotoxin exposure.  In our studies, mice concurrently exposed to 5,000 EU of endotoxin 
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and latex exhibited increased levels of non-specific airway hyper-reactivity which 
correlated with an increase in the mixed cellular alveolitis (i.e. macrophages and 
neutrophils).  
 
Glutaraldehyde was chosen for the evaluation of its modulatory effects on the 
development of latex allergy following dermal exposure due to its extensive use in the 
health care environment.  While the allergic potential of glutaraldehyde is well 
documented, the potential immunodulatory role of glutaraldehyde in the development of 
latex allergy has not been previously investigated.  While no significant modulation of 
latex specific IgE was observed upon co-exposure to concentrations of glutaraldehyde 
surrounding those used in cold sterilant solutions (0.1 – 1%), an augmented total and 
latex specific IgE response was observed in mice concurrently exposed to latex and 
concentrations of glutaraldehyde surrounding the aerosol permissible exposure limit (0.05 
– 0.75ppm).  Mice concurrently exposed to latex and 1ppm of glutaraldehyde did not 
demonstrate elevations in total serum or latex specific IgE.  This trend was reproduced in 
subsequent studies which verified the dose responsive augmentation of the IgE response 
in animals exposed to latex and concentrations of glutaraldehyde up to 0.75ppm and a 
lack of a response in animals exposed concurrently to latex and 1ppm of glutaraldehyde.   
 
Studies have demonstrated the adjuvancy of particulates and proteolytically active 
allergens in the development of an IgE mediated hypersensitivity response.  Numerous 
studies with diesel exhaust particles (DEP) have demonstrated an augmentation of the 
development of an IgE mediated hypersensitivity response upon concurrent exposure 
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with allergen (Suzuki et al., 1996; Lovik et al., 1997; Miyabara et al., 1998; Wang et al., 
1999; Heo et al., 2001).  A study by Heo et al. (Heo et al., 2001) demonstrated that 
intraperitoneal injection of DEP and ovalbumin on the same day resulted in the 
augmentation of ovalbumin specific IgE levels 56 days following initial exposure.  It was 
further shown that altering the administration of DEP either one day before or after 
administration of ovalbumin diminished the immunomodulatory effect.  In a separate 
study, concurrent intranasal exposure of mice to DEP and dust mite allergen weekly for 
at least 3 weeks, was shown to augment the development of dust mite specific IgE and 
IgG1 (Suzuki et al., 1996).  Upon analysis of other immunologically active agents, co-
injection of mice with polystyrene particles was shown to augment the development of 
ovalbumin specific IgE responses (Granum et al., 2001); and increased levels of 
ovalbumin specific IgE have been observed upon co-injection with OVA and a 
proteolytically active dust mite allergen (Gough et al., 2001).  While the mechanism 
behind the augmentation is not understood, it was speculated in each of these previous 
studies that the agent acted to “prime” the cellular response for allergen exposure.  It was 
speculated that the immunological activity induced by glutaraldehyde exposure would 
also stimulate the induction of latex specific IgE upon concurrent exposure to latex 
proteins.   
 
Given the irritant nature of glutaraldehyde, one hypothesized mechanism of its 
role in the augmentation of the IgE response to latex was disruption of the stratum 
corneum.  It has previously been shown that disruption of the skin barrier allows 
enhanced penetration of latex proteins into and through the skin with the potential of 
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reaching the systemic circulation (Hayes et al., 2000) and inducing an IgE response in a 
shorter time period than is required when exposure is to intact skin (Woolhiser et al., 
2000).  In an initial study, in vitro percutaneous penetration of latex proteins was 
evaluated using skin from hairless guinea pigs which were exposed to glutaraldehyde for 
up to 56 days.  The determination for the 56 day time point was due to the observed 
elevation in serum IgE levels in mice concurrently exposed to latex and 0.75ppm 
glutaraldehyde on day 51.  These studies demonstrated no significant alterations in 
hairless guinea pig skin permeability following exposure to either 0.75 or 1ppm of 
glutaraldehyde for up to 56 days.  Although the hairless guinea pig model has been 
shown to be a good surrogate for human tissue in evaluating latex penetration (Hayes et 
al., 2000), studies have not been conducted comparing the penetration of latex proteins 
through the skin of the hairless guinea pig and mouse.  At the European Centre for the 
Validation of Alternative Methods Workshop in 1996, skin sources for in vitro 
percutaneous penetration experiments were ranked based on their relevance to human 
physiology.  While guinea pigs are thought to be a good model for human exposure, 
proteins penetrate more readily through mouse skin due to physiological differences in 
the skin (Howes et al., 1996).  Therefore, to confirm that the elevated IgE levels in mice 
concurrently exposed to latex and 0.75ppm was not due to alterations in barrier function, 
a second study was conducted to evaluate the effects of glutaraldehyde on the 
percutaneous penetration in mice.  At the time of sacrifice, following 86 days of exposure 
when mice were shown to exhibit increased levels of total and latex specific IgE (Figure 
33), skin from the dorsal thorax of mice concurrently exposed to latex and glutaraldehyde 
was subjected to a barrier integrity test.  Bronaugh and Collier (Bronaugh and Collier, 
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1991) previously determined, based on penetration, water partition coefficients and skin 
permeability constants, that skin samples permitting greater than 0.35% 3H2O penetration 
demonstrated sufficient disruption of the barrier function to be considered abraded.  
Although exposure to latex and increasing concentrations of glutaraldehyde sufficiently 
disrupted the barrier integrity to allow up to 1% 3H2O penetration, the amount of 
permeability required to allow significant latex penetration is unknown in mice.  Studies 
conducted by Hayes et al. (Hayes et al., 2000) using a hairless guinea pig model, have 
demonstrated, however, that significant penetration of latex proteins did not occur unless 
skin was abraded to the point that 8% 3H2O penetrated through the skin.   
 
 Glutaraldehyde exposure did not induce significant perturbations in the stratum 
corneum; however other immunological factors within the epidermis may contribute to 
the elevation in total serum IgE levels observed in mice concurrently exposed to latex and 
glutaraldehyde.  Several studies have demonstrated an up-regulation in MHC class II 
expression on Langerhans’ cells during the induction of a contact hypersensitivity 
response.  While studies have not investigated the relationship between MHC class II 
expression on antigen presenting cells and the initiation of IgE mediated responses; it is 
speculated that the mechanism of antigen up-take and presentation is similar to that of 
contact hypersensitivity.  Cumberbatch et al. (Cumberbatch et al., 1992) demonstrated an 
increase in Langerhans’ cell number, as evidenced by an increase in MHC class II 
expressing cells in the epidermal sheets of mice exposed to the contact sensitizer, 1-
chloro-2, 4-dinitrobenzene (DNCB).  Becker et al. (Becker et al., 1992) used a polyclonal 
antibody to the MHC class II molecule to demonstrate an increase in Langerhans’ cells in 
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mice exposed to either DNCB, 2,4-dinitroflourobenzene (DNFB), oxazolone, or 
potassium dichromate for 3 hours.  In addition to demonstrating an increase in 
Langerhans’ cell number in the epidermal sheets of mice exposed to DNFB, Tsuruta et al. 
(Tsuruta et al., 1999) also demonstrated an increase in the dendritic processes of 
activated Langerhans cells.  Based on these previous studies, it was hypothesized that 
concurrent exposure to glutaraldehyde with latex would increase the expression of MHC 
class II expression on Langerhans’ cells and would thereby enhance the antigen 
presentation to T cells in the draining lymph node.  Upon comparison with vehicle 
exposed animals, mice concurrently exposed to 0.75ppm glutaraldehyde with latex 
demonstrated a significant (p<0.05) 15-fold increase in Langerhans’ cell number 
following 2 days of exposure on the dorsal surface of the ear.  While not reaching 
statistical significance, increased Langerhans’ cell numbers were observed throughout the 
time course study in mice concurrently exposed to 0.75ppm glutaraldehyde with NAL, 
suggesting a role for increased antigen presenting cell activity in the augmented latex 
specific IgE response.   
 
 Upon activation, Langerhans’ cells migrate to the draining lymph node to interact 
with T cells and initiate an IgE or T cell mediated hypersensitivity response 
(Cumberbatch et al., 2000).  Upon interacting with the antigen presenting cells and to 
facilitate activation, co-stimulatory molecules are up-regulated on T and B cells.  
Following activation, T and B cells differentiate and proliferate.  Phenotypic analysis of 
the draining lymph node cells has been previously shown to be an effective tool in the 
evaluation of the hypersensitivity response following chemical exposure (Sikorski et al., 
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1996; Gerberick et al., 1997; Manetz and Meade, 1999; Howell et al., 2000; Gerberick et 
al., 2002).  It was hypothesized in these studies that concurrent exposure to latex and 
glutaraldehyde would induce the up-regulation of MHC class II expression on dendritic 
cells and B cell co-stimulatory molecules (B7.2, CD40) resulting in increased cellular 
activation and proliferation.  Exposure to glutaraldehyde at concentrations representative 
of those used in cold sterilant solutions has been shown to induce both cellular 
proliferation and a Th2 cytokine profile (Dearman et al., 1999).  Additionally, recent 
studies have suggested divergent hypersensitivity responses following glutaraldehyde 
exposure with higher concentrations inducing an IgE mediated response and lower 
concentrations inducing a T cell mediated response (Azadi et al., 2002).  In comparison 
to vehicle controls, mice concurrently exposed, in these studies, to latex and 0.75ppm of 
glutaraldehyde for 86 days demonstrated increases in B cell proliferation and CD40 
expression whereas no significant increase was observed in animals exposed to 0.75ppm 
glutaraldehyde or NAL alone.  Upon comparison with mice concurrently exposed to latex 
and 0.75ppm of glutaraldehyde, decreased numbers of B cells were observed in mice 
concurrently exposed to latex and 1ppm of glutaraldehyde.  While the exact role of CD40 
in the development of an IgE mediated hypersensitivity response is unknown and under 
investigation, previous studies have demonstrated the requirement for CD40 in the 
development of IgE (Hermes et al., 1997; Jeppson et al., 1998; Lazaar et al., 1998; 
Oettgen, 2000).  In contrast to mice concurrently exposed to 0.75ppm glutaraldehyde 
with latex, mice exposed to 0.75ppm of glutaraldehyde alone demonstrated an increase in 
T cell proliferation and CD28.  CD28 plays a critical role by providing a secondary signal 
for T cell activation.  This dichotomy of cell type and number suggests the ability of co-
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exposure to latex with low concentrations of glutaraldehyde to prime the immune system 
for a B cell response.  No significant elevations in the expression of MHC class II in the 
draining lymph node cells were observed in any of the exposure groups.  Evaluation at 
earlier time points (days 2 – 29) in a time course study demonstrated no significant 
increases in the expression of any of the cell surface markers or co-stimulatory 
molecules.     
  
Upon activation, antigen presenting cells (i.e. Langerhans cells, macrophages, 
dendritic cells), as well as T and B cells, produce and secrete cytokines to direct the 
immune response.  Previous studies have demonstrated the association between chemical 
exposure leading to IgE mediated hypersensitivity response and the production of IL-4 
(Kurup et al., 1994; Thakker et al., 1999; Xia et al., 1999).  Whereas IL-4 is associated 
with increased IgE production, IL-12 and IFN-γ act to down-regulate the IgE response by 
inhibiting IL-4 production (Manetti et al., 1993; Yoshimoto et al., 1998).  Following 
dermal exposure to glutaraldehyde, mice have been shown to demonstrate increased 
levels of both IL-4 and IL-10 protein in the draining lymph node cells (Dearman et al., 
1999).  It was hypothesized in our studies that concurrent exposure to latex and 
glutaraldehyde would up-regulate the messenger RNA levels of IL-4 and IL-10 while 
down-regulating the expression of IL-12 and IFN-γ.   Contrary to our hypothesis, no 
significant alterations in cytokine message levels were observed in the draining lymph 
node cells of mice exposed to latex and glutaraldehyde for 86 days.   
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While it has been predominantly thought that respiratory exposure results in 
pulmonary complications, and that dermal exposure results in cutaneous complications; 
these studies demonstrate that dermal and respiratory exposure to latex proteins result in 
the induction of similar levels of latex specific IgE and lead to increased airway hyper-
reactivity.  Additionally, these studies demonstrated that other agents encountered in the 
health care environment may modulate the development of a latex specific IgE mediated 
hypersensitivity response.  Mice concurrently exposed to latex and increasing 
concentrations of endotoxin demonstrated a reduction in latex specific IgE levels and 
antigen specific airway hyper-reactivity when compared to mice exposed to latex alone.  
It was further determined that while IgE was down-regulated, concurrent exposure to 
endotoxin with latex induced increased levels of IFN-γ and IL-12 mRNA in the draining 
lymph nodes and an immunoglobulin class switch to latex specific IgG2a and IgA 
production.  The large number of macrophages recruited upon repeated exposure to 
endotoxin and latex are speculated to serve as the primary source for IL-12 which 
stimulates IFN-γ production in T cells and NK cells.  The increased inflammatory 
response in the lungs of mice concurrently exposed to endotoxin with latex is thought to 
be responsible for the increase in non-specific airway hyper-reactivity in these groups.   
 
Exposure to glutaraldehyde at concentrations surrounding the PEL was shown to 
augment the IgE response to latex proteins through an as yet undetermined mechanism.  
While latex gloves are extensively used by health care workers as a protective barrier 
against pathogens, studies have shown that glutaraldehyde penetrates through latex 
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gloves within an hour.  These studies raise the concern that co-exposure to glutaraldehyde 
with latex may augment the induction of latex sensitization.   
 
These studies demonstrate the importance of understanding the role of concurrent 
environmental or occupational exposures in the development of IgE responses to 
allergens and clinical observations attributed to allergic diseases.  Understanding the 
mechanism by which mixed exposures modulate the development of allergic responses 
will allow for improved design, development, and implementation of intervention 
strategies. 
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Appendix 1 
 
Composition of One Liter of HEPES Balanced Hanks Salt Solution 
 
Reagent Concentration (mg/L) 
  
Calcium Chloride (CaCl2), Anhydrous 140 
Dextrose 1,000 
HEPES (C8H18N2O4S) 5,960 
Magnesium Sulfate (MgSO4.7H2O) 200 
Potassium Chloride 400 
Potassium Phosphate (KH2PO4), monobasic 60 
Sodium Bicarbonate (NaHCO3) 320 
Sodium Chloride 7,000 
Sodium Phosphate (Na2HPO4), dibasic 50 
Gentamicin sulfate 50 
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Appendix 2: 
Body Weights of Mice Exposed to Latex Proteins 
 
Table A.   
 
Body Weights of Mice Exposed to 50µg of Latex Proteins for 52 Days. 
  
 
 
 
 
 
 
 
 
 
 
Data presented is representative of the initial time course latex study comparing the 
sensitization rates following exposure to latex via different routes.  Values represent the 
exposure group mean body weights (grams) ± SE.  Mice were weighed prior to initial 
exposure (Pre-Exposure) and on day 52.  Statistical significance from vehicle exposed 
animals was calculated using a Dunnett’s t test.   
 
 
Exposure Group Pre-Exposure Day 52 Weight Change 
Naïve 16.9 ± 0.8 19.3 ± 0.5 1.7 ± 0.3 
Vehicle 17.2 ± 0.4 19.1 ± 0.4 1.7 ± 0.1 
Topical 1 17.2 ± 0.4 19.8 ± 0.4 2.7 ± 0.2 
Topical 2 17.4 ± 0.5 19.9 ± 0.6 2.5 ± 0.6 
Subcutaneous 17.0 ± 0.5 19.5 ± 0.6 2.6 ± 0.4 
Intranasal 17.2 ± 0.3 18.7 ± 0.3 1.5 ± 0.3 
Intratracheal 17.2 ± 0.3 18.3 ± 0.2 0.9 ± 0.2 
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Table B.   
 
 
Body Weights in Mice Dermally Exposed to Increasing Concentrations  
of Latex for 93 Days 
 
 
 
 
 
 
 
 
Values represent the group mean weights (grams) ± standard error in mice dermally 
exposed to latex proteins 5 days a week for 93 days.  Mice weights were obtained prior to 
initial exposure and on day 88 of the study.  The weight change was calculated as the 
difference in body weight between pre-exposure and day 88.  Statistical significance from 
vehicle exposed animals was calculated using a Dunnett’s t test.   
 
 
 
 
Table C.   
 
 
Body Weights in Mice Intranasally Exposed to Increasing Concentrations  
of Latex for 51 Days 
 
 
 
 
 
 
 
 
Values represent the group mean weights (grams) ± standard error in mice intranasally 
exposed to latex proteins 5 days a week for 51 days.  Mice weights were obtained prior to 
initial exposure and on day 51 of the study.  The weight change was calculated as the 
difference in body weight between pre-exposure and day 51.  Statistical significance from 
vehicle exposed animals was calculated using a Dunnett’s t test.   
 
 
 
 
Exposure Group Pre-Exposure Day 88 Weight Change 
Vehicle 18.6 ± 0.4 21.7 ± 0.3 3.1 ± 0.2 
6.25 µg NAL 18.7 ± 0.5 21.1 ± 0.4 2.4 ± 0.3 
12.5 µg NAL 18.2 ± 0.3 19.5 ± 0.2 1.5 ± 0.1 
25 µg NAL 18.7 ± 0.6 21.5 ± 0.8 3.0 ± 0.6 
Exposure Group Pre-Exposure Day 51 Weight Change 
Vehicle 18.5 ± 0.6 19.9 ± 0.8 1.4 ± 0.3 
6.25 µg NAL 18.9 ± 0.6 19.9 ± 0.9 1.1 ± 0.5 
12.5 µg NAL 18.3 ± 0.3 19.2 ± 0.4 0.9 ± 0.4 
25 µg NAL 19.0 ± 0.4 20.1 ± 0.6 1.1 ± 0.3 
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Table D.   
 
 
Body Weights in Mice Intratracheally Exposed to Increasing Concentrations  
of Latex for 79 Days 
 
 
 
 
 
 
 
 
Values represent the group mean weights (grams) ± standard error in mice intratracheally 
exposed to latex proteins 5 days a week for 79 days.  Mice weights were obtained prior to 
initial exposure and on day 79 of the study.  The weight change was calculated as the 
difference in body weight between pre-exposure and day 79.  Statistical significance from 
vehicle exposed animals was calculated using a Dunnett’s t test.   
 
 
 
Exposure Group Pre-Exposure Day 79 Weight Change 
Vehicle 18.2 ± 0.5 20.7 ± 0.4 3.0 ± 0.2 
6.25 µg NAL 17.2 ± 0.4 19.8 ± 0.4 2.6 ± 0.2 
12.5 µg NAL 17.8 ± 0.3 20.0 ± 0.7 2.2 ± 0.4 
25 µg NAL 17.5 ± 0.4 19.8 ± 0.4 2.3 ± 0.1 
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Table E.   
 
 
Body Weights in Mice Intranasally Exposed to Latex and 5,000 – 50,000 EU of 
Endotoxin from Salmonella typhimurium. 
 
 
 
 
 
 
 
 
.  
 
 
 
 
 
 
Values represent the group mean weights (grams) ± standard error in mice intranasally 
exposed to latex proteins and increasing concentrations of endotoxin (5,000 – 50,000 EU) 
5 days a week for 72 days.  Mice weights were obtained prior to initial exposure and on 
day 72 of the study.  The weight change was calculated as the difference in body weight 
between pre-exposure and day 72.  Statistical significance from vehicle exposed animals 
was calculated using a Dunnett’s t test.   
 
 
Exposure Group Pre-Exposure Day 72 Weight Change 
Vehicle 18.9 ± 0.3 20.0 ± 0.4 1.1 ± 0.2 
NAL 19.3 ± 0.5 20.3 ± 0.6 1.0 ± 0.2 
    
S. typhimurium    
  50,000 EU   19.3 ± 0.5 20.7 ± 0.5 1.4 ± 0.2 
5,000 EU & NAL 19.4 ± 0.4 20.5 ± 0.5 1.1 ± 0.2 
  12,500 EU & NAL 19.3 ± 0.9 20.7 ± 1.0 1.4 ± 0.3 
25,000 EU & NAL 19.0 ± 0.4 20.0 ± 0.6 1.0 ± 0.3 
37,500 EU & NAL 18.9 ± 0.4 20.2 ± 0.4 1.3 ± 0.2 
50,000 EU & NAL 19.4 ± 0.4 20.6 ± 0.6 1.2 ± 0.3 
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Table F.   
 
 
Body Weights of Mice Intranasally Exposed to Latex and Three Strains  
of Bacterial Endotoxin for 65 Days 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Values represent the group mean weights (grams) ± standard error in mice intranasally 
exposed to latex proteins and increasing concentrations of endotoxin (50 – 25,000 EU) 5 
days a week for 65 days.  Mice weights were obtained prior to initial exposure and on day 
65 of the study.  The weight change was calculated as the difference in body weight 
between pre-exposure and day 65.  Statistical significance from vehicle exposed animals 
was calculated using a Dunnett’s t test.   
Exposure Group Pre-Exposure Day 65 Weight Change 
Vehicle 18.2 ± 0.4 20.2 ± 0.3 2.0 ± 0.1 
NAL 18.1 ± 0.3 20.3 ± 0.4 2.3 ± 0.2 
    
S. typhimurium    
 25000 EU 18.2 ± 0.3 20.5 ± 0.4 2.3 ± 0.2 
50 EU & NAL 17.5 ± 0.4 20.4 ± 0.4 2.6 ± 0.2 
500 EU & NAL 18.2 ± 0.5 21.1 ± 0.5 2.4 ± 0.2 
1,250 EU & NAL 18.1 ± 0.6 20.2 ± 0.8 2.1 ± 0.3 
2,500 EU & NAL 18.6 ± 0.7 20.9 ± 0.4 1.6 ± 0.2 
5,000 EU & NAL 17.7 ± 0.5 19.8 ± 0.2 1.7 ± 0.2 
25,000 EU & NAL 18.5 ± 0.5 20.7 ± 0.7 2.2 ± 0.3 
    
E. coli    
 25000 EU 17.8 ± 0.3 19.8 ± 0.2 2.0 ± 0.1 
50 EU & NAL 18.1 ± 0.5 20.3 ± 0.6 2.2 ± 0.3 
500 EU & NAL 17.3 ± 0.4 19.0 ± 0.7 1.7 ± 0.5 
1,250 EU & NAL 17.6 ± 0.3 19.7 ± 0.4 2.1 ± 0.4 
2,500 EU & NAL 18.0 ± 0.4 19.5 ± 0.3 1.5 ± 0.3 
5,000 EU & NAL 18.6 ± 0.1 20.5 ± 0.3 1.9 ± 0.2 
25,000 EU & NAL 17.7 ± 0.2 19.4 ± 0.2 1.7 ± 0.1 
    
S. typhosa    
 25000 EU 18.4 ± 0.3 20.5 ± 0.3 2.1 ± 0.1 
50 EU & NAL 18.1 ± 0.4 20.4 ± 0.7 2.3 ± 0.2 
500 EU & NAL 17.8 ± 0.4 19.6 ± 0.4 1.9 ± 0.2 
1,250 EU & NAL 17.5 ± 0.6 19.4 ± 0.7 1.9 ± 0.3 
2,500 EU & NAL 18.2 ± 0.3 21.1 ± 0.4 2.6 ± 0.3 
5,000 EU & NAL 18.7 ± 0.3 21.0 ± 0.5 2.0 ± 0.3 
25,000 EU & NAL 17.1 ± 0.3 19.4 ± 0.2 2.3 ± 0.3 
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Table G.   
 
 
Body Weights of Mice Intratracheally Exposed to Latex and Endotoxin for 67 Days 
 
 
 
 
 
 
 
Values represent the group mean weights (grams) ± standard error in mice intranasally 
exposed to latex proteins and increasing concentrations of endotoxin (50 – 5,000 EU) 5 
days a week for 67 days.  Mice weights were obtained prior to initial exposure and on day 
67 of the study.  The weight change was calculated as the difference in body weight 
between pre-exposure and day 67.  Statistical significance from vehicle exposed animals 
was calculated using a Dunnett’s t test.   
 
Exposure Group Pre-Exposure Day 67 Weight Change 
Vehicle 17.7 ± 0.2 18.7 ± 0.5 1.0 ± 0.6 
NAL 17.9 ± 0.5 19.2 ± 0.6 1.4 ± 0.2 
    
S. typhimurium    
     5000 EU   17.6 ± 0.2 20.0 ± 0.5 2.4 ± 0.6 
50 EU & NAL 17.4 ± 0.6 18.0 ± 0.3 0.6 ± 0.4 
  500 EU & NAL 18.0 ± 0.4 21.1 ± 0.3 3.1 ± 0.4 
1,250 EU & NAL 18.1 ± 0.4 20.2 ± 0.5 2.0 ± 0.2 
2,500 EU & NAL 18.0 ± 0.5 20.8 ± 0.5 2.8 ± 0.3 
5,000 EU & NAL 17.8 ± 0.5 18.2 ± 0.2 0.4 ± 0.5 
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Table H.   
 
 
Body Weights in Mice Concurrently Exposed to Latex and Concentrations of 
Glutaraldehyde Found in Cold Sterilant Solutions (0.1 – 1%) 
 
 
 
 
 
 
 
Values represent the group mean weights (grams) ± standard error in mice intranasally 
exposed to latex proteins and increasing concentrations of glutaraldehyde (0.1 – 1%) 5 
days a week for 72 days.  Mice weights were obtained prior to initial exposure and on day 
72 of the study.  The weight change was calculated as the difference in body weight 
between pre-exposure and day 72.  Statistical significance from vehicle exposed animals 
was calculated using a Dunnett’s t test.   
 
Exposure Group Pre-Exposure Day 72  Weight Change 
Vehicle 18.9 ± 0.4 21.1 ± 0.6 2.2 ± 0.3 
NAL 18.9 ± 0.4 21.8 ± 0.2 3.0 ± 0.5  
Glutaraldehyde     
1.0% 19.1 ± 0.6 22.3 ± 0.7 3.2 ± 0.4 
0.1% & NAL 19.0 ± 0.5 21.5 ± 0.4 2.6 ± 0.2 
  0.5% & NAL 19.4 ± 0.5 21.1 ± 0.6 1.7 ± 0.3 
1.0% & NAL 19.0 ± 0.6 21.6 ± 0.3 2.6 ± 0.5 
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Table I.   
 
 
Body Weights in Mice Concurrently Exposed to Latex and Concentrations of 
Glutaraldehyde Surround the Permissible Exposure Limit (0.05 – 1ppm) for 65 Days 
 
 
 
 
 
 
 
 
Values represent the group mean weights (grams) ± standard error in mice intranasally 
exposed to latex proteins and increasing concentrations of glutaraldehyde (0.05 – 1ppm) 
5 days a week for 65 days.  Mice weights were obtained prior to initial exposure and on 
day 65 of the study.  The weight change was calculated as the difference in body weight 
between pre-exposure and day 65.  Statistical significance from vehicle exposed animals 
was calculated using a Dunnett’s t test.   
Exposure Group Pre-Exposure Day 65  Weight Change 
Vehicle 18.9 ± 0.6 19.6 ± 0.7 0.7 ± 0.2 
NAL 19.3 ± 0.3 20.0 ± 0.3 0.7 ± 0.2 
Glutaraldehyde     
0.75ppm 19.0 ± 0.5 19.2 ± 0.3 0.2 ± 0.2 
0.05ppm & NAL 19.2 ± 0.4 19.9 ± 0.4 0.7 ± 0.2 
  0.2ppm & NAL 19.0 ± 0.7  19.9 ± 0.7 0.9 ± 0.2 
0.5ppm & NAL 19.2 ± 0.6 19.7 ± 0.8 0.5 ± 0.2 
0.75ppm & NAL 19.3 ± 0.2 20.2 ± 0.3 1.0 ± 0.2 
1.0ppm & NAL 19.3 ± 0.5 19.9 ± 0.4 0.6 ± 0.2 
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Table J.   
 
 
Body Weights in a Repeat Study with Mice Concurrently Exposed to Latex and 
Concentrations of Glutaraldehyde Surround the Permissible Exposure Limit (0.05 – 
1ppm) for 86 Days 
 
 
 
 
 
 
 
 
Values represent the group mean weights (grams) ± standard error in mice intranasally 
exposed to latex proteins and increasing concentrations of glutaraldehyde (0.05 – 1ppm) 
5 days a week for 86 days.  Mice weights were obtained prior to initial exposure and on 
day 86 of the study.  The weight change was calculated as the difference in body weight 
between pre-exposure and day 86.  Statistical significance from vehicle exposed animals 
was calculated using a Dunnett’s t test.   
 
Exposure Group Pre-Exposure Day 86  Weight Change 
Vehicle 18.0 ± 0.4 21.5 ± 0.4 3.4 ± 0.3 
NAL 19.0 ± 0.5 21.4 ± 0.8 2.4 ± 0.7 
Glutaraldehyde     
0.75ppm 19.2 ± 0.4 22.4 ± 0.2 3.5 ± 0.2 
0.05ppm & NAL 18.1 ± 0.4 21.2 ± 0.5 3.0 ± 0.8 
  0.2ppm & NAL 18.4 ± 0.5 21.2 ± 0.2 2.8 ± 0.4 
0.5ppm & NAL 19.2 ± 0.5 23.8 ± 0.5 4.6 ± 0.2 
0.75ppm & NAL 18.4 ± 0.6 21.8 ± 1.0 3.3 ± 0.4 
1.0ppm & NAL 18.6 ± 0.3 22.7 ± 0.5 4.2 ± 0.4 
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Table K.   
 
 
Body Weights in Mice Concurrently Exposed on the Ear Pinna to Latex and 
Glutaraldehyde for 86 Days 
 
 
 
 
 
 
 
Values represent the group mean weights (grams) ± standard error in mice intranasally 
exposed to latex proteins and either 0.75 or 1ppm glutaraldehyde 5 days a week on the 
dorsal surface of the ear pinna for 86 days.  Mice weights were obtained prior to initial 
exposure and on day 86 of the study.  The weight change was calculated as the difference 
in body weight between pre-exposure and day 86.  Statistical significance from vehicle 
exposed animals was calculated using a Dunnett’s t test.   
Exposure Group Pre-Exposure Day 86  Weight Change 
Vehicle 19.9 ± 0.2 22.0 ± 0.3 2.2 ± 0.3 
NAL 20.3 ± 0.4 22.7 ± 0.5 2.4 ± 0.2 
Glutaraldehyde     
0.75ppm 19.6 ± 0.2 22.4 ± 0.4 2.8 ± 0.2 
0.75ppm & NAL 19.5 ± 0.3 21.7 ± 0.4 2.2 ± 0.3 
1.0ppm & NAL 20.2 ± 0.4 22.6 ± 0.6 2.4 ± 0.4 
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